<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Pathogens</journal-id>
<journal-id journal-id-type="iso-abbrev">Pathogens</journal-id>
<journal-id journal-id-type="publisher-id">pathogens</journal-id>
<journal-title-group>
<journal-title>Pathogens</journal-title>
</journal-title-group>
<issn pub-type="epub">2076-0817</issn>
<publisher>
<publisher-name>MDPI</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31779153</article-id>
<article-id pub-id-type="pmc">6963306</article-id>
<article-id pub-id-type="doi">10.3390/pathogens8040265</article-id>
<article-id pub-id-type="publisher-id">pathogens-08-00265</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The Importance of Vaccinating Children and Pregnant Women against Influenza Virus Infection</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1352-4378</contrib-id>
<name>
<surname>Misra</surname>
<given-names>Ravi S</given-names>
</name>
<xref ref-type="aff" rid="af1-pathogens-08-00265">1</xref>
<xref ref-type="corresp" rid="c1-pathogens-08-00265">*</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-5042-3031</contrib-id>
<name>
<surname>Nayak</surname>
<given-names>Jennifer L</given-names>
</name>
<xref ref-type="aff" rid="af2-pathogens-08-00265">2</xref>
</contrib>
</contrib-group>
<aff id="af1-pathogens-08-00265"><label>1</label>Department of Pediatrics Division of Neonatology, The University of Rochester Medical Center, Rochester, NY 14623, USA</aff>
<aff id="af2-pathogens-08-00265"><label>2</label>Department of Pediatrics Division of Pediatric Infectious Diseases, The University of Rochester Medical Center, Rochester, NY 14623, USA; <email>jennifer_nayak@urmc.rochester.edu</email></aff>
<author-notes>
<corresp id="c1-pathogens-08-00265"><label>*</label>Correspondence: <email>ravi_misra@urmc.rochester.edu</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>26</day>
<month>11</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<month>12</month>
<year>2019</year>
</pub-date>
<volume>8</volume>
<issue>4</issue>
<elocation-id>265</elocation-id>
<history>
<date date-type="received">
<day>25</day>
<month>9</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>22</day>
<month>11</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© 2019 by the authors.</copyright-statement>
<copyright-year>2019</copyright-year>
<license license-type="open-access">
<license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
</license>
</permissions>
<abstract>
<p>Influenza virus infection is responsible for significant morbidity and mortality in the pediatric and pregnant women populations, with deaths frequently caused by severe influenza-associated lower respiratory tract infection and acute respiratory distress syndrome (ARDS). An appropriate immune response requires controlling the viral infection through activation of antiviral defenses, which involves cells of the lung and immune system. High levels of viral infection or high levels of inflammation in the lower airways can contribute to ARDS. Pregnant women and young children, especially those born prematurely, may develop serious complications if infected with influenza virus. Vaccination against influenza virus will lead to lower infection rates and fewer complications, even if the vaccine is poorly matched to circulating viral strains. Maternal vaccination offers infants protection via antibody transmission through the placenta and breast milk. Despite the health benefits of the influenza vaccine, vaccination rates around the world remain well below targets. Trust in the use of vaccines among the public must be restored in order to increase vaccination rates and decrease the public health burden of influenza.</p>
</abstract>
<kwd-group>
<kwd>pediatrics</kwd>
<kwd>influenza virus</kwd>
<kwd>vaccines</kwd>
<kwd>pregnant women</kwd>
<kwd>ARDS</kwd>
<kwd>lung</kwd>
<kwd>morbidity</kwd>
<kwd>vaccination rate</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-pathogens-08-00265" sec-type="intro">
<title>1. Introduction</title>
<p>Influenza virus infection is a major cause of morbidity and mortality around the world, with over 3 million individuals developing severe disease and resulting in hundreds of thousands of deaths per year [<xref ref-type="bibr" rid="B1-pathogens-08-00265">1</xref>]. Some of the most vulnerable populations include pregnant women and young children, making these groups a high priority target for vaccination. Individuals who are less than 21 years old are considered to be in the pediatric group and subsets include neonates (0 to 28 days), infants (29 days to 2 years), children (2 years to less than 12 years), and adolescents (12 years to 21 years) [<xref ref-type="bibr" rid="B2-pathogens-08-00265">2</xref>]. For individuals who are less than 5 years of age, pediatric influenza-associated infections are estimated at 90 million cases per year, with 1 million cases of influenza-associated severe acute lower respiratory tract infection and 28,000–111,500 deaths, the majority of which occur in developing countries [<xref ref-type="bibr" rid="B3-pathogens-08-00265">3</xref>]. Children less than a year of age are particularly susceptible to infection as they have little pre-existing immunity and may be too young to be vaccinated, relying upon transferred maternal immunity to protect against infection [<xref ref-type="bibr" rid="B4-pathogens-08-00265">4</xref>,<xref ref-type="bibr" rid="B5-pathogens-08-00265">5</xref>,<xref ref-type="bibr" rid="B6-pathogens-08-00265">6</xref>,<xref ref-type="bibr" rid="B7-pathogens-08-00265">7</xref>]. </p>
<p>Several studies report that in fatal cases of influenza virus infection, increased inflammation, and virus are found in the alveoli [<xref ref-type="bibr" rid="B8-pathogens-08-00265">8</xref>,<xref ref-type="bibr" rid="B9-pathogens-08-00265">9</xref>,<xref ref-type="bibr" rid="B10-pathogens-08-00265">10</xref>,<xref ref-type="bibr" rid="B11-pathogens-08-00265">11</xref>,<xref ref-type="bibr" rid="B12-pathogens-08-00265">12</xref>,<xref ref-type="bibr" rid="B13-pathogens-08-00265">13</xref>]. Disruption of the alveolar region due to viral infection and increased inflammation can contribute to the development of acute respiratory distress syndrome (ARDS), which is a major health concern for children and pregnant women [<xref ref-type="bibr" rid="B14-pathogens-08-00265">14</xref>,<xref ref-type="bibr" rid="B15-pathogens-08-00265">15</xref>,<xref ref-type="bibr" rid="B16-pathogens-08-00265">16</xref>,<xref ref-type="bibr" rid="B17-pathogens-08-00265">17</xref>]. Vaccination can help prevent infection, which will, in turn, prevent acute lower respiratory tract infections and ARDS. Vaccines are either in the form of Inactivated Influenza Vaccine (IIV) or Live Attenuated Influenza Virus (LAIV) [<xref ref-type="bibr" rid="B18-pathogens-08-00265">18</xref>]. Current influenza vaccines target predominately the variable region of the hemagglutinin protein. This can allow for viruses to escape the immune system via mutation, leading to vaccine mismatch and increased viral spread [<xref ref-type="bibr" rid="B19-pathogens-08-00265">19</xref>,<xref ref-type="bibr" rid="B20-pathogens-08-00265">20</xref>,<xref ref-type="bibr" rid="B21-pathogens-08-00265">21</xref>,<xref ref-type="bibr" rid="B22-pathogens-08-00265">22</xref>,<xref ref-type="bibr" rid="B23-pathogens-08-00265">23</xref>,<xref ref-type="bibr" rid="B24-pathogens-08-00265">24</xref>,<xref ref-type="bibr" rid="B25-pathogens-08-00265">25</xref>,<xref ref-type="bibr" rid="B26-pathogens-08-00265">26</xref>,<xref ref-type="bibr" rid="B27-pathogens-08-00265">27</xref>]. Scientists are continuing work to develop a universal influenza vaccine that targets a less variable region of the influenza virus and is thus protective against a greater breadth of viral strains but, while substantial progress has been made, challenges remain [<xref ref-type="bibr" rid="B28-pathogens-08-00265">28</xref>,<xref ref-type="bibr" rid="B29-pathogens-08-00265">29</xref>,<xref ref-type="bibr" rid="B30-pathogens-08-00265">30</xref>]. This review will discuss our current understanding of the immune response to influenza vaccination, with a focus on the benefits of vaccinating pregnant women and children against influenza virus.</p>
</sec>
<sec id="sec2-pathogens-08-00265">
<title>2. Body</title>
<sec id="sec2dot1-pathogens-08-00265">
<title>2.1. Background</title>
<p>Influenza virus is a single stranded, negative sense Orthomyxoviridae RNA virus with a genome that contains 8 genomic segments [<xref ref-type="bibr" rid="B31-pathogens-08-00265">31</xref>]. Influenza A and B viruses include the hemagglutinin (HA), neuraminidase (NA), nucleoprotein (NP), matrix protein 1 (M1), matrix protein 2 (M2/BM2), nonstructural protein 1 (NS1), nonstructural protein 2 (NS2) and the RNA polymerase complex (PA, PB1 and PB2), as illustrated in <xref ref-type="fig" rid="pathogens-08-00265-f001">Figure 1</xref>. The strain of influenza A virus is defined by the combination of HA and NA proteins, of which there are 18 and 11 distinct subtypes identified, respectively [<xref ref-type="bibr" rid="B31-pathogens-08-00265">31</xref>]. HA subtypes are classified as group 1 (H1, H2, H5, H6, H8, H9, H11, H12, H13, H16, H17, and H18) or group 2 (H3, H4 H7, H10, H14 and H15) [<xref ref-type="bibr" rid="B28-pathogens-08-00265">28</xref>]. While influenza A virus remains the major focus of public health officials, the pathogenic potential risk of influenza B virus infections must not be ignored [<xref ref-type="bibr" rid="B32-pathogens-08-00265">32</xref>,<xref ref-type="bibr" rid="B33-pathogens-08-00265">33</xref>]. In fact, several studies implicate influenza B viral infection as a substantial health concern in the young pediatric population [<xref ref-type="bibr" rid="B34-pathogens-08-00265">34</xref>,<xref ref-type="bibr" rid="B35-pathogens-08-00265">35</xref>,<xref ref-type="bibr" rid="B36-pathogens-08-00265">36</xref>]. Both molecular and host determinants, such as increased viral replication, host cell death, host antiviral gene response, degree of pre-existing immunity, and transmissibility, can contribute to the pathogenicity of influenza virus [<xref ref-type="bibr" rid="B37-pathogens-08-00265">37</xref>]. </p>
<p>Given the relatively error-prone nature of the influenza virus RNA polymerases, mutations are often introduced which can result in viral escape from host immunity through the process of antigenic drift. Such mutations often are selected for in HA as they can lead to an escape from viral neutralization [<xref ref-type="bibr" rid="B19-pathogens-08-00265">19</xref>,<xref ref-type="bibr" rid="B20-pathogens-08-00265">20</xref>,<xref ref-type="bibr" rid="B21-pathogens-08-00265">21</xref>,<xref ref-type="bibr" rid="B22-pathogens-08-00265">22</xref>,<xref ref-type="bibr" rid="B23-pathogens-08-00265">23</xref>]. However, antigenic drift can also be seen in other viral proteins [<xref ref-type="bibr" rid="B24-pathogens-08-00265">24</xref>,<xref ref-type="bibr" rid="B25-pathogens-08-00265">25</xref>,<xref ref-type="bibr" rid="B27-pathogens-08-00265">27</xref>,<xref ref-type="bibr" rid="B38-pathogens-08-00265">38</xref>]. Alternatively, antigenic shift can occur when viral gene segment recombination results in formation of a novel virus against which there is little pre-existing host immunity [<xref ref-type="bibr" rid="B39-pathogens-08-00265">39</xref>,<xref ref-type="bibr" rid="B40-pathogens-08-00265">40</xref>]. As the general population is often relatively immunologically naïve to a shifted viral strain, such a virus may be able to spread rapidly across the globe potentially causing an influenza pandemic [<xref ref-type="bibr" rid="B41-pathogens-08-00265">41</xref>,<xref ref-type="bibr" rid="B42-pathogens-08-00265">42</xref>,<xref ref-type="bibr" rid="B43-pathogens-08-00265">43</xref>,<xref ref-type="bibr" rid="B44-pathogens-08-00265">44</xref>]. Given that animals, such as birds and pigs, are reservoirs for influenza virus, viral surveillance is an important way to monitor for dangerous viral reassortment [<xref ref-type="bibr" rid="B31-pathogens-08-00265">31</xref>]. Approaches to monitor influenza virus in animals have been developed, such as the One Health program, in order to better understand how virus can spread to humans thereby affecting public health [<xref ref-type="bibr" rid="B45-pathogens-08-00265">45</xref>,<xref ref-type="bibr" rid="B46-pathogens-08-00265">46</xref>]. Containing the spread of influenza virus through vaccination efforts, especially in low- and middle-income countries, is a key way to help protect public health of the population, but in particular children and pregnant women. </p>
</sec>
<sec id="sec2dot2-pathogens-08-00265">
<title>2.2. The Host Immune Response to Influenza Virus Infection</title>
<p>The host response to influenza virus can limit viral infection within the lung, thereby protecting host health. However, failure to appropriately regulate this response can lead to damage of lung alveoli due to excessive inflammation or cytolysis of lung cells due to viral infection. The result is impaired gas exchange, which is a major morbidity associated with influenza virus infection. <xref ref-type="fig" rid="pathogens-08-00265-f002">Figure 2</xref> summarizes factors that are responsible for protecting the host against infection with influenza virus. These include epithelial cells, cells of the innate immune system, the adaptive immune system, cytokines, chemokines, antibodies, and surfactant proteins. </p>
<p>Influenza virus first targets epithelial cells of the proximal respiratory system through HA binding to α2,6-linked sialylated proteins (reviewed in [<xref ref-type="bibr" rid="B21-pathogens-08-00265">21</xref>,<xref ref-type="bibr" rid="B47-pathogens-08-00265">47</xref>,<xref ref-type="bibr" rid="B48-pathogens-08-00265">48</xref>]). Binding and/or internalization of the virus to cells of the epithelium leads to intracellular signaling that alters ion transport, contributing to symptoms of infection [<xref ref-type="bibr" rid="B49-pathogens-08-00265">49</xref>]. Antiviral responses are initiated, including the release of antimicrobial peptides such as surfactants, mucins, LL-37 and β-defensins, which decrease viral binding to epithelial cells and promote recruitment of innate immune cells such as neutrophils [<xref ref-type="bibr" rid="B47-pathogens-08-00265">47</xref>,<xref ref-type="bibr" rid="B50-pathogens-08-00265">50</xref>,<xref ref-type="bibr" rid="B51-pathogens-08-00265">51</xref>]. Surfactant proteins are capable of binding to virus, which helps to limit infectivity and disease severity [<xref ref-type="bibr" rid="B52-pathogens-08-00265">52</xref>,<xref ref-type="bibr" rid="B53-pathogens-08-00265">53</xref>,<xref ref-type="bibr" rid="B54-pathogens-08-00265">54</xref>,<xref ref-type="bibr" rid="B55-pathogens-08-00265">55</xref>]. Upon infection, respiratory epithelial cells sense virus through Toll-Like Receptors (TLRs), retinoic acid-inducible gene I (RIG-I), NOD-like receptors (NLRs), and melanoma differentiation-associated 5 (MDA-5), leading to the expression of type-I and type-III interferons (IFN), interleukin-6 (IL-6), IL-1β, IL-18, and other pro-inflammatory cytokines and chemokines [<xref ref-type="bibr" rid="B56-pathogens-08-00265">56</xref>,<xref ref-type="bibr" rid="B57-pathogens-08-00265">57</xref>,<xref ref-type="bibr" rid="B58-pathogens-08-00265">58</xref>,<xref ref-type="bibr" rid="B59-pathogens-08-00265">59</xref>]. Some of these cytokines and chemokines cause immune cells to extravasate from blood vessels into the site of infection in order to combat the pathogen.</p>
<p>Following influenza virus infection, a classic antiviral response occurs. Among the first cells to become activated are macrophages and dendritic cells, which are critical for the initiation of the antiviral response and instruction of developing adaptive immunity [<xref ref-type="bibr" rid="B60-pathogens-08-00265">60</xref>,<xref ref-type="bibr" rid="B61-pathogens-08-00265">61</xref>]. Many subtypes of dendritic cells are present, some of which are capable of presenting antigen to both CD4+ and CD8+ T cells [<xref ref-type="bibr" rid="B62-pathogens-08-00265">62</xref>]. Delivery of antigen to draining lymph nodes via lymphatic vessels is an important step in activating T cells [<xref ref-type="bibr" rid="B63-pathogens-08-00265">63</xref>,<xref ref-type="bibr" rid="B64-pathogens-08-00265">64</xref>]. Dendritic cells are targeted by influenza virus infection, which can impair the development of the adaptive immune response [<xref ref-type="bibr" rid="B65-pathogens-08-00265">65</xref>]. Once activated, CD8+ T cells will kill virally infected cells, with an important role for lung tissue-resident memory CD8 T cells (T<sub>rm</sub>) in generating rapid antiviral responses upon host reinfection [<xref ref-type="bibr" rid="B66-pathogens-08-00265">66</xref>,<xref ref-type="bibr" rid="B67-pathogens-08-00265">67</xref>]. CD4+ T cells also contribute a multiplicity of functions to anti-influenza immunity, including promoting CD8+ T cell function (activation, expansion, positioning, and memory formation), the innate immune response, help for the B cell response, and independent cytotoxicity [<xref ref-type="bibr" rid="B68-pathogens-08-00265">68</xref>,<xref ref-type="bibr" rid="B69-pathogens-08-00265">69</xref>]. T follicular helper cells, a specialized CD4+ T cell subset, provide cognate help for both the extrafollicular and germinal center B cell responses [<xref ref-type="bibr" rid="B70-pathogens-08-00265">70</xref>,<xref ref-type="bibr" rid="B71-pathogens-08-00265">71</xref>,<xref ref-type="bibr" rid="B72-pathogens-08-00265">72</xref>]. Antibody secreting cells (ASCs) then home to tissues such as the bone marrow, where they receive survival factors that allow for long term survival, imparting immunity via the high levels of antibody they secrete [<xref ref-type="bibr" rid="B73-pathogens-08-00265">73</xref>]. An alternate fate upon B cell activation is to become a memory B cell [<xref ref-type="bibr" rid="B74-pathogens-08-00265">74</xref>,<xref ref-type="bibr" rid="B75-pathogens-08-00265">75</xref>,<xref ref-type="bibr" rid="B76-pathogens-08-00265">76</xref>]. In the case of influenza virus, T cells and B cells recognize viral components including both the surface proteins (HA and NA) and the internal virion proteins (NP, NS1, and M1); see <xref ref-type="fig" rid="pathogens-08-00265-f001">Figure 1</xref> [<xref ref-type="bibr" rid="B69-pathogens-08-00265">69</xref>]. Detectable levels of class-switched antibody are found approximately two weeks following influenza infection [<xref ref-type="bibr" rid="B77-pathogens-08-00265">77</xref>,<xref ref-type="bibr" rid="B78-pathogens-08-00265">78</xref>]. These high-affinity antibodies can then act to interfere with viral binding, viral replication, or target infected cells for killing via mechanisms such as antibody-dependent cellular cytotoxicity (ADCC) [<xref ref-type="bibr" rid="B79-pathogens-08-00265">79</xref>,<xref ref-type="bibr" rid="B80-pathogens-08-00265">80</xref>]. Following successful viral clearance, cells of the immune system become relatively quiescent once again, leaving a pool of memory T and B cells in addition to protective antibodies that will lead to resistance against future influenza infection [<xref ref-type="bibr" rid="B81-pathogens-08-00265">81</xref>,<xref ref-type="bibr" rid="B82-pathogens-08-00265">82</xref>,<xref ref-type="bibr" rid="B83-pathogens-08-00265">83</xref>]. </p>
</sec>
<sec id="sec2dot3-pathogens-08-00265">
<title>2.3. Acute Respiratory Distress Syndrome and Lung Damage as a Consequence of Overwhelming Viral Infection</title>
<p>If the host is unable to control viral infection, respiratory morbidities can occur. One such morbidity is the development of ARDS, which is characterized by pulmonary edema, hypoxemia and a high mortality rate [<xref ref-type="bibr" rid="B15-pathogens-08-00265">15</xref>]. Infectious agents are just one of many potential causes of ARDS, with both direct influenza virus infection and the anti-influenza immune response contributing to damage of the respiratory tract and ARDS development [<xref ref-type="bibr" rid="B17-pathogens-08-00265">17</xref>]. In pregnant women and young children, ARDS is a rare but major health concern following infection with influenza virus [<xref ref-type="bibr" rid="B14-pathogens-08-00265">14</xref>,<xref ref-type="bibr" rid="B15-pathogens-08-00265">15</xref>], with one study demonstrating influenza virus infection to be a factor contributing to a higher risk of death in pregnant women with ARDS [<xref ref-type="bibr" rid="B16-pathogens-08-00265">16</xref>]. </p>
<p>There are many examples of how viral and host factors promote the generation of inflammation in the lung, which is a hallmark of severe influenza-like illness. One report demonstrated that the glycosylation state of HA controlled levels of proinflammatory cytokines produced by human lung epithelial cells [<xref ref-type="bibr" rid="B84-pathogens-08-00265">84</xref>]. Also, influenza viruses that were selected to infect human epithelial cells became more pathogenic by adaptation to the host, thereby increasing illness severity [<xref ref-type="bibr" rid="B85-pathogens-08-00265">85</xref>]. It is well known that viral factors, such as NS1, downregulate the production of interferons, thereby decreasing the host antiviral response [<xref ref-type="bibr" rid="B86-pathogens-08-00265">86</xref>]. While gas-exchanging alveolar type I epithelial cells can generate an antiviral response, high viral loads can overwhelm this and lead to compromised lung function [<xref ref-type="bibr" rid="B87-pathogens-08-00265">87</xref>,<xref ref-type="bibr" rid="B88-pathogens-08-00265">88</xref>]. In some severe cases of influenza virus infection, virus and inflammation were noted in the lower respiratory tract or alveoli, with resulting cellular damage (<xref ref-type="fig" rid="pathogens-08-00265-f002">Figure 2</xref>) [<xref ref-type="bibr" rid="B8-pathogens-08-00265">8</xref>,<xref ref-type="bibr" rid="B9-pathogens-08-00265">9</xref>,<xref ref-type="bibr" rid="B11-pathogens-08-00265">11</xref>,<xref ref-type="bibr" rid="B12-pathogens-08-00265">12</xref>,<xref ref-type="bibr" rid="B13-pathogens-08-00265">13</xref>,<xref ref-type="bibr" rid="B89-pathogens-08-00265">89</xref>]. Additionally, neutrophils have been implicated in the pathophysiology of alveolar damage following infection with influenza virus [<xref ref-type="bibr" rid="B90-pathogens-08-00265">90</xref>]. IL-8/CXCL8 and GM-CSF, which are neutrophil chemotactic agents, are produced by primary human alveolar epithelial cells and may exacerbate the inflammatory process in alveoli, thus increasing the likelihood of developing ARDS [<xref ref-type="bibr" rid="B91-pathogens-08-00265">91</xref>]. TLR3-expressing CD8+ T cells were also found in areas with diffuse alveolar damage in a group of patients who died of severe influenza virus infection [<xref ref-type="bibr" rid="B92-pathogens-08-00265">92</xref>]. These findings suggest several potential interventions aimed at limiting alveolar damage through control of excessive inflammation that may help to reduce the risk of developing ARDS. </p>
<p>Controlling viral load and the resulting pulmonary inflammation through vaccination pre-exposure and use of therapeutics post-exposure could help to decrease lung damage and the resulting respiratory morbidity. In support of this, ferrets and mice that were administered human immunoglobulins had a reduction in viral load as compared to control animals that did not [<xref ref-type="bibr" rid="B93-pathogens-08-00265">93</xref>], with decreased weight loss, decreased mortality, and protection against challenge with H1N1 virus [<xref ref-type="bibr" rid="B94-pathogens-08-00265">94</xref>]. Similarly, data suggested that a high viral load and a strong cytokine response contributed to mortality in humans infected with H5N1 influenza virus [<xref ref-type="bibr" rid="B95-pathogens-08-00265">95</xref>]. One recent study demonstrated that children between one and five years of age had higher viral loads compared to older children, perhaps contributing to their increased susceptibility to influenza virus infection [<xref ref-type="bibr" rid="B96-pathogens-08-00265">96</xref>]. While these results seem to indicate that decreasing viral load would lead to improved outcomes, a recent phase III clinical trial demonstrated that transfer of sera containing high levels of anti-influenza antibody into patients with severe influenza virus infection did not lead to detectable benefit [<xref ref-type="bibr" rid="B97-pathogens-08-00265">97</xref>]. However, administration of some anti-influenza virus antibodies have been shown to reduce viral loads in humans [<xref ref-type="bibr" rid="B98-pathogens-08-00265">98</xref>]. Additional work will be required to determine whether antibody treatments will help to reduce influenza virus load and decrease disease severity.</p>
<p>Following clearance of the infection, lung repair occurs via a complicated interplay between the immune system and epithelium [<xref ref-type="bibr" rid="B99-pathogens-08-00265">99</xref>,<xref ref-type="bibr" rid="B100-pathogens-08-00265">100</xref>,<xref ref-type="bibr" rid="B101-pathogens-08-00265">101</xref>,<xref ref-type="bibr" rid="B102-pathogens-08-00265">102</xref>]. Ineffective repair of alveoli following infection has also been implicated in the development of ARDS [<xref ref-type="bibr" rid="B15-pathogens-08-00265">15</xref>]. Thus, the interaction between the lung and immune system is the key not only to anti-viral responses, but also for post-infection healing. Unfortunately, basic information regarding the interaction of cells found in human lung is lacking in the field of lung biology. Work from our group is attempting to unravel the crosstalk between epithelial cells and immune cells in the developing human lung [<xref ref-type="bibr" rid="B103-pathogens-08-00265">103</xref>,<xref ref-type="bibr" rid="B104-pathogens-08-00265">104</xref>,<xref ref-type="bibr" rid="B105-pathogens-08-00265">105</xref>]. Such information and the experimental models that have been developed will be useful in future studies aimed at identifying treatments to prevent ARDS or encourage lung healing.</p>
</sec>
<sec id="sec2dot4-pathogens-08-00265">
<title>2.4. The Pediatric Immune System is Different than that of the Adult</title>
<p>Differences in immunologic function between young children and adults likely contribute to the increased susceptibility of children to influenza virus infection. The immune system of young children is characterized by a higher frequency of naïve antigen-specific cells [<xref ref-type="bibr" rid="B106-pathogens-08-00265">106</xref>,<xref ref-type="bibr" rid="B107-pathogens-08-00265">107</xref>]. This population also tends to have an overall higher number of circulating T and B cells that decreases drastically by six years of age [<xref ref-type="bibr" rid="B108-pathogens-08-00265">108</xref>]. An increase in regulatory T and B cells is also noted in neonatal blood samples [<xref ref-type="bibr" rid="B109-pathogens-08-00265">109</xref>,<xref ref-type="bibr" rid="B110-pathogens-08-00265">110</xref>,<xref ref-type="bibr" rid="B111-pathogens-08-00265">111</xref>,<xref ref-type="bibr" rid="B112-pathogens-08-00265">112</xref>,<xref ref-type="bibr" rid="B113-pathogens-08-00265">113</xref>]. Despite the increase in the frequency of regulatory T cells in neonatal blood, the functional ability of neonatal regulatory T cells to suppress dendritic cell function and to blunt the immune reaction is diminished relative to adults [<xref ref-type="bibr" rid="B114-pathogens-08-00265">114</xref>]. Additionally, cells of the pediatric innate immune system, including monocytes and dendritic cells, tend to be less stimulatory (e.g., increased IL-10 and decreased IL-12, IL-1β, and IFN-α) when challenged with TLR agonists versus adults [<xref ref-type="bibr" rid="B115-pathogens-08-00265">115</xref>,<xref ref-type="bibr" rid="B116-pathogens-08-00265">116</xref>]. This leads to decreased antigen presentation and T cell co-stimulation capacity. Neutrophil function, such as the generation of reactive oxygen species and neutrophil extracellular traps, is also reduced in neonates relative to adults [<xref ref-type="bibr" rid="B117-pathogens-08-00265">117</xref>]. These characteristics of the pediatric immune system may contribute to the increased morbidity of children upon infection with influenza virus and the need for children to receive two doses of IIV vaccine. Efforts are underway to produce adjuvanted vaccines to help prime a more robust immune response (see below).</p>
</sec>
<sec id="sec2dot5-pathogens-08-00265">
<title>2.5. Alterations in the Immune System and Epithelial Barrier of the Preterm Infants Versus Term Infants</title>
<p>Infants born preterm (&lt;37 weeks gestational age) face a variety of long-term health morbidities. While the threat of developing sepsis is a major concern for all neonates, the concern is even greater for preterm infants [<xref ref-type="bibr" rid="B118-pathogens-08-00265">118</xref>]. Hyporesponsiveness of monocytes to stimulation and decreased TNF-α responsiveness in non-classical monocyte activation have also been noted in preterm infants, especially prior to 30 weeks gestational age, and may contribute to sepsis risk [<xref ref-type="bibr" rid="B119-pathogens-08-00265">119</xref>,<xref ref-type="bibr" rid="B120-pathogens-08-00265">120</xref>]. Infections that are known to cause sepsis compromise the epithelial barrier of the lung and gut, leading to decreased expression of several TLRs and easier access of infectious agents to the underlying tissue, facilitating development of infections [<xref ref-type="bibr" rid="B121-pathogens-08-00265">121</xref>]. Furthermore, antimicrobial factors such as LL-37 are lower in preterm cord blood versus full term controls, which could be reflective of impaired antimicrobial potential in preterm infants [<xref ref-type="bibr" rid="B118-pathogens-08-00265">118</xref>]. Work involving our group has shown that preterm B cell responses to the influenza virus vaccine actually generate a higher peak level of influenza virus-specific antibody versus term controls, with levels equalizing by 9 months after vaccination [<xref ref-type="bibr" rid="B122-pathogens-08-00265">122</xref>,<xref ref-type="bibr" rid="B123-pathogens-08-00265">123</xref>]. We have also reported that CD4+ T cells found in cord blood from preterm infants who are exposed to inflammatory stimuli <italic>in utero</italic> are more likely to produce proinflammatory cytokines, including IL-6 [<xref ref-type="bibr" rid="B124-pathogens-08-00265">124</xref>]. These studies are just some examples of studies found in the literature that illustrate how the immune system of preterm infants is different from term infants. </p>
<p>An additional complication of preterm birth is abnormal lung development. Bronchopulmonary dysplasia (BPD) is a chronic lung disease characterized by inflammation and arrest of alveolar development that affects 30–60% of infants born preterm [<xref ref-type="bibr" rid="B125-pathogens-08-00265">125</xref>,<xref ref-type="bibr" rid="B126-pathogens-08-00265">126</xref>,<xref ref-type="bibr" rid="B127-pathogens-08-00265">127</xref>,<xref ref-type="bibr" rid="B128-pathogens-08-00265">128</xref>]. Studies suggest that part of the oxidative and mechanical damage is the result of respiratory ventilation [<xref ref-type="bibr" rid="B129-pathogens-08-00265">129</xref>]. One paper suggests that BPD could predispose infants to developing pediatric ARDS [<xref ref-type="bibr" rid="B130-pathogens-08-00265">130</xref>]. Of note, a recent study from Australia reports that children with BPD have an increased incidence ratio of being hospitalized due to influenza-related illness (9.0 ratio for children 0–10 years old and 41.6 for the 0–2 year old age range) [<xref ref-type="bibr" rid="B131-pathogens-08-00265">131</xref>]. Additionally, the length of hospital stay for children with BPD was 7 days longer than for children with cystic fibrosis or other chronic lung diseases. Thus, children who are born preterm and develop BPD are at particularly high risk for developing severe influenza illness. </p>
</sec>
<sec id="sec2dot6-pathogens-08-00265">
<title>2.6. Vaccination Strategies for Protecting Public Health Vary Across the World </title>
<p>Influenza vaccine is administered primarily through intramuscular injection (inactivated subunit or split virus) or spraying intranasally (live attenuated influenza virus). Typically, vaccines contain three or four strains of virus (trivalent or quadrivalent respectively), including two influenza A strains (H1 and H3), and one or two influenza B strains [<xref ref-type="bibr" rid="B18-pathogens-08-00265">18</xref>]. A vaccine is considered to confer protection if post-vaccination serum can inhibit influenza mediated hemagglutination <italic>in vitro</italic> at a one to forty or greater dilution, although higher HAI titers may be necessary to achieve similar levels of protection in children [<xref ref-type="bibr" rid="B132-pathogens-08-00265">132</xref>]. Ultimately, the goal of vaccination is to reduce the rate or severity of infection. This can occur by antibodies that interfere with viral binding to target cells (e.g., neutralization) or by inhibiting the “life-cycle” of the virus (e.g., by preventing viral release from infected cells). Antibody-dependent cellular cytotoxicity is another mechanism for killing virally infected cells, which illustrates another important function that antibodies have [<xref ref-type="bibr" rid="B79-pathogens-08-00265">79</xref>,<xref ref-type="bibr" rid="B80-pathogens-08-00265">80</xref>]. In addition to antibodies, a recall response of memory CD4+ and CD8+ T cells allows for protection against influenza virus infection [<xref ref-type="bibr" rid="B133-pathogens-08-00265">133</xref>,<xref ref-type="bibr" rid="B134-pathogens-08-00265">134</xref>]. </p>
<p>Recommendations for vaccinating children and pregnant women vary around the world. In the United States and Canada, it is recommended that all infants and children greater than 6 months of age be vaccinated using IIV, with administration of LAIV only in children greater than 24 months of age due to a reported increased risk of post-LAIV wheezing in infants [<xref ref-type="bibr" rid="B135-pathogens-08-00265">135</xref>,<xref ref-type="bibr" rid="B136-pathogens-08-00265">136</xref>]. As children may be relatively immunologically naïve to influenza virus, those younger than 9 years of age initially receive a priming dose of vaccine followed by a booster vaccine dose at least 28 days later [<xref ref-type="bibr" rid="B136-pathogens-08-00265">136</xref>]. In addition, IIV administration is recommended for women who are or will be pregnant during the influenza season [<xref ref-type="bibr" rid="B137-pathogens-08-00265">137</xref>]. Although the immune system of preterm infants is relatively immature, immunizations are typically given at the same chronological age as in term infants [<xref ref-type="bibr" rid="B138-pathogens-08-00265">138</xref>,<xref ref-type="bibr" rid="B139-pathogens-08-00265">139</xref>]. </p>
<p>Despite broad recommendations for influenza vaccination in some countries, the World Health Organization (WHO) reported that in 2014, only 59% of member countries had vaccination programs in place [<xref ref-type="bibr" rid="B140-pathogens-08-00265">140</xref>]. Given that 41% of countries did not have vaccination programs in place, the chances for the spread of influenza virus is quite high. Viral reassortment can occur in birds and pigs, which has contributed to the generation of novel pandemic influenza virus strains [<xref ref-type="bibr" rid="B141-pathogens-08-00265">141</xref>,<xref ref-type="bibr" rid="B142-pathogens-08-00265">142</xref>]. By decreasing the number of people infected via routine vaccination, there is likely to be a decreased chance for coinfection of birds and pigs with human and animal influenza virus, thus decreasing the chances of reassortment mutants that could become pandemic. Furthermore, if a country has a vaccination plan in place, rapid administration of vaccines in the case of a pandemic would be possible [<xref ref-type="bibr" rid="B143-pathogens-08-00265">143</xref>]. Amongst members of the European Union there is great variability in influenza vaccination requirements [<xref ref-type="bibr" rid="B144-pathogens-08-00265">144</xref>], with a set goal of a 75% vaccination rate in the high-risk population, but actual vaccination rates that are much lower [<xref ref-type="bibr" rid="B145-pathogens-08-00265">145</xref>]. Countries with low- to middle-income typically have low vaccination rates against influenza virus [<xref ref-type="bibr" rid="B146-pathogens-08-00265">146</xref>]. Individuals living in these countries face a higher disease burden than individuals from higher-income countries [<xref ref-type="bibr" rid="B147-pathogens-08-00265">147</xref>]. In countries that do have influenza immunization programs, fewer than half recommended vaccinating pregnant women and less than a third recommended routine vaccination of children [<xref ref-type="bibr" rid="B140-pathogens-08-00265">140</xref>]. Regardless of recommendations, influenza vaccination rates remain suboptimal and demonstrate substantial variability by age, location, and season. In the US, the goal is to vaccinate 70% of the population, but only around 40% of adults were vaccinated each year between 2010 and 2016 [<xref ref-type="bibr" rid="B148-pathogens-08-00265">148</xref>]. Similarly, one Canadian study reported that, on average, only 29% of respondents had been vaccinated in a given year between the 2006 and 2013 influenza seasons [<xref ref-type="bibr" rid="B149-pathogens-08-00265">149</xref>]. Furthermore, one study shows that less than half of pregnant women in the United States were vaccinated over three consecutive influenza seasons [<xref ref-type="bibr" rid="B150-pathogens-08-00265">150</xref>]. Highlighting the importance of vaccination, a study of 358 laboratory-confirmed influenza-associated pediatric deaths between 2010 and 2014 reported that vaccination coverage was low (26% overall and only 31% of high-risk patients) [<xref ref-type="bibr" rid="B151-pathogens-08-00265">151</xref>]. Unfortunately, children delivered prematurely have higher health risks associated with birth during the influenza season and a higher risk for being admitted into the hospital than full-term children [<xref ref-type="bibr" rid="B131-pathogens-08-00265">131</xref>,<xref ref-type="bibr" rid="B152-pathogens-08-00265">152</xref>,<xref ref-type="bibr" rid="B153-pathogens-08-00265">153</xref>], yet a recent study demonstrated that late preterm infants were less likely than term infants to be appropriately vaccinated against influenza by 36 months of age [<xref ref-type="bibr" rid="B154-pathogens-08-00265">154</xref>]. These data highlight the importance of efforts to increase overall influenza vaccination rates among both pregnant women and children. </p>
</sec>
<sec id="sec2dot7-pathogens-08-00265">
<title>2.7. A Key Role for Maternal Vaccination in Protecting Young Infants Against Influenza </title>
<p>The World Health Organization has identified pregnant women as a priority group for receiving influenza vaccines [<xref ref-type="bibr" rid="B155-pathogens-08-00265">155</xref>]. Pregnant women are particularly susceptible to developing severe influenza illness and have an increased risk for hospital admission, although the mortality rate compared to non-pregnant women may not be increased [<xref ref-type="bibr" rid="B156-pathogens-08-00265">156</xref>,<xref ref-type="bibr" rid="B157-pathogens-08-00265">157</xref>,<xref ref-type="bibr" rid="B158-pathogens-08-00265">158</xref>]. Overall, it has been established that vaccinating pregnant women is safe, with no evidence demonstrating a link between immunization during pregnancy and adverse outcomes in offspring [<xref ref-type="bibr" rid="B159-pathogens-08-00265">159</xref>,<xref ref-type="bibr" rid="B160-pathogens-08-00265">160</xref>,<xref ref-type="bibr" rid="B161-pathogens-08-00265">161</xref>,<xref ref-type="bibr" rid="B162-pathogens-08-00265">162</xref>,<xref ref-type="bibr" rid="B163-pathogens-08-00265">163</xref>,<xref ref-type="bibr" rid="B164-pathogens-08-00265">164</xref>,<xref ref-type="bibr" rid="B165-pathogens-08-00265">165</xref>]. Infants born to mothers who were vaccinated against influenza may have a decreased rate of preterm birth, low birthweight, and stillborn birth, although establishing a causal relationship is challenging [<xref ref-type="bibr" rid="B160-pathogens-08-00265">160</xref>,<xref ref-type="bibr" rid="B166-pathogens-08-00265">166</xref>,<xref ref-type="bibr" rid="B167-pathogens-08-00265">167</xref>,<xref ref-type="bibr" rid="B168-pathogens-08-00265">168</xref>,<xref ref-type="bibr" rid="B169-pathogens-08-00265">169</xref>,<xref ref-type="bibr" rid="B170-pathogens-08-00265">170</xref>,<xref ref-type="bibr" rid="B171-pathogens-08-00265">171</xref>]. Infants born to mothers who were severely sick with H1N1 influenza infection have been shown to have an increased risk of preterm birth, decreased 5 min Apgar scores, and an increased risk of death [<xref ref-type="bibr" rid="B172-pathogens-08-00265">172</xref>,<xref ref-type="bibr" rid="B173-pathogens-08-00265">173</xref>,<xref ref-type="bibr" rid="B174-pathogens-08-00265">174</xref>]. These data support vaccinating pregnant women to help improve the health of both the mother and child.</p>
<p>Benefits to the fetus from maternal vaccination against influenza virus include transfer of maternal antibody through the placenta. This is critical for protecting neonates and infants less than six months of age against severe influenza virus infection requiring hospitalization, as these infants are too young to be vaccinated [<xref ref-type="bibr" rid="B7-pathogens-08-00265">7</xref>,<xref ref-type="bibr" rid="B153-pathogens-08-00265">153</xref>]. Studies have demonstrated that some isotypes of anti-influenza antibodies cross the placenta and result in higher HAI titers in cord blood compared to placebo recipients [<xref ref-type="bibr" rid="B175-pathogens-08-00265">175</xref>], with protective antibody transported to the fetus in as little as two weeks post-vaccination [<xref ref-type="bibr" rid="B176-pathogens-08-00265">176</xref>]. Transplacental transport of antibodies requires expression of the neonatal Fc receptor expression, with IgG, especially IgG1, being effectively transported into fetal circulation [<xref ref-type="bibr" rid="B177-pathogens-08-00265">177</xref>,<xref ref-type="bibr" rid="B178-pathogens-08-00265">178</xref>]. Importantly, decreased rates of acute lower respiratory tract infection, influenza virus infections, and influenza-related hospitalizations were reported in infants following maternal vaccination during pregnancy [<xref ref-type="bibr" rid="B179-pathogens-08-00265">179</xref>,<xref ref-type="bibr" rid="B180-pathogens-08-00265">180</xref>,<xref ref-type="bibr" rid="B181-pathogens-08-00265">181</xref>]. While vaccination at any point during pregnancy is recommended, children born to mothers who were vaccinated more than 4 weeks prior to delivery and during the second or third trimester had higher antibody titers against the A(H1N1) virus when compared to those who were born to mother that were vaccinated in the first trimester [<xref ref-type="bibr" rid="B182-pathogens-08-00265">182</xref>]. </p>
<p>Another benefit of maternal vaccination is transfer of protective antibodies to children via breastmilk. This is particularly important for antibodies of the IgA isotype, which are not passed through the placenta [<xref ref-type="bibr" rid="B183-pathogens-08-00265">183</xref>,<xref ref-type="bibr" rid="B184-pathogens-08-00265">184</xref>]. Vaccination of breastfeeding mothers with IIV resulted in significantly higher HAI titers in serum and IgG and IgA levels in breast milk as compared to vaccination using LAIV, suggesting that IIV may be the preferred vaccine for use in breastfeeding mothers [<xref ref-type="bibr" rid="B185-pathogens-08-00265">185</xref>]. Given that preterm infants have lower levels of IgG antibody transferred via the placenta, antibody transferred via breastmilk may be of particular importance to decrease influenza virus infection in the preterm population [<xref ref-type="bibr" rid="B186-pathogens-08-00265">186</xref>,<xref ref-type="bibr" rid="B187-pathogens-08-00265">187</xref>]. Of note, milk from mothers who delivered prematurely had lower levels of total IgG and IgM but not IgA as compared to mothers who delivered at term [<xref ref-type="bibr" rid="B186-pathogens-08-00265">186</xref>]. Increasingly, preterm infants are being fed human donor breast milk, which contains significantly lower concentrations of IgM than non-donor milk, possibly due to the pasteurization process. However, administration of any antibody through donor breast milk would logically be better than receiving none at all. Several recent studies have focused on antibody transfer to the stomachs of preterm infants. Antibodies have been shown to be more stable in the gastric contents of preterm infants versus term infants [<xref ref-type="bibr" rid="B186-pathogens-08-00265">186</xref>], with influenza-virus-specific IgA antibodies being more stable in gastric contents of preterm infants regardless of whether milk is from the birth mother or from a donor [<xref ref-type="bibr" rid="B188-pathogens-08-00265">188</xref>]. </p>
<p>In addition to antibodies, other bioactive molecules are found in breast milk, including cytokines and human milk oligosaccharides (HMOs) that have been shown to inhibit viral entry into cells [<xref ref-type="bibr" rid="B189-pathogens-08-00265">189</xref>,<xref ref-type="bibr" rid="B190-pathogens-08-00265">190</xref>,<xref ref-type="bibr" rid="B191-pathogens-08-00265">191</xref>]. Furthermore, cells are transferred to the infant via breastfeeding, which could play a role in shaping the neonatal and infant microbiome [<xref ref-type="bibr" rid="B192-pathogens-08-00265">192</xref>]. Of note, studies have shown that HMOs fed to mice could be transferred into circulation, had no observable adverse health effects and improved the immune response to influenza virus infection [<xref ref-type="bibr" rid="B193-pathogens-08-00265">193</xref>,<xref ref-type="bibr" rid="B194-pathogens-08-00265">194</xref>,<xref ref-type="bibr" rid="B195-pathogens-08-00265">195</xref>]. In adult humans, HMO ingestion was well tolerated in a two-week oral administration regiment [<xref ref-type="bibr" rid="B196-pathogens-08-00265">196</xref>]. Thus, breast milk offers a variety of factors in addition to antibodies that help to protect offspring against influenza virus infection. Taken together, the above factors contribute to improved maternal and fetal health afforded by vaccinating pregnant women against influenza virus.</p>
</sec>
<sec id="sec2dot8-pathogens-08-00265">
<title>2.8. Adjuvanted Influenza Vaccines</title>
<p>Due to the overall poor immunogenicity of influenza vaccines, the use of immune adjuvants is being evaluated as a strategy to increase vaccine immunogenicity. Several different adjuvants have been tested in pre-clinical models and clinical trials. These include aluminum salt (alum) based approaches, oil and water emulsions (MF59, AS03, and AF03), innate immune cell receptor agonists (e.g., TLRs and the inflammasome), and virosomes (lipid bilayer droplets) [<xref ref-type="bibr" rid="B197-pathogens-08-00265">197</xref>]. These adjuvants utilize multiple mechanisms to increase the immunogencity of influenza vaccines, including activating antigen-presenting cells (APC), increasing antigen uptake by APCs, and recruiting immune cells to the site of vaccine administration [<xref ref-type="bibr" rid="B115-pathogens-08-00265">115</xref>,<xref ref-type="bibr" rid="B116-pathogens-08-00265">116</xref>]. Several clinical trials have been conducted in adults and children indicate that the use of AS03 as an adjuvant in influenza vaccines and increases influenza-virus-specific antibody response [<xref ref-type="bibr" rid="B198-pathogens-08-00265">198</xref>,<xref ref-type="bibr" rid="B199-pathogens-08-00265">199</xref>,<xref ref-type="bibr" rid="B200-pathogens-08-00265">200</xref>,<xref ref-type="bibr" rid="B201-pathogens-08-00265">201</xref>,<xref ref-type="bibr" rid="B202-pathogens-08-00265">202</xref>,<xref ref-type="bibr" rid="B203-pathogens-08-00265">203</xref>,<xref ref-type="bibr" rid="B204-pathogens-08-00265">204</xref>]. Clinical trials using MF-59 as an adjuvant also demonstrated safety and improved rates of seroconversion in preterm and term infants [<xref ref-type="bibr" rid="B205-pathogens-08-00265">205</xref>], with more robust antiviral responses, activation of dendritic cells and an increased CD4+ T cell cytokine response following administration of an adjuvanted vaccine [<xref ref-type="bibr" rid="B206-pathogens-08-00265">206</xref>,<xref ref-type="bibr" rid="B207-pathogens-08-00265">207</xref>,<xref ref-type="bibr" rid="B208-pathogens-08-00265">208</xref>]. MF59 has been approved for use in the United States since 2015 and its use appears to not increase adverse reaction rates [<xref ref-type="bibr" rid="B209-pathogens-08-00265">209</xref>]. Additionally, several studies have examined the use of adjuvanted H1N1 vaccines in pregnant women and have found that these vaccines were well tolerated [<xref ref-type="bibr" rid="B210-pathogens-08-00265">210</xref>,<xref ref-type="bibr" rid="B211-pathogens-08-00265">211</xref>,<xref ref-type="bibr" rid="B212-pathogens-08-00265">212</xref>]. Although the increased immunogenicity is strongly advantageous, there is concern for potential adverse effects, including a possible association between an AS03-adjuvanted monovalent pandemic influenza vaccine and narcolepsy [<xref ref-type="bibr" rid="B213-pathogens-08-00265">213</xref>,<xref ref-type="bibr" rid="B214-pathogens-08-00265">214</xref>,<xref ref-type="bibr" rid="B215-pathogens-08-00265">215</xref>]. A recent paper reports a higher rate of adverse events reported when the vaccine was administered to patients outside of the recommended age groups [<xref ref-type="bibr" rid="B209-pathogens-08-00265">209</xref>]. Reports of adverse events have likely slowed the uptake of adjuvanted influenza vaccines in vulnerable populations such as pregnant women and children. </p>
</sec>
<sec id="sec2dot9-pathogens-08-00265">
<title>2.9. Increasing Vaccination Rates for Influenza</title>
<p>Vaccines must be considered effective at preventing disease and be regarded as safe [<xref ref-type="bibr" rid="B216-pathogens-08-00265">216</xref>]. However, adverse reactions do occur and can include fever, febrile seizures, hypersensitivity reactions, and possibly a small increase in the risk of developing Guillain-Barre syndrome [<xref ref-type="bibr" rid="B217-pathogens-08-00265">217</xref>,<xref ref-type="bibr" rid="B218-pathogens-08-00265">218</xref>]. Several organizations, including the WHO, the European Union, the US government, and independent agencies have mechanisms in place for tracking vaccine safety [<xref ref-type="bibr" rid="B216-pathogens-08-00265">216</xref>,<xref ref-type="bibr" rid="B219-pathogens-08-00265">219</xref>,<xref ref-type="bibr" rid="B220-pathogens-08-00265">220</xref>]. In the United States, the Vaccine Adverse Event Reporting System passively documents post-licensure adverse events following vaccination administration [<xref ref-type="bibr" rid="B221-pathogens-08-00265">221</xref>]. In Europe, the European Medicines Agency is responsible for tracking adverse events through the EudraVigilance Program [<xref ref-type="bibr" rid="B222-pathogens-08-00265">222</xref>]. Such data are valuable, however, a deeper understanding of additional factors that could have contributed to an adverse event is necessary in order to minimize the risk of drawing an invalid conclusion associating an adverse event with vaccination. Vaccinating pregnant women is generally regarded as safe [<xref ref-type="bibr" rid="B159-pathogens-08-00265">159</xref>,<xref ref-type="bibr" rid="B160-pathogens-08-00265">160</xref>,<xref ref-type="bibr" rid="B161-pathogens-08-00265">161</xref>,<xref ref-type="bibr" rid="B162-pathogens-08-00265">162</xref>,<xref ref-type="bibr" rid="B163-pathogens-08-00265">163</xref>,<xref ref-type="bibr" rid="B164-pathogens-08-00265">164</xref>,<xref ref-type="bibr" rid="B165-pathogens-08-00265">165</xref>]. However, some hesitancy over influenza vaccination is present in this population and the benefit of protecting both the mother and the fetus needs to be conveyed as outweighing the risk of potential side effects [<xref ref-type="bibr" rid="B223-pathogens-08-00265">223</xref>,<xref ref-type="bibr" rid="B224-pathogens-08-00265">224</xref>,<xref ref-type="bibr" rid="B225-pathogens-08-00265">225</xref>,<xref ref-type="bibr" rid="B226-pathogens-08-00265">226</xref>].</p>
<p>Perhaps not surprisingly, preemptive action is more cost-effective than is reactive action for a pandemic, although modeling suggests mortality rates don’t differ between preemptive and reactive responses [<xref ref-type="bibr" rid="B227-pathogens-08-00265">227</xref>]. It is estimated that in order to prevent one case of influenza, five individuals would need to be vaccinated with IIV and seven with LAIV [<xref ref-type="bibr" rid="B9-pathogens-08-00265">9</xref>]. The importance of having a well-vaccinated population is at the heart of “herd immunity”, where disruption of influenza transmission will lead to a less severe outbreak [<xref ref-type="bibr" rid="B228-pathogens-08-00265">228</xref>]. Herd immunity in children has been modeled, with studies suggesting that a substantial decrease in influenza infection of non-vaccinated individuals is predicted to occur, but only at very high rates of vaccine coverage (i.e., 90%) [<xref ref-type="bibr" rid="B229-pathogens-08-00265">229</xref>]. Development of more effective vaccines and increasing the rate of vaccination will bring the population closer protection from influenza virus infection [<xref ref-type="bibr" rid="B230-pathogens-08-00265">230</xref>]. Given the strong benefit of vaccinating pregnant women and children and the low vaccination rates across the globe, finding effective ways to increase these vaccination rates is critical for improving public health.</p>
<p>One major reason for vaccine refusal relates to the public’s lack of trust in the pharmaceutical industry, medical providers, and efficacy of the influenza vaccine [<xref ref-type="bibr" rid="B231-pathogens-08-00265">231</xref>]. Some work suggests that mandatory vaccination increases negative feelings and anger regarding vaccines as compared to voluntary vaccination programs [<xref ref-type="bibr" rid="B232-pathogens-08-00265">232</xref>]. Such feelings could also lead to a stronger aversion to all vaccines [<xref ref-type="bibr" rid="B233-pathogens-08-00265">233</xref>]. A particularly influential factor that has led to mistrust of vaccine safety has been rooted in the belief that vaccination is associated with children being placed on the autism spectrum [<xref ref-type="bibr" rid="B234-pathogens-08-00265">234</xref>]. Initial studies making this claim have since been retracted, and subsequent work has not supported this association [<xref ref-type="bibr" rid="B235-pathogens-08-00265">235</xref>,<xref ref-type="bibr" rid="B236-pathogens-08-00265">236</xref>]. Despite this fact, recent studies continue to demonstrate that younger siblings of children on the autism spectrum disorder are not fully vaccinated [<xref ref-type="bibr" rid="B237-pathogens-08-00265">237</xref>,<xref ref-type="bibr" rid="B238-pathogens-08-00265">238</xref>]. This work illustrates the long-lasting harm caused by the initial reports linking vaccine administration to autism. Furthermore, it shows that the general public is still very much concerned with the perceived risk of administering vaccines to children despite a lack of supporting evidence. Rebuilding confidence in vaccines will require communication and trust between clinical providers and patients [<xref ref-type="bibr" rid="B239-pathogens-08-00265">239</xref>,<xref ref-type="bibr" rid="B240-pathogens-08-00265">240</xref>].</p>
<p>Increasing vaccination rates in low- and middle-income countries will require additional resources to help offset the cost of development and implementation of vaccination programs [<xref ref-type="bibr" rid="B225-pathogens-08-00265">225</xref>]. It has been estimated that global supply of influenza virus vaccine is sufficient to cover pregnant women in low- and middle-income countries [<xref ref-type="bibr" rid="B241-pathogens-08-00265">241</xref>]. A recent phase 4 clinical trial demonstrated that developing a vaccination program for pregnant women is possible in Mali, a low-income country [<xref ref-type="bibr" rid="B242-pathogens-08-00265">242</xref>,<xref ref-type="bibr" rid="B243-pathogens-08-00265">243</xref>]. While the Mali study was not sufficiently powered to detect a decrease in ILI, maternal vaccination studies conducted in Bangladesh and South Africa have demonstrated at least partial protection against developing confirmed influenza virus infection [<xref ref-type="bibr" rid="B175-pathogens-08-00265">175</xref>,<xref ref-type="bibr" rid="B180-pathogens-08-00265">180</xref>]. Unfortunately, due to the lack of sufficient data for the benefit of developing such programs, the Global Alliance for Vaccines and Immunization has deprioritized maternal vaccinations against seasonal flu [<xref ref-type="bibr" rid="B244-pathogens-08-00265">244</xref>,<xref ref-type="bibr" rid="B245-pathogens-08-00265">245</xref>,<xref ref-type="bibr" rid="B246-pathogens-08-00265">246</xref>,<xref ref-type="bibr" rid="B247-pathogens-08-00265">247</xref>] while the Global Influenza Initiative recommends that all pregnant women be vaccinated in their third trimester [<xref ref-type="bibr" rid="B225-pathogens-08-00265">225</xref>]. This lack of harmonization between guidelines highlights the additional work needed to develop evidence-based recommendations for programs in resource poor countries [<xref ref-type="bibr" rid="B248-pathogens-08-00265">248</xref>]. Regardless, by increasing vaccine uptake in low- and middle-income countries, not only will human health be improved, but the chances of virus spreading to an expanded geographical region are lessened. This will help to contain virus and likely decrease the chance of establishing a pandemic.</p>
</sec>
</sec>
<sec id="sec3-pathogens-08-00265" sec-type="discussion">
<title>3. Discussion</title>
<p>Influenza infection is a serious health concern, especially for pregnant women and young children. While influenza vaccines are generally considered to be safe, vaccine uptake remains suboptimal. Vaccination of pregnant women provides protection against influenza infection in both the expectant mother as well as the infant due to transplacental transfer of influenza-virus-specific IgG antibody. Additionally, breastfeeding provides antibodies (in particular IgA that is not passed through the placenta) and immunomodulatory factors to prevent and/or combat influenza infection. These factors are particularly important in the first six months of life, as active vaccination is not recommended for this age group. For infants born prematurely, complicating factors such as chronic lung disease increases the risk for developing severe illness after influenza infection. Despite having an immature immune system, vaccination is recommended on schedule in this population and has been shown to be protective. Furthermore, vaccination of these populations will help to guard against the development of ARDS, which is a major health concern following infection with influenza virus.</p>
<p>Influenza viruses undergoes continuous antigenic drift, which leads to lower than ideal vaccine efficacy in some seasons. Furthermore, antigenic shifts resulting in pandemic outbreaks is not uncommon, with 4 pandemics in the 21st century. Next generation influenza vaccines targeted against highly conserved regions of the influenza virus are being developed that may provide more universal protection against even potentially pandemic influenza strains. However, even if conventional vaccine strains of influenza are not well matched to circulating strains, reduced viral shedding and a shorter duration and severity of illness are often observed in the vaccinated population. Such information must be effectively disseminated to members of the public in order to improve vaccine uptake, as misconceptions about influenza vaccine adverse effects and effectiveness remains major obstacles to improving worldwide influenza vaccination rates. </p>
</sec>
<sec id="sec4-pathogens-08-00265" sec-type="conclusions">
<title>4. Conclusions</title>
<p>Influenza vaccination reduces the risk of influenza infection, severe disease, morbidity, and death. Despite this, the rate of influenza vaccination remains well below targets set forth by international and national health officials. While improving vaccination rates, especially among pregnant women and young children, is a high priority, additional large-scale studies would be of benefit to generate evidence-based recommendations in support of existing programs and to increase public confidence in current recommendations. In addition, development of more immunogenic and universally protective influenza vaccines will increase the breadth of protection provided while decreasing the frequency of vaccination required. Such efforts will be critical to increasing uptake of influenza vaccines and will improve the health of at-risk populations, such as children and pregnant women.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>The author thanks Gloria Pryhuber and Carl D’Angio in their support in his writing of the review article. Figures were generated using EDraw Max software.</p>
</ack>
<notes>
<title>Author Contributions</title>
<p>Conceptualization, R.S.M. and J.L.N.; writing—original draft preparation, R.S.M.; writing—review and editing, R.S.M. and J.L.N.; funding acquisition, R.S.M.</p>
</notes>
<notes>
<title>Funding</title>
<p>This research was funded by The University of Rochester Department of Pediatrics.</p>
</notes>
<notes notes-type="COI-statement">
<title>Conflicts of Interest</title>
<p>The authors declare no conflict of interest.</p>
</notes>
<glossary>
<title>Abbreviations</title>
<array orientation="portrait">
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ARDS</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Acute respiratory distress syndrome</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">IIV</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Inactivated Influenza Vaccine</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">LAIV</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Live Attenuated Influenza Virus</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">HA</td>
<td align="left" colspan="1" rowspan="1" valign="middle">hemagglutinin</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">NA</td>
<td align="left" colspan="1" rowspan="1" valign="middle">neuraminidase</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">NP</td>
<td align="left" colspan="1" rowspan="1" valign="middle">nucleoprotein</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">M1</td>
<td align="left" colspan="1" rowspan="1" valign="middle">matrix protein 1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">M2/BM2</td>
<td align="left" colspan="1" rowspan="1" valign="middle">matrix protein 2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">NS1</td>
<td align="left" colspan="1" rowspan="1" valign="middle">nonstructural protein 1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">NS2</td>
<td align="left" colspan="1" rowspan="1" valign="middle">nonstructural protein 2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">TLRs</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Toll-Like Receptors</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">RIG-I</td>
<td align="left" colspan="1" rowspan="1" valign="middle">retinoic acid-inducible gene I</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">NLRs</td>
<td align="left" colspan="1" rowspan="1" valign="middle">NOD-like receptors</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">MDA-5</td>
<td align="left" colspan="1" rowspan="1" valign="middle">melanoma differentiation-associated 5</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">IFN</td>
<td align="left" colspan="1" rowspan="1" valign="middle">interferons</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">IL</td>
<td align="left" colspan="1" rowspan="1" valign="middle">interleukin</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ASCs</td>
<td align="left" colspan="1" rowspan="1" valign="middle">antibody secreting cells</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ADCC</td>
<td align="left" colspan="1" rowspan="1" valign="middle">antibody-dependent cellular cytotoxicity</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">WHO</td>
<td align="left" colspan="1" rowspan="1" valign="middle">World Health Organization</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">AECI</td>
<td align="left" colspan="1" rowspan="1" valign="middle">alveolar epithelial type I</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">AECII</td>
<td align="left" colspan="1" rowspan="1" valign="middle">alveolar epithelial type II</td>
</tr>
</tbody>
</array>
</glossary>
<ref-list>
<title>References</title>
<ref id="B1-pathogens-08-00265">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Doyon-Plourde</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Fakih</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Tadount</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Fortin</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Quach</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Impact of influenza vaccination on healthcare utilization—A systematic review</article-title>
<source/>Vaccine
          <year>2019</year>
<volume>37</volume>
<fpage>3179</fpage>
<lpage>3189</lpage>
<pub-id pub-id-type="doi">10.1016/j.vaccine.2019.04.051</pub-id>
<pub-id pub-id-type="pmid">31047677</pub-id>
</element-citation>
</ref>
<ref id="B2-pathogens-08-00265">
<label>2.</label>
<element-citation publication-type="gov">
<person-group person-group-type="author">
<collab>United_States_Food_and_Drug_Administration</collab>
</person-group>
<article-title>Pediatric Medical Devices</article-title>
<comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.fda.gov/medical-devices/products-and-medical-procedures/pediatric-medical-devices">https://www.fda.gov/medical-devices/products-and-medical-procedures/pediatric-medical-devices</ext-link></comment>
<date-in-citation content-type="access-date" iso-8601-date="2019-11-25">(accessed on 25 November 2019)</date-in-citation>
</element-citation>
</ref>
<ref id="B3-pathogens-08-00265">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nair</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Brooks</surname>
<given-names>W.A.</given-names>
</name>
<name>
<surname>Katz</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Roca</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Berkley</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Madhi</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Simmerman</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Howie</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Global burden of respiratory infections due to seasonal influenza in young children: A systematic review and meta-analysis</article-title>
<source/>Lancet
          <year>2011</year>
<volume>378</volume>
<fpage>1917</fpage>
<lpage>1930</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(11)61051-9</pub-id>
<pub-id pub-id-type="pmid">22078723</pub-id>
</element-citation>
</ref>
<ref id="B4-pathogens-08-00265">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nunes</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Madhi</surname>
<given-names>S.A.</given-names>
</name>
</person-group>
<article-title>Influenza vaccination during pregnancy for prevention of influenza confirmed illness in the infants: A systematic review and meta-analysis</article-title>
<source/>Hum. Vaccines Immunother.
          <year>2018</year>
<volume>14</volume>
<fpage>758</fpage>
<lpage>766</lpage>
<pub-id pub-id-type="doi">10.1080/21645515.2017.1345385</pub-id>
<pub-id pub-id-type="pmid">28708952</pub-id>
</element-citation>
</ref>
<ref id="B5-pathogens-08-00265">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lafond</surname>
<given-names>K.E.</given-names>
</name>
<name>
<surname>Nair</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Rasooly</surname>
<given-names>M.H.</given-names>
</name>
<name>
<surname>Valente</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Booy</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Rahman</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kitsutani</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Guzman</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Coulibaly</surname>
<given-names>D.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Global Role and Burden of Influenza in Pediatric Respiratory Hospitalizations, 1982–2012: A Systematic Analysis</article-title>
<source/>PLoS Med.
          <year>2016</year>
<volume>13</volume>
<elocation-id>e1001977</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pmed.1001977</pub-id>
<pub-id pub-id-type="pmid">27011229</pub-id>
</element-citation>
</ref>
<ref id="B6-pathogens-08-00265">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>Committee On Infectious Diseases</collab>
</person-group>
<article-title>Recommendations for Prevention and Control of Influenza in Children, 2018–2019</article-title>
<source/>Pediatrics
          <year>2018</year>
<volume>142</volume>
<fpage>e20182367</fpage>
<pub-id pub-id-type="doi">10.1542/peds.2018-2367</pub-id>
<pub-id pub-id-type="pmid">30177511</pub-id>
</element-citation>
</ref>
<ref id="B7-pathogens-08-00265">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nunes</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Madhi</surname>
<given-names>S.A.</given-names>
</name>
</person-group>
<article-title>Prevention of influenza-related illness in young infants by maternal vaccination during pregnancy</article-title>
<source/>F1000Research
          <year>2018</year>
<volume>7</volume>
<fpage>122</fpage>
<pub-id pub-id-type="doi">10.12688/f1000research.12473.1</pub-id>
<pub-id pub-id-type="pmid">29445450</pub-id>
</element-citation>
</ref>
<ref id="B8-pathogens-08-00265">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Short</surname>
<given-names>K.R.</given-names>
</name>
<name>
<surname>Kroeze</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Fouchier</surname>
<given-names>R.A.M.</given-names>
</name>
<name>
<surname>Kuiken</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Pathogenesis of influenza-induced acute respiratory distress syndrome</article-title>
<source/>Lancet Infect. Dis.
          <year>2014</year>
<volume>14</volume>
<fpage>57</fpage>
<lpage>69</lpage>
<pub-id pub-id-type="doi">10.1016/S1473-3099(13)70286-X</pub-id>
<pub-id pub-id-type="pmid">24239327</pub-id>
</element-citation>
</ref>
<ref id="B9-pathogens-08-00265">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Simonsen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Schonberger</surname>
<given-names>L.B.</given-names>
</name>
<name>
<surname>Arden</surname>
<given-names>N.H.</given-names>
</name>
<name>
<surname>Cox</surname>
<given-names>N.J.</given-names>
</name>
<name>
<surname>Fukuda</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Pandemic versus epidemic influenza mortality: A pattern of changing age distribution</article-title>
<source/>J. Infect. Dis.
          <year>1998</year>
<volume>178</volume>
<fpage>53</fpage>
<lpage>60</lpage>
<pub-id pub-id-type="doi">10.1086/515616</pub-id>
<pub-id pub-id-type="pmid">9652423</pub-id>
</element-citation>
</ref>
<ref id="B10-pathogens-08-00265">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Short</surname>
<given-names>K.R.</given-names>
</name>
<name>
<surname>Kasper</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>van der Aa</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Andeweg</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Zaaraoui-Boutahar</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Goeijenbier</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Richard</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Herold</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Becker</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Scott</surname>
<given-names>D.P.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Influenza virus damages the alveolar barrier by disrupting epithelial cell tight junctions</article-title>
<source/>Eur. Respir. J.
          <year>2016</year>
<volume>47</volume>
<fpage>954</fpage>
<lpage>966</lpage>
<pub-id pub-id-type="doi">10.1183/13993003.01282-2015</pub-id>
<pub-id pub-id-type="pmid">26743480</pub-id>
</element-citation>
</ref>
<ref id="B11-pathogens-08-00265">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wonderlich</surname>
<given-names>E.R.</given-names>
</name>
<name>
<surname>Swan</surname>
<given-names>Z.D.</given-names>
</name>
<name>
<surname>Bissel</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Hartman</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Carney</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>O’Malley</surname>
<given-names>K.J.</given-names>
</name>
<name>
<surname>Obadan</surname>
<given-names>A.O.</given-names>
</name>
<name>
<surname>Santos</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Sturgeon</surname>
<given-names>T.J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Widespread Virus Replication in Alveoli Drives Acute Respiratory Distress Syndrome in Aerosolized H5N1 Influenza Infection of Macaques</article-title>
<source/>J. Immunol.
          <year>2017</year>
<volume>198</volume>
<fpage>1616</fpage>
<lpage>1626</lpage>
<pub-id pub-id-type="doi">10.4049/jimmunol.1601770</pub-id>
<pub-id pub-id-type="pmid">28062701</pub-id>
</element-citation>
</ref>
<ref id="B12-pathogens-08-00265">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kennedy</surname>
<given-names>E.D.</given-names>
</name>
<name>
<surname>Roy</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Norris</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Fry</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Kanzaria</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Blau</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Shieh</surname>
<given-names>W.J.</given-names>
</name>
<name>
<surname>Zaki</surname>
<given-names>S.R.</given-names>
</name>
<name>
<surname>Waller</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kamimoto</surname>
<given-names>L.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Lower respiratory tract hemorrhage associated with 2009 pandemic influenza A (H1N1) virus infection</article-title>
<source/>Influenza Other Respir. Viruses
          <year>2013</year>
<volume>7</volume>
<fpage>761</fpage>
<lpage>765</lpage>
<pub-id pub-id-type="doi">10.1111/irv.12026</pub-id>
<pub-id pub-id-type="pmid">23279922</pub-id>
</element-citation>
</ref>
<ref id="B13-pathogens-08-00265">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shieh</surname>
<given-names>W.J.</given-names>
</name>
<name>
<surname>Blau</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Denison</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Deleon-Carnes</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Adem</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Bhatnagar</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sumner</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Batten</surname>
<given-names>B.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>2009 pandemic influenza A (H1N1): Pathology and pathogenesis of 100 fatal cases in the United States</article-title>
<source/>Am. J. Pathol.
          <year>2010</year>
<volume>177</volume>
<fpage>166</fpage>
<lpage>175</lpage>
<pub-id pub-id-type="doi">10.2353/ajpath.2010.100115</pub-id>
<pub-id pub-id-type="pmid">20508031</pub-id>
</element-citation>
</ref>
<ref id="B14-pathogens-08-00265">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nye</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Whitley</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Viral Infection in the Development and Progression of Pediatric Acute Respiratory Distress Syndrome</article-title>
<source/>Front. Pediatr.
          <year>2016</year>
<volume>4</volume>
<fpage>128</fpage>
<pub-id pub-id-type="doi">10.3389/fped.2016.00128</pub-id>
<pub-id pub-id-type="pmid">27933286</pub-id>
</element-citation>
</ref>
<ref id="B15-pathogens-08-00265">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matthay</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Zemans</surname>
<given-names>R.L.</given-names>
</name>
<name>
<surname>Zimmerman</surname>
<given-names>G.A.</given-names>
</name>
<name>
<surname>Arabi</surname>
<given-names>Y.M.</given-names>
</name>
<name>
<surname>Beitler</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Mercat</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Herridge</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Randolph</surname>
<given-names>A.G.</given-names>
</name>
<name>
<surname>Calfee</surname>
<given-names>C.S.</given-names>
</name>
</person-group>
<article-title>Acute respiratory distress syndrome</article-title>
<source/>Nat. Rev. Dis Primers
          <year>2019</year>
<volume>5</volume>
<fpage>18</fpage>
<pub-id pub-id-type="doi">10.1038/s41572-019-0069-0</pub-id>
<pub-id pub-id-type="pmid">30872586</pub-id>
</element-citation>
</ref>
<ref id="B16-pathogens-08-00265">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rush</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Martinka</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Kilb</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>McDermid</surname>
<given-names>R.C.</given-names>
</name>
<name>
<surname>Boyd</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Celi</surname>
<given-names>L.A.</given-names>
</name>
</person-group>
<article-title>Acute Respiratory Distress Syndrome in Pregnant Women</article-title>
<source/>Obstet. Gynecol.
          <year>2017</year>
<volume>129</volume>
<fpage>530</fpage>
<lpage>535</lpage>
<pub-id pub-id-type="doi">10.1097/AOG.0000000000001907</pub-id>
<pub-id pub-id-type="pmid">28178046</pub-id>
</element-citation>
</ref>
<ref id="B17-pathogens-08-00265">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kalil</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>P.G.</given-names>
</name>
</person-group>
<article-title>Influenza virus-related critical illness: Pathophysiology and epidemiology</article-title>
<source/>Crit. Care
          <year>2019</year>
<volume>23</volume>
<fpage>258</fpage>
<pub-id pub-id-type="doi">10.1186/s13054-019-2539-x</pub-id>
<pub-id pub-id-type="pmid">31324202</pub-id>
</element-citation>
</ref>
<ref id="B18-pathogens-08-00265">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mameli</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Cocchi</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Fumagalli</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zuccotti</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Influenza Vaccination: Effectiveness, Indications, and Limits in the Pediatric Population</article-title>
<source/>Front. Pediatri.
          <year>2019</year>
<volume>7</volume>
<fpage>317</fpage>
<pub-id pub-id-type="doi">10.3389/fped.2019.00317</pub-id>
</element-citation>
</ref>
<ref id="B19-pathogens-08-00265">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Molecular evolution of hemagglutinin gene of Influenza A virus</article-title>
<source/>Front. Biosci.
          <year>2018</year>
<volume>10</volume>
<fpage>101</fpage>
<lpage>118</lpage>
<pub-id pub-id-type="doi">10.2741/s502</pub-id>
</element-citation>
</ref>
<ref id="B20-pathogens-08-00265">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arai</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kawashita</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Hotta</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hoang</surname>
<given-names>P.V.M.</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>H.L.K.</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>T.C.</given-names>
</name>
<name>
<surname>Vuong</surname>
<given-names>C.D.</given-names>
</name>
<name>
<surname>Le</surname>
<given-names>T.T.</given-names>
</name>
<name>
<surname>Le</surname>
<given-names>M.T.Q.</given-names>
</name>
<name>
<surname>Soda</surname>
<given-names>K.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Multiple polymerase gene mutations for human adaptation occurring in Asian H5N1 influenza virus clinical isolates</article-title>
<source/>Sci. Rep.
          <year>2018</year>
<volume>8</volume>
<fpage>13066</fpage>
<pub-id pub-id-type="doi">10.1038/s41598-018-31397-3</pub-id>
<pub-id pub-id-type="pmid">30166556</pub-id>
</element-citation>
</ref>
<ref id="B21-pathogens-08-00265">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Graaf</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Fouchier</surname>
<given-names>R.A.</given-names>
</name>
</person-group>
<article-title>Role of receptor binding specificity in influenza A virus transmission and pathogenesis</article-title>
<source/>EMBO J.
          <year>2014</year>
<volume>33</volume>
<fpage>823</fpage>
<lpage>841</lpage>
<pub-id pub-id-type="doi">10.1002/embj.201387442</pub-id>
<pub-id pub-id-type="pmid">24668228</pub-id>
</element-citation>
</ref>
<ref id="B22-pathogens-08-00265">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goka</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Vallely</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>Mutton</surname>
<given-names>K.J.</given-names>
</name>
<name>
<surname>Klapper</surname>
<given-names>P.E.</given-names>
</name>
</person-group>
<article-title>Mutations associated with severity of the pandemic influenza A(H1N1)pdm09 in humans: A systematic review and meta-analysis of epidemiological evidence</article-title>
<source/>Arch. Virol.
          <year>2014</year>
<volume>159</volume>
<fpage>3167</fpage>
<lpage>3183</lpage>
<pub-id pub-id-type="doi">10.1007/s00705-014-2179-z</pub-id>
<pub-id pub-id-type="pmid">25078388</pub-id>
</element-citation>
</ref>
<ref id="B23-pathogens-08-00265">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Simon</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Pichon</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Valette</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Burfin</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Richard</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lina</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Josset</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Whole Genome Sequencing of A(H3N2) Influenza Viruses Reveals Variants Associated with Severity during the 2016–2017 Season</article-title>
<source/>Viruses
          <year>2019</year>
<volume>11</volume>
<elocation-id>108</elocation-id>
<pub-id pub-id-type="doi">10.3390/v11020108</pub-id>
<pub-id pub-id-type="pmid">30695992</pub-id>
</element-citation>
</ref>
<ref id="B24-pathogens-08-00265">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arai</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kawashita</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ibrahim</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Elgendy</surname>
<given-names>E.M.</given-names>
</name>
<name>
<surname>Daidoji</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ono</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Takagi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Nakaya</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Matsumoto</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>PB2 mutations arising during H9N2 influenza evolution in the Middle East confer enhanced replication and growth in mammals</article-title>
<source/>PLoS Pathog.
          <year>2019</year>
<volume>15</volume>
<elocation-id>e1007919</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.ppat.1007919</pub-id>
<pub-id pub-id-type="pmid">31265471</pub-id>
</element-citation>
</ref>
<ref id="B25-pathogens-08-00265">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seladi-Schulman</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>Suppiah</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Steel</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lowen</surname>
<given-names>A.C.</given-names>
</name>
</person-group>
<article-title>Filament-producing mutants of influenza A/Puerto Rico/8/1934 (H1N1) virus have higher neuraminidase activities than the spherical wild-type</article-title>
<source/>PLoS ONE
          <year>2014</year>
<volume>9</volume>
<elocation-id>e112462</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0112462</pub-id>
<pub-id pub-id-type="pmid">25383873</pub-id>
</element-citation>
</ref>
<ref id="B26-pathogens-08-00265">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Bhattacharya</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mereness</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lillis</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Misra</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Romas</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Huyck</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Howell</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bandyopadhyay</surname>
<given-names>G.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A novel in vitro model of primary human pediatric lung epithelial cells</article-title>
<source/>Pediatr. Res.
          <year>2019</year>
<pub-id pub-id-type="doi">10.1038/s41390-019-0340-9</pub-id>
</element-citation>
</ref>
<ref id="B27-pathogens-08-00265">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thangavel</surname>
<given-names>R.R.</given-names>
</name>
<name>
<surname>Reed</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Norcross</surname>
<given-names>E.W.</given-names>
</name>
<name>
<surname>Dixon</surname>
<given-names>S.N.</given-names>
</name>
<name>
<surname>Marquart</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Stray</surname>
<given-names>S.J.</given-names>
</name>
</person-group>
<article-title>“Boom” and “Bust” cycles in virus growth suggest multiple selective forces in influenza a evolution</article-title>
<source/>Virol. J.
          <year>2011</year>
<volume>8</volume>
<fpage>180</fpage>
<pub-id pub-id-type="doi">10.1186/1743-422X-8-180</pub-id>
<pub-id pub-id-type="pmid">21501520</pub-id>
</element-citation>
</ref>
<ref id="B28-pathogens-08-00265">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Trieu</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Davies</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Cox</surname>
<given-names>R.J.</given-names>
</name>
</person-group>
<article-title>Improving influenza vaccines: Challenges to effective implementation</article-title>
<source/>Curr. Opin. Immunol.
          <year>2018</year>
<volume>53</volume>
<fpage>88</fpage>
<lpage>95</lpage>
<pub-id pub-id-type="doi">10.1016/j.coi.2018.04.010</pub-id>
<pub-id pub-id-type="pmid">29719276</pub-id>
</element-citation>
</ref>
<ref id="B29-pathogens-08-00265">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Valkenburg</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Leung</surname>
<given-names>N.H.L.</given-names>
</name>
<name>
<surname>Bull</surname>
<given-names>M.B.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>A.P.Y.</given-names>
</name>
<name>
<surname>Poon</surname>
<given-names>L.L.M.</given-names>
</name>
<name>
<surname>Cowling</surname>
<given-names>B.J.</given-names>
</name>
</person-group>
<article-title>The Hurdles From Bench to Bedside in the Realization and Implementation of a Universal Influenza Vaccine</article-title>
<source/>Front. Immunol.
          <year>2018</year>
<volume>9</volume>
<fpage>1479</fpage>
<pub-id pub-id-type="doi">10.3389/fimmu.2018.01479</pub-id>
<pub-id pub-id-type="pmid">30013557</pub-id>
</element-citation>
</ref>
<ref id="B30-pathogens-08-00265">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Epstein</surname>
<given-names>S.L.</given-names>
</name>
</person-group>
<article-title>Universal Influenza Vaccines: Progress in Achieving Broad Cross-Protection In Vivo</article-title>
<source/>Am. J. Epidemiol.
          <year>2018</year>
<volume>187</volume>
<fpage>2603</fpage>
<lpage>2614</lpage>
<pub-id pub-id-type="doi">10.1093/aje/kwy145</pub-id>
<pub-id pub-id-type="pmid">30084906</pub-id>
</element-citation>
</ref>
<ref id="B31-pathogens-08-00265">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krammer</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>G.J.D.</given-names>
</name>
<name>
<surname>Fouchier</surname>
<given-names>R.A.M.</given-names>
</name>
<name>
<surname>Peiris</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kedzierska</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Doherty</surname>
<given-names>P.C.</given-names>
</name>
<name>
<surname>Palese</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Shaw</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Treanor</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Webster</surname>
<given-names>R.G.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Influenza</article-title>
<source/>Nat. Rev. Dis. Primers
          <year>2018</year>
<volume>4</volume>
<fpage>3</fpage>
<pub-id pub-id-type="doi">10.1038/s41572-018-0002-y</pub-id>
<pub-id pub-id-type="pmid">29955068</pub-id>
</element-citation>
</ref>
<ref id="B32-pathogens-08-00265">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharma</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Rebaza</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Dela Cruz</surname>
<given-names>C.S.</given-names>
</name>
</person-group>
<article-title>When “B” becomes “A”: The emerging threat of influenza B virus</article-title>
<source/>Eur. Respir. J.
          <year>2019</year>
<volume>54</volume>
<fpage>1901326</fpage>
<pub-id pub-id-type="doi">10.1183/13993003.01325-2019</pub-id>
<pub-id pub-id-type="pmid">31515409</pub-id>
</element-citation>
</ref>
<ref id="B33-pathogens-08-00265">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Asthagiri Arunkumar</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Krammer</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Universal influenza virus vaccines and therapeutics: Where do we stand with influenza B virus?</article-title>
<source/>Curr. Opin. Immunol.
          <year>2018</year>
<volume>53</volume>
<fpage>45</fpage>
<lpage>50</lpage>
<pub-id pub-id-type="doi">10.1016/j.coi.2018.04.002</pub-id>
<pub-id pub-id-type="pmid">29677684</pub-id>
</element-citation>
</ref>
<ref id="B34-pathogens-08-00265">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Proff</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Gershman</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Lezotte</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Nyquist</surname>
<given-names>A.C.</given-names>
</name>
</person-group>
<article-title>Case-based surveillance of influenza hospitalizations during 2004–2008, Colorado, USA</article-title>
<source/>Emerg. Infect. Dis.
          <year>2009</year>
<volume>15</volume>
<fpage>892</fpage>
<lpage>898</lpage>
<pub-id pub-id-type="doi">10.3201/eid1506.081645</pub-id>
<pub-id pub-id-type="pmid">19523287</pub-id>
</element-citation>
</ref>
<ref id="B35-pathogens-08-00265">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chiu</surname>
<given-names>S.S.</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>K.H.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>B.W.</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>W.H.</given-names>
</name>
<name>
<surname>Lau</surname>
<given-names>Y.L.</given-names>
</name>
<name>
<surname>Peiris</surname>
<given-names>J.S.</given-names>
</name>
</person-group>
<article-title>Virologically confirmed population-based burden of hospitalization caused by influenza A and B among children in Hong Kong</article-title>
<source/>Clin. Infect. Dis.
          <year>2009</year>
<volume>49</volume>
<fpage>1016</fpage>
<lpage>1021</lpage>
<pub-id pub-id-type="doi">10.1086/605570</pub-id>
<pub-id pub-id-type="pmid">19722912</pub-id>
</element-citation>
</ref>
<ref id="B36-pathogens-08-00265">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tran</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Vaudry</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Bettinger</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Halperin</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Scheifele</surname>
<given-names>D.W.</given-names>
</name>
<name>
<surname>Jadvji</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Mersereau</surname>
<given-names>T.</given-names>
</name>
<collab>Members of the Canadian Immunization Monitoring Program Active</collab>
</person-group>
<article-title>Hospitalization for Influenza A Versus B</article-title>
<source/>Pediatrics
          <year>2016</year>
<volume>138</volume>
<fpage>e20154643</fpage>
<pub-id pub-id-type="doi">10.1542/peds.2015-4643</pub-id>
<pub-id pub-id-type="pmid">27535144</pub-id>
</element-citation>
</ref>
<ref id="B37-pathogens-08-00265">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schrauwen</surname>
<given-names>E.J.</given-names>
</name>
<name>
<surname>de Graaf</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Herfst</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Rimmelzwaan</surname>
<given-names>G.F.</given-names>
</name>
<name>
<surname>Osterhaus</surname>
<given-names>A.D.</given-names>
</name>
<name>
<surname>Fouchier</surname>
<given-names>R.A.</given-names>
</name>
</person-group>
<article-title>Determinants of virulence of influenza A virus</article-title>
<source/>Eur. J. Clin. Microbiol. Infect. Dis.
          <year>2014</year>
<volume>33</volume>
<fpage>479</fpage>
<lpage>490</lpage>
<pub-id pub-id-type="doi">10.1007/s10096-013-1984-8</pub-id>
<pub-id pub-id-type="pmid">24078062</pub-id>
</element-citation>
</ref>
<ref id="B38-pathogens-08-00265">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Dou</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ostbye</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Revol</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Daniels</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Structural restrictions for influenza neuraminidase activity promote adaptation and diversification</article-title>
<source/>Nat. Microbiol.
          <year>2019</year>
<pub-id pub-id-type="doi">10.1038/s41564-019-0537-z</pub-id>
</element-citation>
</ref>
<ref id="B39-pathogens-08-00265">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morens</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Taubenberger</surname>
<given-names>J.K.</given-names>
</name>
<name>
<surname>Fauci</surname>
<given-names>A.S.</given-names>
</name>
</person-group>
<article-title>The persistent legacy of the 1918 influenza virus</article-title>
<source/>N. Engl. J. Med.
          <year>2009</year>
<volume>361</volume>
<fpage>225</fpage>
<lpage>229</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMp0904819</pub-id>
<pub-id pub-id-type="pmid">19564629</pub-id>
</element-citation>
</ref>
<ref id="B40-pathogens-08-00265">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lowen</surname>
<given-names>A.C.</given-names>
</name>
</person-group>
<article-title>Constraints, Drivers, and Implications of Influenza A Virus Reassortment</article-title>
<source/>Annu. Rev. Virol.
          <year>2017</year>
<volume>4</volume>
<fpage>105</fpage>
<lpage>121</lpage>
<pub-id pub-id-type="doi">10.1146/annurev-virology-101416-041726</pub-id>
<pub-id pub-id-type="pmid">28548881</pub-id>
</element-citation>
</ref>
<ref id="B41-pathogens-08-00265">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Potter</surname>
<given-names>C.W.</given-names>
</name>
<name>
<surname>Jennings</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>A definition for influenza pandemics based on historical records</article-title>
<source/>J. Infect.
          <year>2011</year>
<volume>63</volume>
<fpage>252</fpage>
<lpage>259</lpage>
<pub-id pub-id-type="doi">10.1016/j.jinf.2011.04.013</pub-id>
<pub-id pub-id-type="pmid">21632115</pub-id>
</element-citation>
</ref>
<ref id="B42-pathogens-08-00265">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Werner</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Schudrowitz</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kohler</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Antigenic variation of neuraminidase of human type A influenza (H3N2) viruses isolated in Berlin (West)</article-title>
<source/>Zentralbl Bakteriol Orig A
          <year>1975</year>
<volume>233</volume>
<fpage>440</fpage>
<lpage>446</lpage>
<pub-id pub-id-type="pmid">56831</pub-id>
</element-citation>
</ref>
<ref id="B43-pathogens-08-00265">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kelly</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>The classical definition of a pandemic is not elusive</article-title>
<source/>Bull. World Health Organ.
          <year>2011</year>
<volume>89</volume>
<fpage>540</fpage>
<lpage>541</lpage>
<pub-id pub-id-type="doi">10.2471/BLT.11.088815</pub-id>
<pub-id pub-id-type="pmid">21734771</pub-id>
</element-citation>
</ref>
<ref id="B44-pathogens-08-00265">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Doshi</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>The elusive definition of pandemic influenza</article-title>
<source/>Bull. World Health Organ.
          <year>2011</year>
<volume>89</volume>
<fpage>532</fpage>
<lpage>538</lpage>
<pub-id pub-id-type="doi">10.2471/BLT.11.086173</pub-id>
<pub-id pub-id-type="pmid">21734768</pub-id>
</element-citation>
</ref>
<ref id="B45-pathogens-08-00265">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zinsstag</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Schelling</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Waltner-Toews</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Tanner</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>From “one medicine” to “one health” and systemic approaches to health and well-being</article-title>
<source/>Prev. Vet. Med.
          <year>2011</year>
<volume>101</volume>
<fpage>148</fpage>
<lpage>156</lpage>
<pub-id pub-id-type="doi">10.1016/j.prevetmed.2010.07.003</pub-id>
<pub-id pub-id-type="pmid">20832879</pub-id>
</element-citation>
</ref>
<ref id="B46-pathogens-08-00265">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Short</surname>
<given-names>K.R.</given-names>
</name>
<name>
<surname>Richard</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Verhagen</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>van Riel</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Schrauwen</surname>
<given-names>E.J.</given-names>
</name>
<name>
<surname>van den Brand</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Manz</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Bodewes</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Herfst</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>One health, multiple challenges: The inter-species transmission of influenza A virus</article-title>
<source/>One Health
          <year>2015</year>
<volume>1</volume>
<fpage>1</fpage>
<lpage>13</lpage>
<pub-id pub-id-type="doi">10.1016/j.onehlt.2015.03.001</pub-id>
<pub-id pub-id-type="pmid">26309905</pub-id>
</element-citation>
</ref>
<ref id="B47-pathogens-08-00265">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Denney</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ho</surname>
<given-names>L.P.</given-names>
</name>
</person-group>
<article-title>The role of respiratory epithelium in host defence against influenza virus infection</article-title>
<source/>Biomed. J.
          <year>2018</year>
<volume>41</volume>
<fpage>218</fpage>
<lpage>233</lpage>
<pub-id pub-id-type="doi">10.1016/j.bj.2018.08.004</pub-id>
<pub-id pub-id-type="pmid">30348265</pub-id>
</element-citation>
</ref>
<ref id="B48-pathogens-08-00265">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luo</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Influenza virus entry</article-title>
<source/>Adv. Exp. Med. Biol.
          <year>2012</year>
<volume>726</volume>
<fpage>201</fpage>
<lpage>221</lpage>
<pub-id pub-id-type="doi">10.1007/978-1-4614-0980-9_9</pub-id>
<pub-id pub-id-type="pmid">22297515</pub-id>
</element-citation>
</ref>
<ref id="B49-pathogens-08-00265">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Londino</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Lazrak</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Collawn</surname>
<given-names>J.F.</given-names>
</name>
<name>
<surname>Bebok</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Harrod</surname>
<given-names>K.S.</given-names>
</name>
<name>
<surname>Matalon</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Influenza virus infection alters ion channel function of airway and alveolar cells: Mechanisms and physiological sequelae</article-title>
<source/>Am. J. Physiol. Lung Cell. Mol. Physiol.
          <year>2017</year>
<volume>313</volume>
<fpage>L845</fpage>
<lpage>L858</lpage>
<pub-id pub-id-type="doi">10.1152/ajplung.00244.2017</pub-id>
<pub-id pub-id-type="pmid">28775098</pub-id>
</element-citation>
</ref>
<ref id="B50-pathogens-08-00265">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Z.G.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z.N.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>T.T.</given-names>
</name>
<name>
<surname>Thong</surname>
<given-names>K.T.</given-names>
</name>
<name>
<surname>Ong</surname>
<given-names>Y.K.</given-names>
</name>
<name>
<surname>Chow</surname>
<given-names>V.T.K.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>K.S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Upregulation of cell-surface mucin MUC15 in human nasal epithelial cells upon influenza A virus infection</article-title>
<source/>BMC Infect. Dis.
          <year>2019</year>
<volume>19</volume>
<elocation-id>622</elocation-id>
<pub-id pub-id-type="doi">10.1186/s12879-019-4213-y</pub-id>
<pub-id pub-id-type="pmid">31307416</pub-id>
</element-citation>
</ref>
<ref id="B51-pathogens-08-00265">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hsieh</surname>
<given-names>I.N.</given-names>
</name>
<name>
<surname>De Luna</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>White</surname>
<given-names>M.R.</given-names>
</name>
<name>
<surname>Hartshorn</surname>
<given-names>K.L.</given-names>
</name>
</person-group>
<article-title>The Role and Molecular Mechanism of Action of Surfactant Protein D in Innate Host Defense Against Influenza A Virus</article-title>
<source/>Front. Immunol.
          <year>2018</year>
<volume>9</volume>
<fpage>1368</fpage>
<pub-id pub-id-type="doi">10.3389/fimmu.2018.01368</pub-id>
<pub-id pub-id-type="pmid">29951070</pub-id>
</element-citation>
</ref>
<ref id="B52-pathogens-08-00265">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nikolaidis</surname>
<given-names>N.M.</given-names>
</name>
<name>
<surname>White</surname>
<given-names>M.R.</given-names>
</name>
<name>
<surname>Allen</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Tripathi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Qi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>McDonald</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Taubenberger</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Seaton</surname>
<given-names>B.A.</given-names>
</name>
<name>
<surname>McCormack</surname>
<given-names>F.X.</given-names>
</name>
<name>
<surname>Crouch</surname>
<given-names>E.C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutations flanking the carbohydrate binding site of surfactant protein D confer antiviral activity for pandemic influenza A viruses</article-title>
<source/>Am. J. Physiol. Lung Cell. Mol. Physiol.
          <year>2014</year>
<volume>306</volume>
<fpage>L1036</fpage>
<lpage>L1044</lpage>
<pub-id pub-id-type="doi">10.1152/ajplung.00035.2014</pub-id>
<pub-id pub-id-type="pmid">24705721</pub-id>
</element-citation>
</ref>
<ref id="B53-pathogens-08-00265">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Herrera-Ramos</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Lopez-Rodriguez</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ruiz-Hernandez</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Horcajada</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Borderias</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Lerma</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Blanquer</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Perez-Gonzalez</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Garcia-Laorden</surname>
<given-names>M.I.</given-names>
</name>
<name>
<surname>Florido</surname>
<given-names>Y.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Surfactant protein A genetic variants associate with severe respiratory insufficiency in pandemic influenza A virus infection</article-title>
<source/>Crit. Care
          <year>2014</year>
<volume>18</volume>
<fpage>R127</fpage>
<pub-id pub-id-type="doi">10.1186/cc13934</pub-id>
<pub-id pub-id-type="pmid">24950659</pub-id>
</element-citation>
</ref>
<ref id="B54-pathogens-08-00265">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benne</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Kraaijeveld</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>van Strijp</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Brouwer</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Harmsen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Verhoef</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>van Golde</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>van Iwaarden</surname>
<given-names>J.F.</given-names>
</name>
</person-group>
<article-title>Interactions of surfactant protein A with influenza A viruses: Binding and neutralization</article-title>
<source/>J. Infect. Dis.
          <year>1995</year>
<volume>171</volume>
<fpage>335</fpage>
<lpage>341</lpage>
<pub-id pub-id-type="doi">10.1093/infdis/171.2.335</pub-id>
<pub-id pub-id-type="pmid">7844369</pub-id>
</element-citation>
</ref>
<ref id="B55-pathogens-08-00265">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>To</surname>
<given-names>K.K.W.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>Y.Q.</given-names>
</name>
<name>
<surname>Hung</surname>
<given-names>I.F.N.</given-names>
</name>
<name>
<surname>Ip</surname>
<given-names>W.C.T.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>Z.S.</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>A.S.F.</given-names>
</name>
<name>
<surname>Kao</surname>
<given-names>R.Y.T.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>A.K.L.</given-names>
</name>
<name>
<surname>Chau</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Surfactant protein B gene polymorphism is associated with severe influenza</article-title>
<source/>Chest
          <year>2014</year>
<volume>145</volume>
<fpage>1237</fpage>
<lpage>1243</lpage>
<pub-id pub-id-type="doi">10.1378/chest.13-1651</pub-id>
<pub-id pub-id-type="pmid">24337193</pub-id>
</element-citation>
</ref>
<ref id="B56-pathogens-08-00265">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hamilton</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Sachs</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>J.K.</given-names>
</name>
<name>
<surname>Langlois</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Palese</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Heaton</surname>
<given-names>N.S.</given-names>
</name>
</person-group>
<article-title>Club cells surviving influenza A virus infection induce temporary nonspecific antiviral immunity</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2016</year>
<volume>113</volume>
<fpage>3861</fpage>
<lpage>3866</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1522376113</pub-id>
<pub-id pub-id-type="pmid">27001854</pub-id>
</element-citation>
</ref>
<ref id="B57-pathogens-08-00265">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chamberlain</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Korwin-Mihavics</surname>
<given-names>B.R.</given-names>
</name>
<name>
<surname>Nakada</surname>
<given-names>E.M.</given-names>
</name>
<name>
<surname>Bruno</surname>
<given-names>S.R.</given-names>
</name>
<name>
<surname>Heppner</surname>
<given-names>D.E.</given-names>
</name>
<name>
<surname>Chapman</surname>
<given-names>D.G.</given-names>
</name>
<name>
<surname>Hoffman</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>van der Vliet</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Suratt</surname>
<given-names>B.T.</given-names>
</name>
<name>
<surname>Dienz</surname>
<given-names>O.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Lung epithelial protein disulfide isomerase A3 (PDIA3) plays an important role in influenza infection, inflammation, and airway mechanics</article-title>
<source/>Redox Biol.
          <year>2019</year>
<volume>22</volume>
<fpage>101129</fpage>
<pub-id pub-id-type="doi">10.1016/j.redox.2019.101129</pub-id>
<pub-id pub-id-type="pmid">30735910</pub-id>
</element-citation>
</ref>
<ref id="B58-pathogens-08-00265">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sell</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>McKinstry</surname>
<given-names>K.K.</given-names>
</name>
<name>
<surname>Strutt</surname>
<given-names>T.M.</given-names>
</name>
</person-group>
<article-title>Mouse Models Reveal Role of T-Cytotoxic and T-Reg Cells in Immune Response to Influenza: Implications for Vaccine Design</article-title>
<source/>Viruses
          <year>2019</year>
<volume>11</volume>
<elocation-id>52</elocation-id>
<pub-id pub-id-type="doi">10.3390/v11010052</pub-id>
</element-citation>
</ref>
<ref id="B59-pathogens-08-00265">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>T.H.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>H.K.</given-names>
</name>
</person-group>
<article-title>Differential roles of lung dendritic cell subsets against respiratory virus infection</article-title>
<source/>Immune Netw.
          <year>2014</year>
<volume>14</volume>
<fpage>128</fpage>
<lpage>137</lpage>
<pub-id pub-id-type="doi">10.4110/in.2014.14.3.128</pub-id>
<pub-id pub-id-type="pmid">24999309</pub-id>
</element-citation>
</ref>
<ref id="B60-pathogens-08-00265">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Mullarkey</surname>
<given-names>C.E.</given-names>
</name>
<name>
<surname>Hamilton</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>C.K.</given-names>
</name>
<name>
<surname>Leon</surname>
<given-names>P.E.</given-names>
</name>
<name>
<surname>Uccellini</surname>
<given-names>M.B.</given-names>
</name>
<name>
<surname>Chromikova</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Henry</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hoffman</surname>
<given-names>K.W.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Alveolar macrophages are critical for broadly-reactive antibody-mediated protection against influenza A virus in mice</article-title>
<source/>Nat. Commun.
          <year>2017</year>
<volume>8</volume>
<fpage>846</fpage>
<pub-id pub-id-type="doi">10.1038/s41467-017-00928-3</pub-id>
<pub-id pub-id-type="pmid">29018261</pub-id>
</element-citation>
</ref>
<ref id="B61-pathogens-08-00265">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumagai</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Takeuchi</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Kato</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Matsui</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Morii</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Aozasa</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kawai</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Akira</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Alveolar macrophages are the primary interferon-alpha producer in pulmonary infection with RNA viruses</article-title>
<source/>Immunity
          <year>2007</year>
<volume>27</volume>
<fpage>240</fpage>
<lpage>252</lpage>
<pub-id pub-id-type="doi">10.1016/j.immuni.2007.07.013</pub-id>
<pub-id pub-id-type="pmid">17723216</pub-id>
</element-citation>
</ref>
<ref id="B62-pathogens-08-00265">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vangeti</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Smed-Sorensen</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Respiratory Mononuclear Phagocytes in Human Influenza A Virus Infection: Their Role in Immune Protection and As Targets of the Virus</article-title>
<source/>Front. Immunol.
          <year>2018</year>
<volume>9</volume>
<fpage>1521</fpage>
<pub-id pub-id-type="doi">10.3389/fimmu.2018.01521</pub-id>
<pub-id pub-id-type="pmid">30018617</pub-id>
</element-citation>
</ref>
<ref id="B63-pathogens-08-00265">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spitaels</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Roose</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Saelens</surname>
<given-names>X.</given-names>
</name>
</person-group>
<article-title>Influenza and Memory T Cells: How to Awake the Force</article-title>
<source/>Vaccines
          <year>2016</year>
<volume>4</volume>
<elocation-id>33</elocation-id>
<pub-id pub-id-type="doi">10.3390/vaccines4040033</pub-id>
<pub-id pub-id-type="pmid">27754364</pub-id>
</element-citation>
</ref>
<ref id="B64-pathogens-08-00265">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lambrecht</surname>
<given-names>B.N.</given-names>
</name>
<name>
<surname>Hammad</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Lung dendritic cells in respiratory viral infection and asthma: From protection to immunopathology</article-title>
<source/>Annu. Rev. Immunol.
          <year>2012</year>
<volume>30</volume>
<fpage>243</fpage>
<lpage>270</lpage>
<pub-id pub-id-type="doi">10.1146/annurev-immunol-020711-075021</pub-id>
<pub-id pub-id-type="pmid">22224777</pub-id>
</element-citation>
</ref>
<ref id="B65-pathogens-08-00265">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smed-Sorensen</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Chalouni</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Chatterjee</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Cohn</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Blattmann</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Delamarre</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Mellman</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Influenza A virus infection of human primary dendritic cells impairs their ability to cross-present antigen to CD8 T cells</article-title>
<source/>PLoS Pathog.
          <year>2012</year>
<volume>8</volume>
<elocation-id>e1002572</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.ppat.1002572</pub-id>
<pub-id pub-id-type="pmid">22412374</pub-id>
</element-citation>
</ref>
<ref id="B66-pathogens-08-00265">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pizzolla</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>T.H.O.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Brooks</surname>
<given-names>A.G.</given-names>
</name>
<name>
<surname>Kedzierska</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Heath</surname>
<given-names>W.R.</given-names>
</name>
<name>
<surname>Reading</surname>
<given-names>P.C.</given-names>
</name>
<name>
<surname>Wakim</surname>
<given-names>L.M.</given-names>
</name>
</person-group>
<article-title>Resident memory CD8+ T cells in the upper respiratory tract prevent pulmonary influenza virus infection</article-title>
<source/>Sci. Immunol.
          <year>2017</year>
<volume>2</volume>
<fpage>eaam6970</fpage>
<pub-id pub-id-type="doi">10.1126/sciimmunol.aam6970</pub-id>
<pub-id pub-id-type="pmid">28783656</pub-id>
</element-citation>
</ref>
<ref id="B67-pathogens-08-00265">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>Y.T.</given-names>
</name>
<name>
<surname>Bouchard</surname>
<given-names>K.R.</given-names>
</name>
<name>
<surname>Benechet</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Khanna</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Cauley</surname>
<given-names>L.S.</given-names>
</name>
</person-group>
<article-title>Lung-resident memory CD8 T cells (TRM) are indispensable for optimal cross-protection against pulmonary virus infection</article-title>
<source/>J. Leukoc. Biol.
          <year>2014</year>
<volume>95</volume>
<fpage>215</fpage>
<lpage>224</lpage>
<pub-id pub-id-type="doi">10.1189/jlb.0313180</pub-id>
<pub-id pub-id-type="pmid">24006506</pub-id>
</element-citation>
</ref>
<ref id="B68-pathogens-08-00265">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sant</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Richards</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Nayak</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Distinct and complementary roles of CD4 T cells in protective immunity to influenza virus</article-title>
<source/>Curr. Opin. Immunol.
          <year>2018</year>
<volume>53</volume>
<fpage>13</fpage>
<lpage>21</lpage>
<pub-id pub-id-type="doi">10.1016/j.coi.2018.03.019</pub-id>
<pub-id pub-id-type="pmid">29621639</pub-id>
</element-citation>
</ref>
<ref id="B69-pathogens-08-00265">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sant</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>DiPiazza</surname>
<given-names>A.T.</given-names>
</name>
<name>
<surname>Nayak</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Rattan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Richards</surname>
<given-names>K.A.</given-names>
</name>
</person-group>
<article-title>CD4 T cells in protection from influenza virus: Viral antigen specificity and functional potential</article-title>
<source/>Immunol. Rev.
          <year>2018</year>
<volume>284</volume>
<fpage>91</fpage>
<lpage>105</lpage>
<pub-id pub-id-type="doi">10.1111/imr.12662</pub-id>
<pub-id pub-id-type="pmid">29944766</pub-id>
</element-citation>
</ref>
<ref id="B70-pathogens-08-00265">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Biram</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Davidzohn</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Shulman</surname>
<given-names>Z.</given-names>
</name>
</person-group>
<article-title>T cell interactions with B cells during germinal center formation, a three-step model</article-title>
<source/>Immunol. Rev.
          <year>2019</year>
<volume>288</volume>
<fpage>37</fpage>
<lpage>48</lpage>
<pub-id pub-id-type="doi">10.1111/imr.12737</pub-id>
<pub-id pub-id-type="pmid">30874355</pub-id>
</element-citation>
</ref>
<ref id="B71-pathogens-08-00265">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takahashi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Onodera</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Adachi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ato</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Adaptive B Cell Responses to Influenza Virus Infection in the Lung</article-title>
<source/>Viral Immunol.
          <year>2017</year>
<volume>30</volume>
<fpage>431</fpage>
<lpage>437</lpage>
<pub-id pub-id-type="doi">10.1089/vim.2017.0025</pub-id>
<pub-id pub-id-type="pmid">28661720</pub-id>
</element-citation>
</ref>
<ref id="B72-pathogens-08-00265">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shinnakasu</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kurosaki</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Regulation of memory B and plasma cell differentiation</article-title>
<source/>Curr. Opin. Immunol.
          <year>2017</year>
<volume>45</volume>
<fpage>126</fpage>
<lpage>131</lpage>
<pub-id pub-id-type="doi">10.1016/j.coi.2017.03.003</pub-id>
<pub-id pub-id-type="pmid">28359033</pub-id>
</element-citation>
</ref>
<ref id="B73-pathogens-08-00265">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nguyen</surname>
<given-names>D.C.</given-names>
</name>
<name>
<surname>Garimalla</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kyu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Albizua</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Galipeau</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chiang</surname>
<given-names>K.Y.</given-names>
</name>
<name>
<surname>Waller</surname>
<given-names>E.K.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Gibson</surname>
<given-names>G.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Factors of the bone marrow microniche that support human plasma cell survival and immunoglobulin secretion</article-title>
<source/>Nat. Commun.
          <year>2018</year>
<volume>9</volume>
<fpage>3698</fpage>
<pub-id pub-id-type="doi">10.1038/s41467-018-05853-7</pub-id>
<pub-id pub-id-type="pmid">30209264</pub-id>
</element-citation>
</ref>
<ref id="B74-pathogens-08-00265">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lavine</surname>
<given-names>S.D.</given-names>
</name>
<name>
<surname>Cockroft</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hoh</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Bambakidis</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Khalessi</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Woo</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Riina</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Siddiqui</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hirsch</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Chong</surname>
<given-names>W.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Erratum to: Training guidelines for endovascular stroke intervention: An international multi-society consensus document</article-title>
<source/>Neuroradiology
          <year>2017</year>
<volume>59</volume>
<fpage>829</fpage>
<pub-id pub-id-type="doi">10.1007/s00234-017-1861-8</pub-id>
<pub-id pub-id-type="pmid">28634647</pub-id>
</element-citation>
</ref>
<ref id="B75-pathogens-08-00265">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ellebedy</surname>
<given-names>A.H.</given-names>
</name>
<name>
<surname>Jackson</surname>
<given-names>K.J.</given-names>
</name>
<name>
<surname>Kissick</surname>
<given-names>H.T.</given-names>
</name>
<name>
<surname>Nakaya</surname>
<given-names>H.I.</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>C.W.</given-names>
</name>
<name>
<surname>Roskin</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>McElroy</surname>
<given-names>A.K.</given-names>
</name>
<name>
<surname>Oshansky</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Elbein</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Defining antigen-specific plasmablast and memory B cell subsets in human blood after viral infection or vaccination</article-title>
<source/>Nat. Immunol.
          <year>2016</year>
<volume>17</volume>
<fpage>1226</fpage>
<lpage>1234</lpage>
<pub-id pub-id-type="doi">10.1038/ni.3533</pub-id>
<pub-id pub-id-type="pmid">27525369</pub-id>
</element-citation>
</ref>
<ref id="B76-pathogens-08-00265">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Good-Jacobson</surname>
<given-names>K.L.</given-names>
</name>
</person-group>
<article-title>Strength in diversity: Phenotypic, functional, and molecular heterogeneity within the memory B cell repertoire</article-title>
<source/>Immunol. Rev.
          <year>2018</year>
<volume>284</volume>
<fpage>67</fpage>
<lpage>78</lpage>
<pub-id pub-id-type="doi">10.1111/imr.12663</pub-id>
<pub-id pub-id-type="pmid">29944763</pub-id>
</element-citation>
</ref>
<ref id="B77-pathogens-08-00265">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ellebedy</surname>
<given-names>A.H.</given-names>
</name>
</person-group>
<article-title>Immunizing the Immune: Can We Overcome Influenza’s Most Formidable Challenge?</article-title>
<source/>Vaccines
          <year>2018</year>
<volume>6</volume>
<elocation-id>68</elocation-id>
<pub-id pub-id-type="doi">10.3390/vaccines6040068</pub-id>
</element-citation>
</ref>
<ref id="B78-pathogens-08-00265">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lam</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Baumgarth</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>The Multifaceted B Cell Response to Influenza Virus</article-title>
<source/>J. Immunol.
          <year>2019</year>
<volume>202</volume>
<fpage>351</fpage>
<lpage>359</lpage>
<pub-id pub-id-type="doi">10.4049/jimmunol.1801208</pub-id>
<pub-id pub-id-type="pmid">30617116</pub-id>
</element-citation>
</ref>
<ref id="B79-pathogens-08-00265">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Padilla-Quirarte</surname>
<given-names>H.O.</given-names>
</name>
<name>
<surname>Lopez-Guerrero</surname>
<given-names>D.V.</given-names>
</name>
<name>
<surname>Gutierrez-Xicotencatl</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Esquivel-Guadarrama</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Protective Antibodies Against Influenza Proteins</article-title>
<source/>Front. Immunol.
          <year>2019</year>
<volume>10</volume>
<fpage>1677</fpage>
<pub-id pub-id-type="doi">10.3389/fimmu.2019.01677</pub-id>
<pub-id pub-id-type="pmid">31379866</pub-id>
</element-citation>
</ref>
<ref id="B80-pathogens-08-00265">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vanderven</surname>
<given-names>H.A.</given-names>
</name>
<name>
<surname>Jegaskanda</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wheatley</surname>
<given-names>A.K.</given-names>
</name>
<name>
<surname>Kent</surname>
<given-names>S.J.</given-names>
</name>
</person-group>
<article-title>Antibody-dependent cellular cytotoxicity and influenza virus</article-title>
<source/>Curr. Opin. Virol.
          <year>2017</year>
<volume>22</volume>
<fpage>89</fpage>
<lpage>96</lpage>
<pub-id pub-id-type="doi">10.1016/j.coviro.2016.12.002</pub-id>
<pub-id pub-id-type="pmid">28088123</pub-id>
</element-citation>
</ref>
<ref id="B81-pathogens-08-00265">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>DiPiazza</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Richards</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Knowlden</surname>
<given-names>Z.A.</given-names>
</name>
<name>
<surname>Nayak</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Sant</surname>
<given-names>A.J.</given-names>
</name>
</person-group>
<article-title>The Role of CD4 T Cell Memory in Generating Protective Immunity to Novel and Potentially Pandemic Strains of Influenza</article-title>
<source/>Front. Immunol.
          <year>2016</year>
<volume>7</volume>
<fpage>10</fpage>
<pub-id pub-id-type="doi">10.3389/fimmu.2016.00010</pub-id>
<pub-id pub-id-type="pmid">26834750</pub-id>
</element-citation>
</ref>
<ref id="B82-pathogens-08-00265">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dhume</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>McKinstry</surname>
<given-names>K.K.</given-names>
</name>
</person-group>
<article-title>Early programming and late-acting checkpoints governing the development of CD4 T-cell memory</article-title>
<source/>Immunology
          <year>2018</year>
<volume>155</volume>
<fpage>53</fpage>
<lpage>62</lpage>
<pub-id pub-id-type="doi">10.1111/imm.12942</pub-id>
<pub-id pub-id-type="pmid">29701246</pub-id>
</element-citation>
</ref>
<ref id="B83-pathogens-08-00265">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Auladell</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Hensen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Chua</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Fox</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>T.H.O.</given-names>
</name>
<name>
<surname>Doherty</surname>
<given-names>P.C.</given-names>
</name>
<name>
<surname>Kedzierska</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Recalling the Future: Immunological Memory Toward Unpredictable Influenza Viruses</article-title>
<source/>Front. Immunol.
          <year>2019</year>
<volume>10</volume>
<fpage>1400</fpage>
<pub-id pub-id-type="doi">10.3389/fimmu.2019.01400</pub-id>
<pub-id pub-id-type="pmid">31312199</pub-id>
</element-citation>
</ref>
<ref id="B84-pathogens-08-00265">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hrincius</surname>
<given-names>E.R.</given-names>
</name>
<name>
<surname>Liedmann</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Finkelstein</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Vogel</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Gansebom</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Samarasinghe</surname>
<given-names>A.E.</given-names>
</name>
<name>
<surname>You</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Cormier</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>McCullers</surname>
<given-names>J.A.</given-names>
</name>
</person-group>
<article-title>Acute Lung Injury Results from Innate Sensing of Viruses by an ER Stress Pathway</article-title>
<source/>Cell Rep.
          <year>2015</year>
<volume>11</volume>
<fpage>1591</fpage>
<lpage>1603</lpage>
<pub-id pub-id-type="doi">10.1016/j.celrep.2015.05.012</pub-id>
<pub-id pub-id-type="pmid">26051937</pub-id>
</element-citation>
</ref>
<ref id="B85-pathogens-08-00265">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>D.T.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>C.Y.</given-names>
</name>
<name>
<surname>Chi</surname>
<given-names>Y.H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W.L.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>L.Y.</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Hsu</surname>
<given-names>W.M.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>L.M.</given-names>
</name>
</person-group>
<article-title>Adaptation of influenza A (H7N9) virus in primary human airway epithelial cells</article-title>
<source/>Sci. Rep.
          <year>2017</year>
<volume>7</volume>
<fpage>11300</fpage>
<pub-id pub-id-type="doi">10.1038/s41598-017-10749-5</pub-id>
<pub-id pub-id-type="pmid">28900138</pub-id>
</element-citation>
</ref>
<ref id="B86-pathogens-08-00265">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krug</surname>
<given-names>R.M.</given-names>
</name>
</person-group>
<article-title>Functions of the influenza A virus NS1 protein in antiviral defense</article-title>
<source/>Curr. Opin. Virol.
          <year>2015</year>
<volume>12</volume>
<fpage>1</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="doi">10.1016/j.coviro.2015.01.007</pub-id>
<pub-id pub-id-type="pmid">25638592</pub-id>
</element-citation>
</ref>
<ref id="B87-pathogens-08-00265">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sanders</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Vogel</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>McClaren</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Bajracharya</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Doherty</surname>
<given-names>P.C.</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>P.G.</given-names>
</name>
</person-group>
<article-title>Compromised respiratory function in lethal influenza infection is characterized by the depletion of type I alveolar epithelial cells beyond threshold levels</article-title>
<source/>Am. J. Physiol. Lung Cell. Mol. Physiol.
          <year>2013</year>
<volume>304</volume>
<fpage>L481</fpage>
<lpage>L488</lpage>
<pub-id pub-id-type="doi">10.1152/ajplung.00343.2012</pub-id>
<pub-id pub-id-type="pmid">23355384</pub-id>
</element-citation>
</ref>
<ref id="B88-pathogens-08-00265">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rosenberger</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Podyminogin</surname>
<given-names>R.L.</given-names>
</name>
<name>
<surname>Askovich</surname>
<given-names>P.S.</given-names>
</name>
<name>
<surname>Navarro</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Kaiser</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Sanders</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>McClaren</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Tam</surname>
<given-names>V.C.</given-names>
</name>
<name>
<surname>Dash</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Noonan</surname>
<given-names>J.G.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Characterization of innate responses to influenza virus infection in a novel lung type I epithelial cell model</article-title>
<source/>J. Gen. Virol.
          <year>2014</year>
<volume>95</volume>
<fpage>350</fpage>
<lpage>362</lpage>
<pub-id pub-id-type="doi">10.1099/vir.0.058438-0</pub-id>
<pub-id pub-id-type="pmid">24243730</pub-id>
</element-citation>
</ref>
<ref id="B89-pathogens-08-00265">
<label>89.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gisslen</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Alvarez</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wells</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Soo</surname>
<given-names>M.T.</given-names>
</name>
<name>
<surname>Lambers</surname>
<given-names>D.S.</given-names>
</name>
<name>
<surname>Knox</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>Meinzen-Derr</surname>
<given-names>J.K.</given-names>
</name>
<name>
<surname>Chougnet</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Jobe</surname>
<given-names>A.H.</given-names>
</name>
<name>
<surname>Kallapur</surname>
<given-names>S.G.</given-names>
</name>
</person-group>
<article-title>Fetal inflammation associated with minimal acute morbidity in moderate/late preterm infants. Archives of disease in childhood</article-title>
<source/>Fetal Neonatal Ed.
          <year>2016</year>
<volume>101</volume>
<fpage>F513</fpage>
<lpage>F519</lpage>
<pub-id pub-id-type="doi">10.1136/archdischild-2015-308518</pub-id>
</element-citation>
</ref>
<ref id="B90-pathogens-08-00265">
<label>90.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname>
<given-names>B.M.</given-names>
</name>
<name>
<surname>Shojaei</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Teoh</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Meyers</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ho</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ball</surname>
<given-names>T.B.</given-names>
</name>
<name>
<surname>Keynan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Pisipati</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Eisen</surname>
<given-names>D.P.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Neutrophils-related host factors associated with severe disease and fatality in patients with influenza infection</article-title>
<source/>Nat. Commun.
          <year>2019</year>
<volume>10</volume>
<fpage>3422</fpage>
<pub-id pub-id-type="doi">10.1038/s41467-019-11249-y</pub-id>
<pub-id pub-id-type="pmid">31366921</pub-id>
</element-citation>
</ref>
<ref id="B91-pathogens-08-00265">
<label>91.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ito</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Correll</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Zemans</surname>
<given-names>R.L.</given-names>
</name>
<name>
<surname>Leslie</surname>
<given-names>C.C.</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>R.C.</given-names>
</name>
<name>
<surname>Mason</surname>
<given-names>R.J.</given-names>
</name>
</person-group>
<article-title>Influenza induces IL-8 and GM-CSF secretion by human alveolar epithelial cells through HGF/c-Met and TGF-alpha/EGFR signaling</article-title>
<source/>Am. J. Physiol. Lung Cell. Mol. Physiol.
          <year>2015</year>
<volume>308</volume>
<fpage>L1178</fpage>
<lpage>L1188</lpage>
<pub-id pub-id-type="doi">10.1152/ajplung.00290.2014</pub-id>
<pub-id pub-id-type="pmid">26033355</pub-id>
</element-citation>
</ref>
<ref id="B92-pathogens-08-00265">
<label>92.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mauad</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hajjar</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Callegari</surname>
<given-names>G.D.</given-names>
</name>
<name>
<surname>da Silva</surname>
<given-names>L.F.</given-names>
</name>
<name>
<surname>Schout</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Galas</surname>
<given-names>F.R.</given-names>
</name>
<name>
<surname>Alves</surname>
<given-names>V.A.</given-names>
</name>
<name>
<surname>Malheiros</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Auler</surname>
<given-names>J.O.</given-names>
<suffix>Jr.</suffix>
</name>
<name>
<surname>Ferreira</surname>
<given-names>A.F.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Lung pathology in fatal novel human influenza A (H1N1) infection</article-title>
<source/>Am. J. Respir. Crit. Care Med.
          <year>2010</year>
<volume>181</volume>
<fpage>72</fpage>
<lpage>79</lpage>
<pub-id pub-id-type="doi">10.1164/rccm.200909-1420OC</pub-id>
<pub-id pub-id-type="pmid">19875682</pub-id>
</element-citation>
</ref>
<ref id="B93-pathogens-08-00265">
<label>93.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rockman</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lowther</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Camuglia</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Vandenberg</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Fabri</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Miescher</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Pearse</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Middleton</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Kent</surname>
<given-names>S.J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Intravenous Immunoglobulin Protects Against Severe Pandemic Influenza Infection</article-title>
<source/>EBioMedicine
          <year>2017</year>
<volume>19</volume>
<fpage>119</fpage>
<lpage>127</lpage>
<pub-id pub-id-type="doi">10.1016/j.ebiom.2017.04.010</pub-id>
<pub-id pub-id-type="pmid">28408242</pub-id>
</element-citation>
</ref>
<ref id="B94-pathogens-08-00265">
<label>94.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hohenadl</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wodal</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Kerschbaum</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Fritz</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Howard</surname>
<given-names>M.K.</given-names>
</name>
<name>
<surname>Farcet</surname>
<given-names>M.R.</given-names>
</name>
<name>
<surname>Portsmouth</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>McVey</surname>
<given-names>J.K.</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Ehrlich</surname>
<given-names>H.J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Hyperimmune intravenous immunoglobulin containing high titers of pandemic H1N1 hemagglutinin and neuraminidase antibodies provides dose-dependent protection against lethal virus challenge in SCID mice</article-title>
<source/>Virol. J.
          <year>2014</year>
<volume>11</volume>
<fpage>70</fpage>
<pub-id pub-id-type="doi">10.1186/1743-422X-11-70</pub-id>
<pub-id pub-id-type="pmid">24739285</pub-id>
</element-citation>
</ref>
<ref id="B95-pathogens-08-00265">
<label>95.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Jong</surname>
<given-names>M.D.</given-names>
</name>
<name>
<surname>Simmons</surname>
<given-names>C.P.</given-names>
</name>
<name>
<surname>Thanh</surname>
<given-names>T.T.</given-names>
</name>
<name>
<surname>Hien</surname>
<given-names>V.M.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>G.J.</given-names>
</name>
<name>
<surname>Chau</surname>
<given-names>T.N.</given-names>
</name>
<name>
<surname>Hoang</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Chau</surname>
<given-names>N.V.</given-names>
</name>
<name>
<surname>Khanh</surname>
<given-names>T.H.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>V.C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia</article-title>
<source/>Nat. Med.
          <year>2006</year>
<volume>12</volume>
<fpage>1203</fpage>
<lpage>1207</lpage>
<pub-id pub-id-type="doi">10.1038/nm1477</pub-id>
<pub-id pub-id-type="pmid">16964257</pub-id>
</element-citation>
</ref>
<ref id="B96-pathogens-08-00265">
<label>96.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roosenhoff</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Reed</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Kenwright</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Schutten</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Boucher</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Monto</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Clinch</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Whitley</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Nguyen-Van-Tam</surname>
<given-names>J.S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Viral Kinetics and Resistance Development in Children Treated with Neuraminidase Inhibitors: The Influenza Resistance Information Study (IRIS)</article-title>
<source/>Clin. Infect. Dis.
          <year>2019</year>
<fpage>ciz939</fpage>
<pub-id pub-id-type="doi">10.1093/cid/ciz939</pub-id>
<pub-id pub-id-type="pmid">31560055</pub-id>
</element-citation>
</ref>
<ref id="B97-pathogens-08-00265">
<label>97.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beigel</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Aga</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Elie-Turenne</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Tebas</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>Metcalf</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Ozment</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Raviprakash</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Beeler</surname>
<given-names>J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Anti-influenza immune plasma for the treatment of patients with severe influenza A: A randomised, double-blind, phase 3 trial</article-title>
<source/>Lancet Respir. Med.
          <year>2019</year>
<volume>7</volume>
<fpage>941</fpage>
<lpage>950</lpage>
<pub-id pub-id-type="doi">10.1016/S2213-2600(19)30199-7</pub-id>
<pub-id pub-id-type="pmid">31582360</pub-id>
</element-citation>
</ref>
<ref id="B98-pathogens-08-00265">
<label>98.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sedeyn</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Saelens</surname>
<given-names>X.</given-names>
</name>
</person-group>
<article-title>New antibody-based prevention and treatment options for influenza</article-title>
<source/>Antivir. Res
          <year>2019</year>
<volume>170</volume>
<fpage>104562</fpage>
<pub-id pub-id-type="doi">10.1016/j.antiviral.2019.104562</pub-id>
<pub-id pub-id-type="pmid">31323236</pub-id>
</element-citation>
</ref>
<ref id="B99-pathogens-08-00265">
<label>99.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vermillion</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Ursin</surname>
<given-names>R.L.</given-names>
</name>
<name>
<surname>Kuok</surname>
<given-names>D.I.T.</given-names>
</name>
<name>
<surname>Vom Steeg</surname>
<given-names>L.G.</given-names>
</name>
<name>
<surname>Wohlgemuth</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Hall</surname>
<given-names>O.J.</given-names>
</name>
<name>
<surname>Fink</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Sasse</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ndeh</surname>
<given-names>R.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Production of amphiregulin and recovery from influenza is greater in males than females</article-title>
<source/>Biol. Sex Differ.
          <year>2018</year>
<volume>9</volume>
<fpage>24</fpage>
<pub-id pub-id-type="doi">10.1186/s13293-018-0184-8</pub-id>
<pub-id pub-id-type="pmid">30012205</pub-id>
</element-citation>
</ref>
<ref id="B100-pathogens-08-00265">
<label>100.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Madan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Karp</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>Braciale</surname>
<given-names>T.J.</given-names>
</name>
</person-group>
<article-title>Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10</article-title>
<source/>Nat. Med.
          <year>2009</year>
<volume>15</volume>
<fpage>277</fpage>
<lpage>284</lpage>
<pub-id pub-id-type="doi">10.1038/nm.1929</pub-id>
<pub-id pub-id-type="pmid">19234462</pub-id>
</element-citation>
</ref>
<ref id="B101-pathogens-08-00265">
<label>101.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tate</surname>
<given-names>M.D.</given-names>
</name>
<name>
<surname>Schilter</surname>
<given-names>H.C.</given-names>
</name>
<name>
<surname>Brooks</surname>
<given-names>A.G.</given-names>
</name>
<name>
<surname>Reading</surname>
<given-names>P.C.</given-names>
</name>
</person-group>
<article-title>Responses of mouse airway epithelial cells and alveolar macrophages to virulent and avirulent strains of influenza A virus</article-title>
<source/>Viral Immunol.
          <year>2011</year>
<volume>24</volume>
<fpage>77</fpage>
<lpage>88</lpage>
<pub-id pub-id-type="doi">10.1089/vim.2010.0118</pub-id>
<pub-id pub-id-type="pmid">21449718</pub-id>
</element-citation>
</ref>
<ref id="B102-pathogens-08-00265">
<label>102.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Engeland</surname>
<given-names>C.G.</given-names>
</name>
<name>
<surname>Bosch</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Cacioppo</surname>
<given-names>J.T.</given-names>
</name>
<name>
<surname>Marucha</surname>
<given-names>P.T.</given-names>
</name>
</person-group>
<article-title>Mucosal wound healing: The roles of age and sex</article-title>
<source/>Arch. Surg.
          <year>2006</year>
<volume>141</volume>
<fpage>1193</fpage>
<lpage>1197</lpage>
<pub-id pub-id-type="doi">10.1001/archsurg.141.12.1193</pub-id>
<pub-id pub-id-type="pmid">17178961</pub-id>
</element-citation>
</ref>
<ref id="B103-pathogens-08-00265">
<label>103.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bandyopadhyay</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Huyck</surname>
<given-names>H.L.</given-names>
</name>
<name>
<surname>Misra</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Bhattacharya</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Mereness</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lillis</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Myers</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Ashton</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bushnell</surname>
<given-names>T.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Dissociation, cellular isolation, and initial molecular characterization of neonatal and pediatric human lung tissues</article-title>
<source/>Am. J. Physiol. Lung Cell. Mol. Physiol.
          <year>2018</year>
<volume>315</volume>
<fpage>L576</fpage>
<lpage>L583</lpage>
<pub-id pub-id-type="doi">10.1152/ajplung.00041.2018</pub-id>
<pub-id pub-id-type="pmid">29975103</pub-id>
</element-citation>
</ref>
<ref id="B104-pathogens-08-00265">
<label>104.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kyle</surname>
<given-names>J.E.</given-names>
</name>
<name>
<surname>Clair</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Bandyopadhyay</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Misra</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Zink</surname>
<given-names>E.M.</given-names>
</name>
<name>
<surname>Bloodsworth</surname>
<given-names>K.J.</given-names>
</name>
<name>
<surname>Shukla</surname>
<given-names>A.K.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lillis</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Myers</surname>
<given-names>J.R.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cell type-resolved human lung lipidome reveals cellular cooperation in lung function</article-title>
<source/>Sci. Rep.
          <year>2018</year>
<volume>8</volume>
<fpage>13455</fpage>
<pub-id pub-id-type="doi">10.1038/s41598-018-31640-x</pub-id>
<pub-id pub-id-type="pmid">30194354</pub-id>
</element-citation>
</ref>
<ref id="B105-pathogens-08-00265">
<label>105.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Du</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Clair</surname>
<given-names>G.C.</given-names>
</name>
<name>
<surname>Al Alam</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Danopoulos</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Schnell</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Kitzmiller</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Misra</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Bhattacharya</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Warburton</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Mariani</surname>
<given-names>T.J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Integration of transcriptomic and proteomic data identifies biological functions in cell populations from human infant lung</article-title>
<source/>Am. J. Physiol. Lung Cell. Mol. Physiol.
          <year>2019</year>
<volume>317</volume>
<fpage>L347</fpage>
<lpage>L360</lpage>
<pub-id pub-id-type="doi">10.1152/ajplung.00475.2018</pub-id>
<pub-id pub-id-type="pmid">31268347</pub-id>
</element-citation>
</ref>
<ref id="B106-pathogens-08-00265">
<label>106.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Simon</surname>
<given-names>A.K.</given-names>
</name>
<name>
<surname>Hollander</surname>
<given-names>G.A.</given-names>
</name>
<name>
<surname>McMichael</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Evolution of the immune system in humans from infancy to old age</article-title>
<source/>Proc. Biol. Sci.
          <year>2015</year>
<volume>282</volume>
<fpage>20143085</fpage>
<pub-id pub-id-type="doi">10.1098/rspb.2014.3085</pub-id>
<pub-id pub-id-type="pmid">26702035</pub-id>
</element-citation>
</ref>
<ref id="B107-pathogens-08-00265">
<label>107.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Esteve-Sole</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Vlagea</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Deya-Martinez</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Yague</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Plaza-Martin</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Juan</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Alsina</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>B Regulatory Cells: Players in Pregnancy and Early Life</article-title>
<source/>Int. J. Mol. Sci.
          <year>2018</year>
<volume>19</volume>
<elocation-id>2099</elocation-id>
<pub-id pub-id-type="doi">10.3390/ijms19072099</pub-id>
<pub-id pub-id-type="pmid">30029515</pub-id>
</element-citation>
</ref>
<ref id="B108-pathogens-08-00265">
<label>108.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tosato</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Bucciol</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Pantano</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Putti</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Sanzari</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Basso</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Plebani</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Lymphocytes subsets reference values in childhood</article-title>
<source/>Cytometry A
          <year>2015</year>
<volume>87</volume>
<fpage>81</fpage>
<lpage>85</lpage>
<pub-id pub-id-type="doi">10.1002/cyto.a.22520</pub-id>
<pub-id pub-id-type="pmid">25132325</pub-id>
</element-citation>
</ref>
<ref id="B109-pathogens-08-00265">
<label>109.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Miyahara</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Khattar</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Stepkowski</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>W.</given-names>
</name>
</person-group>
<article-title>“Default” generation of neonatal regulatory T cells</article-title>
<source/>J. Immunol.
          <year>2010</year>
<volume>185</volume>
<fpage>71</fpage>
<lpage>78</lpage>
<pub-id pub-id-type="doi">10.4049/jimmunol.0903806</pub-id>
<pub-id pub-id-type="pmid">20498359</pub-id>
</element-citation>
</ref>
<ref id="B110-pathogens-08-00265">
<label>110.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takahata</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Nomura</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Takada</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ohga</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Furuno</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hikino</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nakayama</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Sakaguchi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hara</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>CD25+CD4+ T cells in human cord blood: An immunoregulatory subset with naive phenotype and specific expression of forkhead box p3 (Foxp3) gene</article-title>
<source/>Exp. Hematol.
          <year>2004</year>
<volume>32</volume>
<fpage>622</fpage>
<lpage>629</lpage>
<pub-id pub-id-type="doi">10.1016/j.exphem.2004.03.012</pub-id>
<pub-id pub-id-type="pmid">15246158</pub-id>
</element-citation>
</ref>
<ref id="B111-pathogens-08-00265">
<label>111.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sarvaria</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Basar</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Mehta</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Shaim</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Muftuoglu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Khoder</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sekine</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Gokdemir</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Kondo</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Marin</surname>
<given-names>D.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>IL-10+ regulatory B cells are enriched in cord blood and may protect against cGVHD after cord blood transplantation</article-title>
<source/>Blood
          <year>2016</year>
<volume>128</volume>
<fpage>1346</fpage>
<lpage>1361</lpage>
<pub-id pub-id-type="doi">10.1182/blood-2016-01-695122</pub-id>
<pub-id pub-id-type="pmid">27439912</pub-id>
</element-citation>
</ref>
<ref id="B112-pathogens-08-00265">
<label>112.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Esteve-Sole</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Teixido</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Deya-Martinez</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Yague</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Plaza-Martin</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Juan</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Alsina</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Characterization of the Highly Prevalent Regulatory CD24(hi)CD38(hi) B-Cell Population in Human Cord Blood</article-title>
<source/>Front. Immunol.
          <year>2017</year>
<volume>8</volume>
<fpage>201</fpage>
<pub-id pub-id-type="doi">10.3389/fimmu.2017.00201</pub-id>
<pub-id pub-id-type="pmid">28326080</pub-id>
</element-citation>
</ref>
<ref id="B113-pathogens-08-00265">
<label>113.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>High-dose of intravenous immunoglobulin modulates immune tolerance in premature infants</article-title>
<source/>BMC Pediatr.
          <year>2018</year>
<volume>18</volume>
<elocation-id>74</elocation-id>
<pub-id pub-id-type="doi">10.1186/s12887-018-1055-5</pub-id>
<pub-id pub-id-type="pmid">29466960</pub-id>
</element-citation>
</ref>
<ref id="B114-pathogens-08-00265">
<label>114.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rueda</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Moreno-Fernandez</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Jackson</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Kallapur</surname>
<given-names>S.G.</given-names>
</name>
<name>
<surname>Jobe</surname>
<given-names>A.H.</given-names>
</name>
<name>
<surname>Chougnet</surname>
<given-names>C.A.</given-names>
</name>
</person-group>
<article-title>Neonatal regulatory T cells have reduced capacity to suppress dendritic cell function</article-title>
<source/>Eur. J. Immunol.
          <year>2015</year>
<volume>45</volume>
<fpage>2582</fpage>
<lpage>2592</lpage>
<pub-id pub-id-type="doi">10.1002/eji.201445371</pub-id>
<pub-id pub-id-type="pmid">26046326</pub-id>
</element-citation>
</ref>
<ref id="B115-pathogens-08-00265">
<label>115.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coates</surname>
<given-names>B.M.</given-names>
</name>
<name>
<surname>Staricha</surname>
<given-names>K.L.</given-names>
</name>
<name>
<surname>Wiese</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Ridge</surname>
<given-names>K.M.</given-names>
</name>
</person-group>
<article-title>Influenza A Virus Infection, Innate Immunity, and Childhood</article-title>
<source/>JAMA Pediatr.
          <year>2015</year>
<volume>169</volume>
<fpage>956</fpage>
<lpage>963</lpage>
<pub-id pub-id-type="doi">10.1001/jamapediatrics.2015.1387</pub-id>
<pub-id pub-id-type="pmid">26237589</pub-id>
</element-citation>
</ref>
<ref id="B116-pathogens-08-00265">
<label>116.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Papaioannou</surname>
<given-names>N.E.</given-names>
</name>
<name>
<surname>Pasztoi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Schraml</surname>
<given-names>B.U.</given-names>
</name>
</person-group>
<article-title>Understanding the Functional Properties of Neonatal Dendritic Cells: A Doorway to Enhance Vaccine Effectiveness?</article-title>
<source/>Front. Immunol.
          <year>2018</year>
<volume>9</volume>
<fpage>3123</fpage>
<pub-id pub-id-type="doi">10.3389/fimmu.2018.03123</pub-id>
<pub-id pub-id-type="pmid">30687326</pub-id>
</element-citation>
</ref>
<ref id="B117-pathogens-08-00265">
<label>117.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lawrence</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Corriden</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Nizet</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>Age-Appropriate Functions and Dysfunctions of the Neonatal Neutrophil</article-title>
<source/>Front. Pediatr.
          <year>2017</year>
<volume>5</volume>
<fpage>23</fpage>
<pub-id pub-id-type="doi">10.3389/fped.2017.00023</pub-id>
<pub-id pub-id-type="pmid">28293548</pub-id>
</element-citation>
</ref>
<ref id="B118-pathogens-08-00265">
<label>118.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kollmann</surname>
<given-names>T.R.</given-names>
</name>
<name>
<surname>Kampmann</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Mazmanian</surname>
<given-names>S.K.</given-names>
</name>
<name>
<surname>Marchant</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Levy</surname>
<given-names>O.</given-names>
</name>
</person-group>
<article-title>Protecting the Newborn and Young Infant from Infectious Diseases: Lessons from Immune Ontogeny</article-title>
<source/>Immunity
          <year>2017</year>
<volume>46</volume>
<fpage>350</fpage>
<lpage>363</lpage>
<pub-id pub-id-type="doi">10.1016/j.immuni.2017.03.009</pub-id>
<pub-id pub-id-type="pmid">28329702</pub-id>
</element-citation>
</ref>
<ref id="B119-pathogens-08-00265">
<label>119.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wisgrill</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Groschopf</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Herndl</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Sadeghi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Spittler</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Berger</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Forster-Waldl</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Reduced TNF-alpha response in preterm neonates is associated with impaired nonclassic monocyte function</article-title>
<source/>J. Leukoc. Biol.
          <year>2016</year>
<volume>100</volume>
<fpage>607</fpage>
<lpage>612</lpage>
<pub-id pub-id-type="doi">10.1189/jlb.4A0116-001RR</pub-id>
<pub-id pub-id-type="pmid">26965638</pub-id>
</element-citation>
</ref>
<ref id="B120-pathogens-08-00265">
<label>120.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Jong</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Strunk</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Burgner</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Lavoie</surname>
<given-names>P.M.</given-names>
</name>
<name>
<surname>Currie</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>The phenotype and function of preterm infant monocytes: Implications for susceptibility to infection</article-title>
<source/>J. Leukoc. Biol.
          <year>2017</year>
<volume>102</volume>
<fpage>645</fpage>
<lpage>656</lpage>
<pub-id pub-id-type="doi">10.1189/jlb.4RU0317-111R</pub-id>
<pub-id pub-id-type="pmid">28630102</pub-id>
</element-citation>
</ref>
<ref id="B121-pathogens-08-00265">
<label>121.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Collins</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Weitkamp</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Wynn</surname>
<given-names>J.L.</given-names>
</name>
</person-group>
<article-title>Why are preterm newborns at increased risk of infection? Archives of disease in childhood</article-title>
<source/>Fetal Neonatal Ed.
          <year>2018</year>
<volume>103</volume>
<fpage>F391</fpage>
<lpage>F394</lpage>
<pub-id pub-id-type="doi">10.1136/archdischild-2017-313595</pub-id>
</element-citation>
</ref>
<ref id="B122-pathogens-08-00265">
<label>122.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>D’Angio</surname>
<given-names>C.T.</given-names>
</name>
<name>
<surname>Wyman</surname>
<given-names>C.P.</given-names>
</name>
<name>
<surname>Misra</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Halliley</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hunn</surname>
<given-names>J.E.</given-names>
</name>
<name>
<surname>Fallone</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>F.E.</given-names>
</name>
</person-group>
<article-title>Plasma cell and serum antibody responses to influenza vaccine in preterm and full-term infants</article-title>
<source/>Vaccine
          <year>2017</year>
<volume>35</volume>
<fpage>5163</fpage>
<lpage>5171</lpage>
<pub-id pub-id-type="doi">10.1016/j.vaccine.2017.07.115</pub-id>
<pub-id pub-id-type="pmid">28807607</pub-id>
</element-citation>
</ref>
<ref id="B123-pathogens-08-00265">
<label>123.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>D’Angio</surname>
<given-names>C.T.</given-names>
</name>
<name>
<surname>Heyne</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Duara</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Holmes</surname>
<given-names>L.C.</given-names>
</name>
<name>
<surname>O’Shea</surname>
<given-names>T.M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Sanchez</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>Welliver</surname>
<given-names>R.C.</given-names>
</name>
<name>
<surname>Ryan</surname>
<given-names>R.M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Immunogenicity of trivalent influenza vaccine in extremely low-birth-weight, premature versus term infants</article-title>
<source/>Pediatr. Infect. Dis. J.
          <year>2011</year>
<volume>30</volume>
<fpage>570</fpage>
<lpage>574</lpage>
<pub-id pub-id-type="doi">10.1097/INF.0b013e31820c1fdf</pub-id>
<pub-id pub-id-type="pmid">21273938</pub-id>
</element-citation>
</ref>
<ref id="B124-pathogens-08-00265">
<label>124.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Misra</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Shah</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Fowell</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Scheible</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Misra</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Huyck</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wyman</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ryan</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Reynolds</surname>
<given-names>A.M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Preterm cord blood CD4(+) T cells exhibit increased IL-6 production in chorioamnionitis and decreased CD4(+) T cells in bronchopulmonary dysplasia</article-title>
<source/>Hum. Immunol.
          <year>2015</year>
<volume>76</volume>
<fpage>329</fpage>
<lpage>338</lpage>
<pub-id pub-id-type="doi">10.1016/j.humimm.2015.03.007</pub-id>
<pub-id pub-id-type="pmid">25797206</pub-id>
</element-citation>
</ref>
<ref id="B125-pathogens-08-00265">
<label>125.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jobe</surname>
<given-names>A.H.</given-names>
</name>
</person-group>
<article-title>Mechanisms of Lung Injury and Bronchopulmonary Dysplasia</article-title>
<source/>Am. J. Perinatol.
          <year>2016</year>
<volume>33</volume>
<fpage>1076</fpage>
<lpage>1078</lpage>
<pub-id pub-id-type="doi">10.1055/s-0036-1586107</pub-id>
<pub-id pub-id-type="pmid">27603539</pub-id>
</element-citation>
</ref>
<ref id="B126-pathogens-08-00265">
<label>126.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mitra</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Disher</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Pichler</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>D’Souza</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>McCord</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Chayapathi</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Schmolzer</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Delivery room interventions to prevent bronchopulmonary dysplasia in preterm infants: A protocol for a systematic review and network meta-analysis</article-title>
<source/>BMJ Open
          <year>2019</year>
<volume>9</volume>
<fpage>e028066</fpage>
<pub-id pub-id-type="doi">10.1136/bmjopen-2018-028066</pub-id>
</element-citation>
</ref>
<ref id="B127-pathogens-08-00265">
<label>127.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coalson</surname>
<given-names>J.J.</given-names>
</name>
</person-group>
<article-title>Pathology of bronchopulmonary dysplasia</article-title>
<source/>Semin. Perinatol.
          <year>2006</year>
<volume>30</volume>
<fpage>179</fpage>
<lpage>184</lpage>
<pub-id pub-id-type="doi">10.1053/j.semperi.2006.05.004</pub-id>
<pub-id pub-id-type="pmid">16860157</pub-id>
</element-citation>
</ref>
<ref id="B128-pathogens-08-00265">
<label>128.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Papagianis</surname>
<given-names>P.C.</given-names>
</name>
<name>
<surname>Pillow</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Moss</surname>
<given-names>T.J.</given-names>
</name>
</person-group>
<article-title>Bronchopulmonary dysplasia: Pathophysiology and potential anti-inflammatory therapies</article-title>
<source/>Paediatr. Respir. Rev.
          <year>2019</year>
<volume>30</volume>
<fpage>34</fpage>
<lpage>41</lpage>
<pub-id pub-id-type="doi">10.1016/j.prrv.2018.07.007</pub-id>
<pub-id pub-id-type="pmid">30201135</pub-id>
</element-citation>
</ref>
<ref id="B129-pathogens-08-00265">
<label>129.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Collins</surname>
<given-names>J.J.P.</given-names>
</name>
<name>
<surname>Tibboel</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>de Kleer</surname>
<given-names>I.M.</given-names>
</name>
<name>
<surname>Reiss</surname>
<given-names>I.K.M.</given-names>
</name>
<name>
<surname>Rottier</surname>
<given-names>R.J.</given-names>
</name>
</person-group>
<article-title>The Future of Bronchopulmonary Dysplasia: Emerging Pathophysiological Concepts and Potential New Avenues of Treatment</article-title>
<source/>Front. Med.
          <year>2017</year>
<volume>4</volume>
<fpage>61</fpage>
<pub-id pub-id-type="doi">10.3389/fmed.2017.00061</pub-id>
</element-citation>
</ref>
<ref id="B130-pathogens-08-00265">
<label>130.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhandari</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Carroll</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Bhandari</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>BPD Following Preterm Birth: A Model for Chronic Lung Disease and a Substrate for ARDS in Childhood</article-title>
<source/>Front. Pediatr.
          <year>2016</year>
<volume>4</volume>
<fpage>60</fpage>
<pub-id pub-id-type="doi">10.3389/fped.2016.00060</pub-id>
<pub-id pub-id-type="pmid">27379219</pub-id>
</element-citation>
</ref>
<ref id="B131-pathogens-08-00265">
<label>131.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Homaira</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Briggs</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Oei</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Hilder</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Bajuk</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Snelling</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Chambers</surname>
<given-names>G.M.</given-names>
</name>
<name>
<surname>Jaffe</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Impact of influenza on hospitalization rates in children with a range of chronic lung diseases</article-title>
<source/>Influenza Other Respir. Viruses
          <year>2019</year>
<volume>13</volume>
<fpage>233</fpage>
<lpage>239</lpage>
<pub-id pub-id-type="doi">10.1111/irv.12633</pub-id>
<pub-id pub-id-type="pmid">30701672</pub-id>
</element-citation>
</ref>
<ref id="B132-pathogens-08-00265">
<label>132.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Black</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nicolay</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Vesikari</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Knuf</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Del Giudice</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Della Cioppa</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Clemens</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Rappuoli</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children</article-title>
<source/>Pediatr. Infect. Dis. J.
          <year>2011</year>
<volume>30</volume>
<fpage>1081</fpage>
<lpage>1085</lpage>
<pub-id pub-id-type="doi">10.1097/INF.0b013e3182367662</pub-id>
<pub-id pub-id-type="pmid">21983214</pub-id>
</element-citation>
</ref>
<ref id="B133-pathogens-08-00265">
<label>133.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilkinson</surname>
<given-names>T.M.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C.K.</given-names>
</name>
<name>
<surname>Chui</surname>
<given-names>C.S.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>A.K.</given-names>
</name>
<name>
<surname>Perkins</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Liebner</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Lambkin-Williams</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Gilbert</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Oxford</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Nicholas</surname>
<given-names>B.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Preexisting influenza-specific CD4(+) T cells correlate with disease protection against influenza challenge in humans</article-title>
<source/>Nat. Med.
          <year>2012</year>
<volume>18</volume>
<fpage>274</fpage>
<lpage>280</lpage>
<pub-id pub-id-type="doi">10.1038/nm.2612</pub-id>
<pub-id pub-id-type="pmid">22286307</pub-id>
</element-citation>
</ref>
<ref id="B134-pathogens-08-00265">
<label>134.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sridhar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Begom</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bermingham</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hoschler</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Adamson</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Carman</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Bean</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Barclay</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Deeks</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Lalvani</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Cellular immune correlates of protection against symptomatic pandemic influenza</article-title>
<source/>Nat. Med.
          <year>2013</year>
<volume>19</volume>
<fpage>1305</fpage>
<lpage>1312</lpage>
<pub-id pub-id-type="doi">10.1038/nm.3350</pub-id>
<pub-id pub-id-type="pmid">24056771</pub-id>
</element-citation>
</ref>
<ref id="B135-pathogens-08-00265">
<label>135.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Belshe</surname>
<given-names>R.B.</given-names>
</name>
<name>
<surname>Edwards</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Vesikari</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Black</surname>
<given-names>S.V.</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>R.E.</given-names>
</name>
<name>
<surname>Hultquist</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kemble</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Connor</surname>
<given-names>E.M.</given-names>
</name>
<name>
<surname>Group</surname>
<given-names>C.-T.C.E.S.</given-names>
</name>
</person-group>
<article-title>Live attenuated versus inactivated influenza vaccine in infants and young children</article-title>
<source/>N. Engl. J. Med.
          <year>2007</year>
<volume>356</volume>
<fpage>685</fpage>
<lpage>696</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMoa065368</pub-id>
<pub-id pub-id-type="pmid">17301299</pub-id>
</element-citation>
</ref>
<ref id="B136-pathogens-08-00265">
<label>136.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grohskopf</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Alyanak</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Broder</surname>
<given-names>K.R.</given-names>
</name>
<name>
<surname>Walter</surname>
<given-names>E.B.</given-names>
</name>
<name>
<surname>Fry</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Jernigan</surname>
<given-names>D.B.</given-names>
</name>
</person-group>
<article-title>Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices-United States, 2019–2020 Influenza Season</article-title>
<source/>MMWR Recomm. Rep.
          <year>2019</year>
<volume>68</volume>
<fpage>1</fpage>
<lpage>21</lpage>
<pub-id pub-id-type="doi">10.15585/mmwr.rr6803a1</pub-id>
</element-citation>
</ref>
<ref id="B137-pathogens-08-00265">
<label>137.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>ACOG Committee on Obstetric Practice</collab>
</person-group>
<article-title>ACOG Committee Opinion No. 732: Influenza Vaccination During Pregnancy</article-title>
<source/>Obstet. Gynecol.
          <year>2018</year>
<volume>131</volume>
<fpage>e109</fpage>
<lpage>e114</lpage>
<pub-id pub-id-type="doi">10.1097/AOG.0000000000002588</pub-id>
<pub-id pub-id-type="pmid">29578985</pub-id>
</element-citation>
</ref>
<ref id="B138-pathogens-08-00265">
<label>138.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gagneur</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Pinquier</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Quach</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Immunization of preterm infants</article-title>
<source/>Hum. Vaccines Immunother.
          <year>2015</year>
<volume>11</volume>
<fpage>2556</fpage>
<lpage>2563</lpage>
<pub-id pub-id-type="doi">10.1080/21645515.2015.1074358</pub-id>
</element-citation>
</ref>
<ref id="B139-pathogens-08-00265">
<label>139.</label>
<element-citation publication-type="gov">
<person-group person-group-type="author">
<collab>Center for Disease Control and Prevention</collab>
</person-group>
<article-title>Special Situations; General Best Practice Guidelines for Immunization: Best Practices Guidance of the Advisory Committee on Immunization Practices (ACIP)</article-title>
<comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/special-situations.html">https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/special-situations.html</ext-link></comment>
<date-in-citation content-type="access-date" iso-8601-date="2019-09-17">(accessed on 17 September 2019)</date-in-citation>
</element-citation>
</ref>
<ref id="B140-pathogens-08-00265">
<label>140.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ortiz</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Perut</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dumolard</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wijesinghe</surname>
<given-names>P.R.</given-names>
</name>
<name>
<surname>Jorgensen</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Ropero</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Danovaro-Holliday</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Heffelfinger</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Tevi-Benissan</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Teleb</surname>
<given-names>N.A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A global review of national influenza immunization policies: Analysis of the 2014 WHO/UNICEF Joint Reporting Form on immunization</article-title>
<source/>Vaccine
          <year>2016</year>
<volume>34</volume>
<fpage>5400</fpage>
<lpage>5405</lpage>
<pub-id pub-id-type="doi">10.1016/j.vaccine.2016.07.045</pub-id>
<pub-id pub-id-type="pmid">27646030</pub-id>
</element-citation>
</ref>
<ref id="B141-pathogens-08-00265">
<label>141.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paules</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Subbarao</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Influenza</article-title>
<source/>Lancet
          <year>2017</year>
<volume>390</volume>
<fpage>697</fpage>
<lpage>708</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(17)30129-0</pub-id>
<pub-id pub-id-type="pmid">28302313</pub-id>
</element-citation>
</ref>
<ref id="B142-pathogens-08-00265">
<label>142.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rajao</surname>
<given-names>D.S.</given-names>
</name>
<name>
<surname>Gauger</surname>
<given-names>P.C.</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>T.K.</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>N.S.</given-names>
</name>
<name>
<surname>Abente</surname>
<given-names>E.J.</given-names>
</name>
<name>
<surname>Killian</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Perez</surname>
<given-names>D.R.</given-names>
</name>
<name>
<surname>Sutton</surname>
<given-names>T.C.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Vincent</surname>
<given-names>A.L.</given-names>
</name>
</person-group>
<article-title>Novel Reassortant Human-Like H3N2 and H3N1 Influenza A Viruses Detected in Pigs Are Virulent and Antigenically Distinct from Swine Viruses Endemic to the United States</article-title>
<source/>J. Virol.
          <year>2015</year>
<volume>89</volume>
<fpage>11213</fpage>
<lpage>11222</lpage>
<pub-id pub-id-type="doi">10.1128/JVI.01675-15</pub-id>
<pub-id pub-id-type="pmid">26311895</pub-id>
</element-citation>
</ref>
<ref id="B143-pathogens-08-00265">
<label>143.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Hirve</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kieny</surname>
<given-names>M.P.</given-names>
</name>
</person-group>
<article-title>Seasonal vaccines—Critical path to pandemic influenza response</article-title>
<source/>Vaccine
          <year>2017</year>
<volume>35</volume>
<fpage>851</fpage>
<lpage>852</lpage>
<pub-id pub-id-type="doi">10.1016/j.vaccine.2016.12.056</pub-id>
<pub-id pub-id-type="pmid">28087149</pub-id>
</element-citation>
</ref>
<ref id="B144-pathogens-08-00265">
<label>144.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sheikh</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Biundo</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Courcier</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Damm</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Launay</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Maes</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Marcos</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Matthews</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Meijer</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Poscia</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A report on the status of vaccination in Europe</article-title>
<source/>Vaccine
          <year>2018</year>
<volume>36</volume>
<fpage>4979</fpage>
<lpage>4992</lpage>
<pub-id pub-id-type="doi">10.1016/j.vaccine.2018.06.044</pub-id>
<pub-id pub-id-type="pmid">30037416</pub-id>
</element-citation>
</ref>
<ref id="B145-pathogens-08-00265">
<label>145.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ohlrogge</surname>
<given-names>A.W.</given-names>
</name>
<name>
<surname>Suggs</surname>
<given-names>L.S.</given-names>
</name>
</person-group>
<article-title>Flu vaccination communication in Europe: What does the government communicate and how?</article-title>
<source/>Vaccine
          <year>2018</year>
<volume>36</volume>
<fpage>6512</fpage>
<lpage>6519</lpage>
<pub-id pub-id-type="doi">10.1016/j.vaccine.2018.04.042</pub-id>
<pub-id pub-id-type="pmid">29703556</pub-id>
</element-citation>
</ref>
<ref id="B146-pathogens-08-00265">
<label>146.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Samaan</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>McPherson</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Partridge</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>A review of the evidence to support influenza vaccine introduction in countries and areas of WHO’s Western Pacific Region</article-title>
<source/>PLoS ONE
          <year>2013</year>
<volume>8</volume>
<elocation-id>e70003</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0070003</pub-id>
<pub-id pub-id-type="pmid">23875015</pub-id>
</element-citation>
</ref>
<ref id="B147-pathogens-08-00265">
<label>147.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fischer</surname>
<given-names>W.A.</given-names>
<suffix>2nd</suffix>
</name>
<name>
<surname>Gong</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bhagwanjee</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sevransky</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Global burden of influenza as a cause of cardiopulmonary morbidity and mortality</article-title>
<source/>Glob. Heart
          <year>2014</year>
<volume>9</volume>
<fpage>325</fpage>
<lpage>336</lpage>
<pub-id pub-id-type="doi">10.1016/j.gheart.2014.08.004</pub-id>
<pub-id pub-id-type="pmid">25667184</pub-id>
</element-citation>
</ref>
<ref id="B148-pathogens-08-00265">
<label>148.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>Hung</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>O’Halloran</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Srivastav</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>W.W.</given-names>
</name>
<name>
<surname>Singleton</surname>
<given-names>J.A.</given-names>
</name>
</person-group>
<article-title>Seasonal Influenza Vaccination Coverage Trends Among Adult Populations, U.S., 2010–2016</article-title>
<source/>Am. J. Prev. Med.
          <year>2019</year>
<volume>57</volume>
<fpage>458</fpage>
<lpage>469</lpage>
<pub-id pub-id-type="doi">10.1016/j.amepre.2019.04.007</pub-id>
<pub-id pub-id-type="pmid">31473066</pub-id>
</element-citation>
</ref>
<ref id="B149-pathogens-08-00265">
<label>149.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Buchan</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Kwong</surname>
<given-names>J.C.</given-names>
</name>
</person-group>
<article-title>Trends in influenza vaccine coverage and vaccine hesitancy in Canada, 2006/07 to 2013/14: Results from cross-sectional survey data</article-title>
<source/>CMAJ Open
          <year>2016</year>
<volume>4</volume>
<fpage>E455</fpage>
<lpage>E462</lpage>
<pub-id pub-id-type="doi">10.9778/cmajo.20160050</pub-id>
</element-citation>
</ref>
<ref id="B150-pathogens-08-00265">
<label>150.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ding</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kahn</surname>
<given-names>K.E.</given-names>
</name>
<name>
<surname>Black</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>O’Halloran</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>W.W.</given-names>
</name>
</person-group>
<article-title>Influenza Vaccination Coverage Among Pregnant Women in the U.S., 2012–2015</article-title>
<source/>Am. J. Prev. Med.
          <year>2019</year>
<volume>56</volume>
<fpage>477</fpage>
<lpage>486</lpage>
<pub-id pub-id-type="doi">10.1016/j.amepre.2018.11.020</pub-id>
<pub-id pub-id-type="pmid">30777706</pub-id>
</element-citation>
</ref>
<ref id="B151-pathogens-08-00265">
<label>151.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Flannery</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Reynolds</surname>
<given-names>S.B.</given-names>
</name>
<name>
<surname>Blanton</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Santibanez</surname>
<given-names>T.A.</given-names>
</name>
<name>
<surname>O’Halloran</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>P.-J.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Foppa</surname>
<given-names>I.M.</given-names>
</name>
<name>
<surname>Gargiullo</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Bresee</surname>
<given-names>J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Influenza Vaccine Effectiveness Against Pediatric Deaths: 2010–2014</article-title>
<source/>Pediatrics
          <year>2017</year>
<volume>139</volume>
<fpage>e20164244</fpage>
<pub-id pub-id-type="doi">10.1542/peds.2016-4244</pub-id>
<pub-id pub-id-type="pmid">28557757</pub-id>
</element-citation>
</ref>
<ref id="B152-pathogens-08-00265">
<label>152.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hartel</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Humberg</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Viemann</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Stein</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Orlikowsky</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Rupp</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kopp</surname>
<given-names>M.V.</given-names>
</name>
<name>
<surname>Herting</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Gopel</surname>
<given-names>W.</given-names>
</name>
</person-group>
<article-title>Preterm Birth during Influenza Season Is Associated with Adverse Outcome in Very Low Birth Weight Infants</article-title>
<source/>Front. Pediatrics
          <year>2016</year>
<volume>4</volume>
<fpage>130</fpage>
<pub-id pub-id-type="doi">10.3389/fped.2016.00130</pub-id>
</element-citation>
</ref>
<ref id="B153-pathogens-08-00265">
<label>153.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neuzil</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Mellen</surname>
<given-names>B.G.</given-names>
</name>
<name>
<surname>Wright</surname>
<given-names>P.F.</given-names>
</name>
<name>
<surname>Mitchel</surname>
<given-names>E.F.</given-names>
<suffix>Jr.</suffix>
</name>
<name>
<surname>Griffin</surname>
<given-names>M.R.</given-names>
</name>
</person-group>
<article-title>The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children</article-title>
<source/>N. Engl. J. Med.
          <year>2000</year>
<volume>342</volume>
<fpage>225</fpage>
<lpage>231</lpage>
<pub-id pub-id-type="doi">10.1056/NEJM200001273420401</pub-id>
<pub-id pub-id-type="pmid">10648763</pub-id>
</element-citation>
</ref>
<ref id="B154-pathogens-08-00265">
<label>154.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hofstetter</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Jacobson</surname>
<given-names>E.N.</given-names>
</name>
<name>
<surname>deHart</surname>
<given-names>M.P.</given-names>
</name>
<name>
<surname>Englund</surname>
<given-names>J.A.</given-names>
</name>
</person-group>
<article-title>Early Childhood Vaccination Status of Preterm Infants</article-title>
<source/>Pediatrics
          <year>2019</year>
<volume>144</volume>
<fpage>e20183520</fpage>
<pub-id pub-id-type="doi">10.1542/peds.2018-3520</pub-id>
<pub-id pub-id-type="pmid">31391213</pub-id>
</element-citation>
</ref>
<ref id="B155-pathogens-08-00265">
<label>155.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>World Health Organization</collab>
</person-group>
<article-title>Vaccines against influenza WHO position paper—November 2012</article-title>
<source/>Wkly. Epidemiol. Rec.
          <year>2012</year>
<volume>87</volume>
<fpage>461</fpage>
<lpage>476</lpage>
<pub-id pub-id-type="pmid">23210147</pub-id>
</element-citation>
</ref>
<ref id="B156-pathogens-08-00265">
<label>156.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mertz</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Lo</surname>
<given-names>C.K.</given-names>
</name>
<name>
<surname>Lytvyn</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ortiz</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Loeb</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Flurisk</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Pregnancy as a risk factor for severe influenza infection: An individual participant data meta-analysis</article-title>
<source/>BMC Infect. Dis.
          <year>2019</year>
<volume>19</volume>
<elocation-id>683</elocation-id>
<pub-id pub-id-type="doi">10.1186/s12879-019-4318-3</pub-id>
<pub-id pub-id-type="pmid">31375073</pub-id>
</element-citation>
</ref>
<ref id="B157-pathogens-08-00265">
<label>157.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mertz</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>T.H.</given-names>
</name>
<name>
<surname>Johnstone</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lam</surname>
<given-names>P.P.</given-names>
</name>
<name>
<surname>Science</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kuster</surname>
<given-names>S.P.</given-names>
</name>
<name>
<surname>Fadel</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Tran</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Fernandez</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Bhatnagar</surname>
<given-names>N.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Populations at risk for severe or complicated influenza illness: Systematic review and meta-analysis</article-title>
<source/>BMJ
          <year>2013</year>
<volume>347</volume>
<fpage>f5061</fpage>
<pub-id pub-id-type="doi">10.1136/bmj.f5061</pub-id>
<pub-id pub-id-type="pmid">23974637</pub-id>
</element-citation>
</ref>
<ref id="B158-pathogens-08-00265">
<label>158.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mertz</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Geraci</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Winkup</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gessner</surname>
<given-names>B.D.</given-names>
</name>
<name>
<surname>Ortiz</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Loeb</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Pregnancy as a risk factor for severe outcomes from influenza virus infection: A systematic review and meta-analysis of observational studies</article-title>
<source/>Vaccine
          <year>2017</year>
<volume>35</volume>
<fpage>521</fpage>
<lpage>528</lpage>
<pub-id pub-id-type="doi">10.1016/j.vaccine.2016.12.012</pub-id>
<pub-id pub-id-type="pmid">28024955</pub-id>
</element-citation>
</ref>
<ref id="B159-pathogens-08-00265">
<label>159.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sperling</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Riley</surname>
<given-names>L.E.</given-names>
</name>
<collab>Immunization and Emerging Infections Expert Work Group</collab>
</person-group>
<article-title>Influenza Vaccination, Pregnancy Safety, and Risk of Early Pregnancy Loss</article-title>
<source/>Obstet. Gynecol.
          <year>2018</year>
<volume>131</volume>
<fpage>799</fpage>
<lpage>802</lpage>
<pub-id pub-id-type="doi">10.1097/AOG.0000000000002573</pub-id>
<pub-id pub-id-type="pmid">29630014</pub-id>
</element-citation>
</ref>
<ref id="B160-pathogens-08-00265">
<label>160.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zerbo</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Modaressi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Goddard</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Bok</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Fireman</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>N.P.</given-names>
</name>
<name>
<surname>Baxter</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>No association between influenza vaccination during pregnancy and adverse birth outcomes</article-title>
<source/>Vaccine
          <year>2017</year>
<volume>35</volume>
<fpage>3186</fpage>
<lpage>3190</lpage>
<pub-id pub-id-type="doi">10.1016/j.vaccine.2017.04.074</pub-id>
<pub-id pub-id-type="pmid">28483192</pub-id>
</element-citation>
</ref>
<ref id="B161-pathogens-08-00265">
<label>161.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walsh</surname>
<given-names>L.K.</given-names>
</name>
<name>
<surname>Donelle</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Dodds</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Hawken</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Benchimol</surname>
<given-names>E.I.</given-names>
</name>
<name>
<surname>Chakraborty</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Guttmann</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kwong</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>MacDonald</surname>
<given-names>N.E.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Health outcomes of young children born to mothers who received 2009 pandemic H1N1 influenza vaccination during pregnancy: Retrospective cohort study</article-title>
<source/>BMJ
          <year>2019</year>
<volume>366</volume>
<fpage>l4151</fpage>
<pub-id pub-id-type="doi">10.1136/bmj.l4151</pub-id>
<pub-id pub-id-type="pmid">31292120</pub-id>
</element-citation>
</ref>
<ref id="B162-pathogens-08-00265">
<label>162.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McHugh</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Marshall</surname>
<given-names>H.S.</given-names>
</name>
<name>
<surname>Perrett</surname>
<given-names>K.P.</given-names>
</name>
<name>
<surname>Nolan</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Wood</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Lambert</surname>
<given-names>S.B.</given-names>
</name>
<name>
<surname>Richmond</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Ware</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Binks</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Binks</surname>
<given-names>M.J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The Safety of Influenza and Pertussis Vaccination in Pregnancy in a Cohort of Australian Mother-Infant Pairs, 2012–2015: FluMum Study</article-title>
<source/>Clin. Infect. Dis.
          <year>2019</year>
<volume>68</volume>
<fpage>402</fpage>
<lpage>408</lpage>
<pub-id pub-id-type="doi">10.1093/cid/ciy517</pub-id>
<pub-id pub-id-type="pmid">30475988</pub-id>
</element-citation>
</ref>
<ref id="B163-pathogens-08-00265">
<label>163.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chambers</surname>
<given-names>C.D.</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>D.L.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>Y.J.</given-names>
</name>
<name>
<surname>Louik</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Mitchell</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Schatz</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>K.L.</given-names>
</name>
<collab>OTIS Collaborative Research Group</collab>
</person-group>
<article-title>Safety of the 2010-11, 2011–2012, 2012–2013, and 2013-14 seasonal influenza vaccines in pregnancy: Birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants, a study from the cohort arm of VAMPSS</article-title>
<source/>Vaccine
          <year>2016</year>
<volume>34</volume>
<fpage>4443</fpage>
<lpage>4449</lpage>
<pub-id pub-id-type="doi">10.1016/j.vaccine.2016.06.054</pub-id>
<pub-id pub-id-type="pmid">27449682</pub-id>
</element-citation>
</ref>
<ref id="B164-pathogens-08-00265">
<label>164.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moro</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Baumblatt</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Cragan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Tepper</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Cano</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Surveillance of Adverse Events After Seasonal Influenza Vaccination in Pregnant Women and Their Infants in the Vaccine Adverse Event Reporting System, July 2010–May 2016</article-title>
<source/>Drug Saf.
          <year>2017</year>
<volume>40</volume>
<fpage>145</fpage>
<lpage>152</lpage>
<pub-id pub-id-type="doi">10.1007/s40264-016-0482-1</pub-id>
<pub-id pub-id-type="pmid">27988883</pub-id>
</element-citation>
</ref>
<ref id="B165-pathogens-08-00265">
<label>165.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eaton</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Fireman</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Baxter</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Gee</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>N.P.</given-names>
</name>
</person-group>
<article-title>Birth outcomes following immunization of pregnant women with pandemic H1N1 influenza vaccine 2009–2010</article-title>
<source/>Vaccine
          <year>2018</year>
<volume>36</volume>
<fpage>2733</fpage>
<lpage>2739</lpage>
<pub-id pub-id-type="doi">10.1016/j.vaccine.2017.08.080</pub-id>
<pub-id pub-id-type="pmid">28917536</pub-id>
</element-citation>
</ref>
<ref id="B166-pathogens-08-00265">
<label>166.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nunes</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Aqil</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Omer</surname>
<given-names>S.B.</given-names>
</name>
<name>
<surname>Madhi</surname>
<given-names>S.A.</given-names>
</name>
</person-group>
<article-title>The Effects of Influenza Vaccination during Pregnancy on Birth Outcomes: A Systematic Review and Meta-Analysis</article-title>
<source/>Am. J. Perinatol.
          <year>2016</year>
<volume>33</volume>
<fpage>1104</fpage>
<lpage>1114</lpage>
<pub-id pub-id-type="doi">10.1055/s-0036-1586101</pub-id>
<pub-id pub-id-type="pmid">27603545</pub-id>
</element-citation>
</ref>
<ref id="B167-pathogens-08-00265">
<label>167.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hutcheon</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Fell</surname>
<given-names>D.B.</given-names>
</name>
<name>
<surname>Jackson</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Kramer</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Ortiz</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Savitz</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Platt</surname>
<given-names>R.W.</given-names>
</name>
</person-group>
<article-title>Detectable Risks in Studies of the Fetal Benefits of Maternal Influenza Vaccination</article-title>
<source/>Am. J. Epidemiol.
          <year>2016</year>
<volume>184</volume>
<fpage>227</fpage>
<lpage>232</lpage>
<pub-id pub-id-type="doi">10.1093/aje/kww048</pub-id>
<pub-id pub-id-type="pmid">27365363</pub-id>
</element-citation>
</ref>
<ref id="B168-pathogens-08-00265">
<label>168.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>X.</given-names>
</name>
</person-group>
<article-title>A systematic review and meta-analysis of fetal outcomes following the administration of influenza A/H1N1 vaccination during pregnancy</article-title>
<source/>Int. J. Gynaecol. Obstet.
          <year>2018</year>
<volume>141</volume>
<fpage>141</fpage>
<lpage>150</lpage>
<pub-id pub-id-type="doi">10.1002/ijgo.12394</pub-id>
<pub-id pub-id-type="pmid">29149524</pub-id>
</element-citation>
</ref>
<ref id="B169-pathogens-08-00265">
<label>169.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kallen</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Olausson</surname>
<given-names>P.O.</given-names>
</name>
</person-group>
<article-title>Vaccination against H1N1 influenza with Pandemrix((R)) during pregnancy and delivery outcome: A Swedish register study</article-title>
<source/>BJOG
          <year>2012</year>
<volume>119</volume>
<fpage>1583</fpage>
<lpage>1590</lpage>
<pub-id pub-id-type="doi">10.1111/j.1471-0528.2012.03470.x</pub-id>
<pub-id pub-id-type="pmid">22901103</pub-id>
</element-citation>
</ref>
<ref id="B170-pathogens-08-00265">
<label>170.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van der Maas</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Dijs-Elsinga</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kemmeren</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>van Lier</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Knol</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>de Melker</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Safety of vaccination against influenza A (H1N1) during pregnancy in the Netherlands: Results on pregnancy outcomes and infant’s health: Cross-sectional linkage study</article-title>
<source/>BJOG
          <year>2016</year>
<volume>123</volume>
<fpage>709</fpage>
<lpage>717</lpage>
<pub-id pub-id-type="doi">10.1111/1471-0528.13329</pub-id>
<pub-id pub-id-type="pmid">25754741</pub-id>
</element-citation>
</ref>
<ref id="B171-pathogens-08-00265">
<label>171.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z.W.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Y.P.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>T.Y.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>X.J.</given-names>
</name>
<name>
<surname>Arck</surname>
<given-names>P.C.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Hocher</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.P.</given-names>
</name>
</person-group>
<article-title>A Systematic Review and Meta-Analysis of Influenza A Virus Infection During Pregnancy Associated with an Increased Risk for Stillbirth and Low Birth Weight</article-title>
<source/>Kidney Blood Press. Res.
          <year>2017</year>
<volume>42</volume>
<fpage>232</fpage>
<lpage>243</lpage>
<pub-id pub-id-type="doi">10.1159/000477221</pub-id>
<pub-id pub-id-type="pmid">28514782</pub-id>
</element-citation>
</ref>
<ref id="B172-pathogens-08-00265">
<label>172.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ribeiro</surname>
<given-names>A.F.</given-names>
</name>
<name>
<surname>Pellini</surname>
<given-names>A.C.G.</given-names>
</name>
<name>
<surname>Kitagawa</surname>
<given-names>B.Y.</given-names>
</name>
<name>
<surname>Marques</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Madalosso</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Fred</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Albernaz</surname>
<given-names>R.K.M.</given-names>
</name>
<name>
<surname>Carvalhanas</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Zanetta</surname>
<given-names>D.M.T.</given-names>
</name>
</person-group>
<article-title>Severe influenza A(H1N1)pdm09 in pregnant women and neonatal outcomes, State of Sao Paulo, Brazil, 2009</article-title>
<source/>PLoS ONE
          <year>2018</year>
<volume>13</volume>
<elocation-id>e0194392</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0194392</pub-id>
<pub-id pub-id-type="pmid">29579099</pub-id>
</element-citation>
</ref>
<ref id="B173-pathogens-08-00265">
<label>173.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Newsome</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Alverson</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>McIntyre</surname>
<given-names>A.F.</given-names>
</name>
<name>
<surname>Fine</surname>
<given-names>A.D.</given-names>
</name>
<name>
<surname>Wasserman</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lofy</surname>
<given-names>K.H.</given-names>
</name>
<name>
<surname>Acosta</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Louie</surname>
<given-names>J.K.</given-names>
</name>
<name>
<surname>Jones-Vessey</surname>
<given-names>K.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Outcomes of infants born to women with influenza A(H1N1)pdm09</article-title>
<source/>Birth Defects Res.
          <year>2019</year>
<volume>111</volume>
<fpage>88</fpage>
<lpage>95</lpage>
<pub-id pub-id-type="doi">10.1002/bdr2.1445</pub-id>
<pub-id pub-id-type="pmid">30623611</pub-id>
</element-citation>
</ref>
<ref id="B174-pathogens-08-00265">
<label>174.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fell</surname>
<given-names>D.B.</given-names>
</name>
<name>
<surname>Savitz</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Kramer</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Gessner</surname>
<given-names>B.D.</given-names>
</name>
<name>
<surname>Katz</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Knight</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Luteijn</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Marshall</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Bhat</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Gravett</surname>
<given-names>M.G.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Maternal influenza and birth outcomes: Systematic review of comparative studies</article-title>
<source/>BJOG
          <year>2017</year>
<volume>124</volume>
<fpage>48</fpage>
<lpage>59</lpage>
<pub-id pub-id-type="doi">10.1111/1471-0528.14143</pub-id>
<pub-id pub-id-type="pmid">27264387</pub-id>
</element-citation>
</ref>
<ref id="B175-pathogens-08-00265">
<label>175.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Madhi</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Cutland</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>Kuwanda</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Weinberg</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hugo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Adrian</surname>
<given-names>P.V.</given-names>
</name>
<name>
<surname>Niekerk</surname>
<given-names>N.V.</given-names>
</name>
<name>
<surname>Treurnicht</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Ortiz</surname>
<given-names>J.R.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Influenza Vaccination of Pregnant Women and Protection of Their Infants</article-title>
<source/>N. Engl. J. Med.
          <year>2014</year>
<volume>371</volume>
<fpage>918</fpage>
<lpage>931</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMoa1401480</pub-id>
<pub-id pub-id-type="pmid">25184864</pub-id>
</element-citation>
</ref>
<ref id="B176-pathogens-08-00265">
<label>176.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nunes</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Cutland</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>Dighero</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Bate</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hugo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>van Niekerk</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kuwanda</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Izu</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Weinberg</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Kinetics of Hemagglutination-Inhibiting Antibodies Following Maternal Influenza Vaccination Among Mothers With and Those Without HIV Infection and Their Infants</article-title>
<source/>J. Infect. Dis.
          <year>2015</year>
<volume>212</volume>
<fpage>1976</fpage>
<lpage>1987</lpage>
<pub-id pub-id-type="doi">10.1093/infdis/jiv339</pub-id>
<pub-id pub-id-type="pmid">26080370</pub-id>
</element-citation>
</ref>
<ref id="B177-pathogens-08-00265">
<label>177.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Malek</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sager</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kuhn</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Nicolaides</surname>
<given-names>K.H.</given-names>
</name>
<name>
<surname>Schneider</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Evolution of maternofetal transport of immunoglobulins during human pregnancy</article-title>
<source/>Am. J. Reprod. Immunol.
          <year>1996</year>
<volume>36</volume>
<fpage>248</fpage>
<lpage>255</lpage>
<pub-id pub-id-type="doi">10.1111/j.1600-0897.1996.tb00172.x</pub-id>
<pub-id pub-id-type="pmid">8955500</pub-id>
</element-citation>
</ref>
<ref id="B178-pathogens-08-00265">
<label>178.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Palmeira</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Costa-Carvalho</surname>
<given-names>B.T.</given-names>
</name>
<name>
<surname>Arslanian</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Pontes</surname>
<given-names>G.N.</given-names>
</name>
<name>
<surname>Nagao</surname>
<given-names>A.T.</given-names>
</name>
<name>
<surname>Carneiro-Sampaio</surname>
<given-names>M.M.</given-names>
</name>
</person-group>
<article-title>Transfer of antibodies across the placenta and in breast milk from mothers on intravenous immunoglobulin</article-title>
<source/>Pediatric Allergy Immunol.
          <year>2009</year>
<volume>20</volume>
<fpage>528</fpage>
<lpage>535</lpage>
<pub-id pub-id-type="doi">10.1111/j.1399-3038.2008.00828.x</pub-id>
</element-citation>
</ref>
<ref id="B179-pathogens-08-00265">
<label>179.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nunes</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Cutland</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Downs</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Weinberg</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ortiz</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Neuzil</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Simões</surname>
<given-names>E.A.F.</given-names>
</name>
<name>
<surname>Klugman</surname>
<given-names>K.P.</given-names>
</name>
<name>
<surname>Madhi</surname>
<given-names>S.A.</given-names>
</name>
</person-group>
<article-title>Efficacy of Maternal Influenza Vaccination Against All-Cause Lower Respiratory Tract Infection Hospitalizations in Young Infants: Results From a Randomized Controlled Trial</article-title>
<source/>Clin. Infect. Dis.
          <year>2017</year>
<volume>65</volume>
<fpage>1066</fpage>
<lpage>1071</lpage>
<pub-id pub-id-type="doi">10.1093/cid/cix497</pub-id>
<pub-id pub-id-type="pmid">28575286</pub-id>
</element-citation>
</ref>
<ref id="B180-pathogens-08-00265">
<label>180.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zaman</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Roy</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Arifeen</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Rahman</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Raqib</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Omer</surname>
<given-names>S.B.</given-names>
</name>
<name>
<surname>Shahid</surname>
<given-names>N.S.</given-names>
</name>
<name>
<surname>Breiman</surname>
<given-names>R.F.</given-names>
</name>
<name>
<surname>Breiman</surname>
<given-names>R.E.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Effectiveness of Maternal Influenza Immunization in Mothers and Infants</article-title>
<source/>N. Engl. J. Med.
          <year>2008</year>
<volume>359</volume>
<fpage>1555</fpage>
<lpage>1564</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMoa0708630</pub-id>
<pub-id pub-id-type="pmid">18799552</pub-id>
</element-citation>
</ref>
<ref id="B181-pathogens-08-00265">
<label>181.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benowitz</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Esposito</surname>
<given-names>D.B.</given-names>
</name>
<name>
<surname>Gracey</surname>
<given-names>K.D.</given-names>
</name>
<name>
<surname>Shapiro</surname>
<given-names>E.D.</given-names>
</name>
<name>
<surname>Vázquez</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Influenza Vaccine Given to Pregnant Women Reduces Hospitalization Due to Influenza in Their Infants</article-title>
<source/>Clin. Infect. Dis.
          <year>2010</year>
<volume>51</volume>
<fpage>1355</fpage>
<lpage>1361</lpage>
<pub-id pub-id-type="doi">10.1086/657309</pub-id>
<pub-id pub-id-type="pmid">21058908</pub-id>
</element-citation>
</ref>
<ref id="B182-pathogens-08-00265">
<label>182.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhong</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Haltalli</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Holder</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Rice</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Donaldson</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>O’Driscoll</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Le-Doare</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kampmann</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Tregoning</surname>
<given-names>J.S.</given-names>
</name>
</person-group>
<article-title>The impact of timing of maternal influenza immunization on infant antibody levels at birth</article-title>
<source/>Clin. Exp. Immunol.
          <year>2019</year>
<volume>195</volume>
<fpage>139</fpage>
<lpage>152</lpage>
<pub-id pub-id-type="doi">10.1111/cei.13234</pub-id>
<pub-id pub-id-type="pmid">30422307</pub-id>
</element-citation>
</ref>
<ref id="B183-pathogens-08-00265">
<label>183.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schlaudecker</surname>
<given-names>E.P.</given-names>
</name>
<name>
<surname>Steinhoff</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Omer</surname>
<given-names>S.B.</given-names>
</name>
<name>
<surname>McNeal</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Roy</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Arifeen</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Dodd</surname>
<given-names>C.N.</given-names>
</name>
<name>
<surname>Raqib</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Breiman</surname>
<given-names>R.F.</given-names>
</name>
<name>
<surname>Zaman</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>IgA and neutralizing antibodies to influenza a virus in human milk: A randomized trial of antenatal influenza immunization</article-title>
<source/>PLoS ONE
          <year>2013</year>
<volume>8</volume>
<elocation-id>e70867</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0070867</pub-id>
<pub-id pub-id-type="pmid">23967126</pub-id>
</element-citation>
</ref>
<ref id="B184-pathogens-08-00265">
<label>184.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jarvinen</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Seppo</surname>
<given-names>A.E.</given-names>
</name>
<name>
<surname>Zand</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Novel multiplex assay for profiling influenza antibodies in breast milk and serum of mother-infant pairs</article-title>
<source/>F1000Research
          <year>2018</year>
<volume>7</volume>
<fpage>1822</fpage>
<pub-id pub-id-type="doi">10.12688/f1000research.16717.1</pub-id>
<pub-id pub-id-type="pmid">30918628</pub-id>
</element-citation>
</ref>
<ref id="B185-pathogens-08-00265">
<label>185.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brady</surname>
<given-names>R.C.</given-names>
</name>
<name>
<surname>Jackson</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Frey</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Shane</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Walter</surname>
<given-names>E.B.</given-names>
</name>
<name>
<surname>Swamy</surname>
<given-names>G.K.</given-names>
</name>
<name>
<surname>Schlaudecker</surname>
<given-names>E.P.</given-names>
</name>
<name>
<surname>Szefer</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Wolff</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>McNeal</surname>
<given-names>M.M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Randomized trial comparing the safety and antibody responses to live attenuated versus inactivated influenza vaccine when administered to breastfeeding women</article-title>
<source/>Vaccine
          <year>2018</year>
<volume>36</volume>
<fpage>4663</fpage>
<lpage>4671</lpage>
<pub-id pub-id-type="doi">10.1016/j.vaccine.2018.06.036</pub-id>
<pub-id pub-id-type="pmid">29961606</pub-id>
</element-citation>
</ref>
<ref id="B186-pathogens-08-00265">
<label>186.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Demers-Mathieu</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Underwood</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Beverly</surname>
<given-names>R.L.</given-names>
</name>
<name>
<surname>Nielsen</surname>
<given-names>S.D.</given-names>
</name>
<name>
<surname>Dallas</surname>
<given-names>D.C.</given-names>
</name>
</person-group>
<article-title>Comparison of Human Milk Immunoglobulin Survival during Gastric Digestion between Preterm and Term Infants</article-title>
<source/>Nutrients
          <year>2018</year>
<volume>10</volume>
<elocation-id>631</elocation-id>
<pub-id pub-id-type="doi">10.3390/nu10050631</pub-id>
</element-citation>
</ref>
<ref id="B187-pathogens-08-00265">
<label>187.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van den Berg</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Westerbeek</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Berbers</surname>
<given-names>G.A.</given-names>
</name>
<name>
<surname>van Gageldonk</surname>
<given-names>P.G.</given-names>
</name>
<name>
<surname>van der Klis</surname>
<given-names>F.R.</given-names>
</name>
<name>
<surname>van Elburg</surname>
<given-names>R.M.</given-names>
</name>
</person-group>
<article-title>Transplacental transport of IgG antibodies specific for pertussis, diphtheria, tetanus, haemophilus influenzae type b, and Neisseria meningitidis serogroup C is lower in preterm compared with term infants</article-title>
<source/>Pediatric Infect. Dis. J.
          <year>2010</year>
<volume>29</volume>
<fpage>801</fpage>
<lpage>805</lpage>
<pub-id pub-id-type="doi">10.1097/INF.0b013e3181dc4f77</pub-id>
</element-citation>
</ref>
<ref id="B188-pathogens-08-00265">
<label>188.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Demers-Mathieu</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Huston</surname>
<given-names>R.K.</given-names>
</name>
<name>
<surname>Markell</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>McCulley</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>R.L.</given-names>
</name>
<name>
<surname>Dallas</surname>
<given-names>D.C.</given-names>
</name>
</person-group>
<article-title>Antenatal Influenza A-Specific IgA, IgM, and IgG Antibodies in Mother’s Own Breast Milk and Donor Breast Milk, and Gastric Contents and Stools from Preterm Infants</article-title>
<source/>Nutrients
          <year>2019</year>
<volume>11</volume>
<elocation-id>1567</elocation-id>
<pub-id pub-id-type="doi">10.3390/nu11071567</pub-id>
</element-citation>
</ref>
<ref id="B189-pathogens-08-00265">
<label>189.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sunwoo</surname>
<given-names>S.Y.</given-names>
</name>
<name>
<surname>Schotsaert</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Morozov</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>A.S.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>McDowell</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Meade</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Nachbagauer</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Garcia-Sastre</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A Universal Influenza Virus Vaccine Candidate Tested in a Pig Vaccination-Infection Model in the Presence of Maternal Antibodies</article-title>
<source/>Vaccines
          <year>2018</year>
<volume>6</volume>
<elocation-id>64</elocation-id>
<pub-id pub-id-type="doi">10.3390/vaccines6030064</pub-id>
</element-citation>
</ref>
<ref id="B190-pathogens-08-00265">
<label>190.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grabarics</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Csernak</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Balogh</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Beni</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Analytical characterization of human milk oligosaccharides-potential applications in pharmaceutical analysis</article-title>
<source/>J. Pharm. Biomed. Anal.
          <year>2017</year>
<volume>146</volume>
<fpage>168</fpage>
<lpage>178</lpage>
<pub-id pub-id-type="doi">10.1016/j.jpba.2017.08.039</pub-id>
<pub-id pub-id-type="pmid">28881314</pub-id>
</element-citation>
</ref>
<ref id="B191-pathogens-08-00265">
<label>191.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trend</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Strunk</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Lloyd</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Kok</surname>
<given-names>C.H.</given-names>
</name>
<name>
<surname>Metcalfe</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Geddes</surname>
<given-names>D.T.</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>C.T.</given-names>
</name>
<name>
<surname>Richmond</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Doherty</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Simmer</surname>
<given-names>K.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Levels of innate immune factors in preterm and term mothers’ breast milk during the 1st month postpartum</article-title>
<source/>Br. J. Nutr.
          <year>2016</year>
<volume>115</volume>
<fpage>1178</fpage>
<lpage>1193</lpage>
<pub-id pub-id-type="doi">10.1017/S0007114516000234</pub-id>
<pub-id pub-id-type="pmid">26891901</pub-id>
</element-citation>
</ref>
<ref id="B192-pathogens-08-00265">
<label>192.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bedin</surname>
<given-names>A.S.</given-names>
</name>
<name>
<surname>Moles</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Rutagwera</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Nagot</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kankasa</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Tylleskar</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Valverde-Villegas</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Durand</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Van de Perre</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Tuaillon</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>MAIT cells, TCR gammadelta+ cells and ILCs cells in human breast milk and blood from HIV infected and uninfected women</article-title>
<source/>Pediatric Allergy Immunol.
          <year>2019</year>
<volume>30</volume>
<fpage>479</fpage>
<lpage>487</lpage>
<pub-id pub-id-type="doi">10.1111/pai.13037</pub-id>
</element-citation>
</ref>
<ref id="B193-pathogens-08-00265">
<label>193.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xiao</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Leusink-Muis</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kettelarij</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>van Ark</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Blijenberg</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Hesen</surname>
<given-names>N.A.</given-names>
</name>
<name>
<surname>Stahl</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Overbeek</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Garssen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Folkerts</surname>
<given-names>G.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Human Milk Oligosaccharide 2′-Fucosyllactose Improves Innate and Adaptive Immunity in an Influenza-Specific Murine Vaccination Model</article-title>
<source/>Front. Immunol.
          <year>2018</year>
<volume>9</volume>
<fpage>452</fpage>
<pub-id pub-id-type="doi">10.3389/fimmu.2018.00452</pub-id>
<pub-id pub-id-type="pmid">29593719</pub-id>
</element-citation>
</ref>
<ref id="B194-pathogens-08-00265">
<label>194.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coulet</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Phothirath</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Allais</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Schilter</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Pre-clinical safety evaluation of the synthetic human milk, nature-identical, oligosaccharide 2′-O-Fucosyllactose (2′FL)</article-title>
<source/>Regul. Toxicol. Pharmacol.
          <year>2014</year>
<volume>68</volume>
<fpage>59</fpage>
<lpage>69</lpage>
<pub-id pub-id-type="doi">10.1016/j.yrtph.2013.11.005</pub-id>
<pub-id pub-id-type="pmid">24262411</pub-id>
</element-citation>
</ref>
<ref id="B195-pathogens-08-00265">
<label>195.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vazquez</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Barranco</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ramirez</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gruart</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Delgado-Garcia</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Martinez-Lara</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Blanco</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Castanys</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Buck</surname>
<given-names>R.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Effects of a human milk oligosaccharide, 2′-fucosyllactose, on hippocampal long-term potentiation and learning capabilities in rodents</article-title>
<source/>J. Nutr. Biochem.
          <year>2015</year>
<volume>26</volume>
<fpage>455</fpage>
<lpage>465</lpage>
<pub-id pub-id-type="doi">10.1016/j.jnutbio.2014.11.016</pub-id>
<pub-id pub-id-type="pmid">25662731</pub-id>
</element-citation>
</ref>
<ref id="B196-pathogens-08-00265">
<label>196.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elison</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Vigsnaes</surname>
<given-names>L.K.</given-names>
</name>
<name>
<surname>Rindom Krogsgaard</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Rasmussen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sorensen</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>McConnell</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Hennet</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Sommer</surname>
<given-names>M.O.</given-names>
</name>
<name>
<surname>Bytzer</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Oral supplementation of healthy adults with 2′-O-fucosyllactose and lacto-N-neotetraose is well tolerated and shifts the intestinal microbiota</article-title>
<source/>Br. J. Nutr.
          <year>2016</year>
<volume>116</volume>
<fpage>1356</fpage>
<lpage>1368</lpage>
<pub-id pub-id-type="doi">10.1017/S0007114516003354</pub-id>
<pub-id pub-id-type="pmid">27719686</pub-id>
</element-citation>
</ref>
<ref id="B197-pathogens-08-00265">
<label>197.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tregoning</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Russell</surname>
<given-names>R.F.</given-names>
</name>
<name>
<surname>Kinnear</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Adjuvanted influenza vaccines</article-title>
<source/>Hum. Vaccines Immunother.
          <year>2018</year>
<volume>14</volume>
<fpage>550</fpage>
<lpage>564</lpage>
<pub-id pub-id-type="doi">10.1080/21645515.2017.1415684</pub-id>
</element-citation>
</ref>
<ref id="B198-pathogens-08-00265">
<label>198.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Diez-Domingo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Garces-Sanchez</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Baldo</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Planelles</surname>
<given-names>M.V.</given-names>
</name>
<name>
<surname>Ubeda</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>JuBert</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mares</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Moris</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Garcia-Corbeira</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Drame</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Immunogenicity and Safety of H5N1 A/Vietnam/1194/2004 (Clade 1) AS03-adjuvanted prepandemic candidate influenza vaccines in children aged 3 to 9 years: A phase ii, randomized, open, controlled study</article-title>
<source/>Pediatric Infect. Dis. J.
          <year>2010</year>
<volume>29</volume>
<fpage>e35</fpage>
<lpage>e46</lpage>
<pub-id pub-id-type="doi">10.1097/INF.0b013e3181daf921</pub-id>
</element-citation>
</ref>
<ref id="B199-pathogens-08-00265">
<label>199.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Waddington</surname>
<given-names>C.S.</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>W.T.</given-names>
</name>
<name>
<surname>Oeser</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Reiner</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>John</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Wilkins</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Casey</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Eccleston</surname>
<given-names>P.E.</given-names>
</name>
<name>
<surname>Allen</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Okike</surname>
<given-names>I.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: Open label, randomised, parallel group, multicentre study</article-title>
<source/>BMJ
          <year>2010</year>
<volume>340</volume>
<fpage>c2649</fpage>
<pub-id pub-id-type="doi">10.1136/bmj.c2649</pub-id>
<pub-id pub-id-type="pmid">20508026</pub-id>
</element-citation>
</ref>
<ref id="B200-pathogens-08-00265">
<label>200.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Monto</surname>
<given-names>A.S.</given-names>
</name>
<name>
<surname>Malosh</surname>
<given-names>R.E.</given-names>
</name>
<name>
<surname>Petrie</surname>
<given-names>J.G.</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>E.T.</given-names>
</name>
</person-group>
<article-title>The Doctrine of Original Antigenic Sin: Separating Good From Evil</article-title>
<source/>J. Infect. Dis.
          <year>2017</year>
<volume>215</volume>
<fpage>1782</fpage>
<lpage>1788</lpage>
<pub-id pub-id-type="doi">10.1093/infdis/jix173</pub-id>
<pub-id pub-id-type="pmid">28398521</pub-id>
</element-citation>
</ref>
<ref id="B201-pathogens-08-00265">
<label>201.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jackson</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>W.H.</given-names>
</name>
<name>
<surname>Stapleton</surname>
<given-names>J.T.</given-names>
</name>
<name>
<surname>Dekker</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>Wald</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Brady</surname>
<given-names>R.C.</given-names>
</name>
<name>
<surname>Edupuganti</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Winokur</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Mulligan</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Keyserling</surname>
<given-names>H.L.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Immunogenicity and safety of varying dosages of a monovalent 2009 H1N1 influenza vaccine given with and without AS03 adjuvant system in healthy adults and older persons</article-title>
<source/>J. Infect. Dis.
          <year>2012</year>
<volume>206</volume>
<fpage>811</fpage>
<lpage>820</lpage>
<pub-id pub-id-type="doi">10.1093/infdis/jis427</pub-id>
<pub-id pub-id-type="pmid">22782949</pub-id>
</element-citation>
</ref>
<ref id="B202-pathogens-08-00265">
<label>202.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carmona</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Omenaca</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Tejedor</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Merino</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Vaman</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Dieussaert</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Gillard</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Aristegui</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6–35 months</article-title>
<source/>Vaccine
          <year>2010</year>
<volume>28</volume>
<fpage>5837</fpage>
<lpage>5844</lpage>
<pub-id pub-id-type="doi">10.1016/j.vaccine.2010.06.065</pub-id>
<pub-id pub-id-type="pmid">20600478</pub-id>
</element-citation>
</ref>
<ref id="B203-pathogens-08-00265">
<label>203.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garcia-Sicilia</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gillard</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Carmona</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Tejedor</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Aristegui</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Merino</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Behre</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Caplanusi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Vaman</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Dieussaert</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Immunogenicity and safety of AS03-adjuvanted H1N1 pandemic vaccines in children and adolescents</article-title>
<source/>Vaccine
          <year>2011</year>
<volume>29</volume>
<fpage>4353</fpage>
<lpage>4361</lpage>
<pub-id pub-id-type="doi">10.1016/j.vaccine.2011.04.011</pub-id>
<pub-id pub-id-type="pmid">21504774</pub-id>
</element-citation>
</ref>
<ref id="B204-pathogens-08-00265">
<label>204.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laupeze</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Herve</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Di Pasquale</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Tavares Da Silva</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Adjuvant Systems for vaccines: 13years of post-licensure experience in diverse populations have progressed the way adjuvanted vaccine safety is investigated and understood</article-title>
<source/>Vaccine
          <year>2019</year>
<volume>37</volume>
<fpage>5670</fpage>
<lpage>5680</lpage>
<pub-id pub-id-type="doi">10.1016/j.vaccine.2019.07.098</pub-id>
<pub-id pub-id-type="pmid">31420171</pub-id>
</element-citation>
</ref>
<ref id="B205-pathogens-08-00265">
<label>205.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Esposito</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Pugni</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Daleno</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ronchi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Valzano</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Serra</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Mosca</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Principi</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Influenza A/H1N1 MF59-adjuvanted vaccine in preterm and term children aged 6 to 23 months</article-title>
<source/>Pediatrics
          <year>2011</year>
<volume>127</volume>
<fpage>e1161</fpage>
<lpage>e1168</lpage>
<pub-id pub-id-type="doi">10.1542/peds.2010-1920</pub-id>
<pub-id pub-id-type="pmid">21464195</pub-id>
</element-citation>
</ref>
<ref id="B206-pathogens-08-00265">
<label>206.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakaya</surname>
<given-names>H.I.</given-names>
</name>
<name>
<surname>Clutterbuck</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Kazmin</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Cortese</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bosinger</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>N.B.</given-names>
</name>
<name>
<surname>Zak</surname>
<given-names>D.E.</given-names>
</name>
<name>
<surname>Aderem</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>T.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Systems biology of immunity to MF59-adjuvanted versus nonadjuvanted trivalent seasonal influenza vaccines in early childhood</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2016</year>
<volume>113</volume>
<fpage>1853</fpage>
<lpage>1858</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1519690113</pub-id>
<pub-id pub-id-type="pmid">26755593</pub-id>
</element-citation>
</ref>
<ref id="B207-pathogens-08-00265">
<label>207.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zedda</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Forleo-Neto</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Vertruyen</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Raes</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Marchant</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Jansen</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Clouting</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Arora</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Beatty</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Galli</surname>
<given-names>G.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Dissecting the immune response to MF59-adjuvanted and nonadjuvanted seasonal influenza vaccines in children less than three years of age</article-title>
<source/>Pediatr. Infect. Dis. J.
          <year>2015</year>
<volume>34</volume>
<fpage>73</fpage>
<lpage>78</lpage>
<pub-id pub-id-type="doi">10.1097/INF.0000000000000465</pub-id>
<pub-id pub-id-type="pmid">25037034</pub-id>
</element-citation>
</ref>
<ref id="B208-pathogens-08-00265">
<label>208.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mastelic Gavillet</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Eberhardt</surname>
<given-names>C.S.</given-names>
</name>
<name>
<surname>Auderset</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Castellino</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Seubert</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Tregoning</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Lambert</surname>
<given-names>P.H.</given-names>
</name>
<name>
<surname>de Gregorio</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Del Giudice</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Siegrist</surname>
<given-names>C.A.</given-names>
</name>
</person-group>
<article-title>MF59 Mediates Its B Cell Adjuvanticity by Promoting T Follicular Helper Cells and Thus Germinal Center Responses in Adult and Early Life</article-title>
<source/>J. Immunol.
          <year>2015</year>
<volume>194</volume>
<fpage>4836</fpage>
<lpage>4845</lpage>
<pub-id pub-id-type="doi">10.4049/jimmunol.1402071</pub-id>
<pub-id pub-id-type="pmid">25870238</pub-id>
</element-citation>
</ref>
<ref id="B209-pathogens-08-00265">
<label>209.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haber</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Moro</surname>
<given-names>P.L.</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Dores</surname>
<given-names>G.M.</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Cano</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Post-licensure surveillance of trivalent adjuvanted influenza vaccine (aIIV3; Fluad), Vaccine Adverse Event Reporting System (VAERS), United States, July 2016–June 2018</article-title>
<source/>Vaccine
          <year>2019</year>
<volume>37</volume>
<fpage>1516</fpage>
<lpage>1520</lpage>
<pub-id pub-id-type="doi">10.1016/j.vaccine.2019.01.052</pub-id>
<pub-id pub-id-type="pmid">30739795</pub-id>
</element-citation>
</ref>
<ref id="B210-pathogens-08-00265">
<label>210.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sakala</surname>
<given-names>I.G.</given-names>
</name>
<name>
<surname>Honda-Okubo</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Fung</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Petrovsky</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Influenza immunization during pregnancy: Benefits for mother and infant</article-title>
<source/>Hum. Vaccines Immunother.
          <year>2016</year>
<volume>12</volume>
<fpage>3065</fpage>
<lpage>3071</lpage>
<pub-id pub-id-type="doi">10.1080/21645515.2016.1215392</pub-id>
</element-citation>
</ref>
<ref id="B211-pathogens-08-00265">
<label>211.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baum</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Leino</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Gissler</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kilpi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Jokinen</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Perinatal survival and health after maternal influenza A(H1N1)pdm09 vaccination: A cohort study of pregnancies stratified by trimester of vaccination</article-title>
<source/>Vaccine
          <year>2015</year>
<volume>33</volume>
<fpage>4850</fpage>
<lpage>4857</lpage>
<pub-id pub-id-type="doi">10.1016/j.vaccine.2015.07.061</pub-id>
<pub-id pub-id-type="pmid">26238723</pub-id>
</element-citation>
</ref>
<ref id="B212-pathogens-08-00265">
<label>212.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ludvigsson</surname>
<given-names>J.F.</given-names>
</name>
<name>
<surname>Strom</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Lundholm</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Cnattingius</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ekbom</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ortqvist</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Feltelius</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Granath</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Stephansson</surname>
<given-names>O.</given-names>
</name>
</person-group>
<article-title>Maternal vaccination against H1N1 influenza and offspring mortality: Population based cohort study and sibling design</article-title>
<source/>BMJ
          <year>2015</year>
<volume>351</volume>
<fpage>h5585</fpage>
<pub-id pub-id-type="doi">10.1136/bmj.h5585</pub-id>
<pub-id pub-id-type="pmid">26572546</pub-id>
</element-citation>
</ref>
<ref id="B213-pathogens-08-00265">
<label>213.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miller</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Andrews</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Stellitano</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Stowe</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Winstone</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Shneerson</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Verity</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: Retrospective analysis</article-title>
<source/>BMJ Br. Med. J.
          <year>2013</year>
<volume>346</volume>
<fpage>f794</fpage>
<pub-id pub-id-type="doi">10.1136/bmj.f794</pub-id>
<pub-id pub-id-type="pmid">23444425</pub-id>
</element-citation>
</ref>
<ref id="B214-pathogens-08-00265">
<label>214.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sarkanen</surname>
<given-names>T.O.</given-names>
</name>
<name>
<surname>Alakuijala</surname>
<given-names>A.P.E.</given-names>
</name>
<name>
<surname>Dauvilliers</surname>
<given-names>Y.A.</given-names>
</name>
<name>
<surname>Partinen</surname>
<given-names>M.M.</given-names>
</name>
</person-group>
<article-title>Incidence of narcolepsy after H1N1 influenza and vaccinations: Systematic review and meta-analysis</article-title>
<source/>Sleep Med. Rev.
          <year>2018</year>
<volume>38</volume>
<fpage>177</fpage>
<lpage>186</lpage>
<pub-id pub-id-type="doi">10.1016/j.smrv.2017.06.006</pub-id>
<pub-id pub-id-type="pmid">28847694</pub-id>
</element-citation>
</ref>
<ref id="B215-pathogens-08-00265">
<label>215.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Verstraeten</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Cohet</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Santos</surname>
<given-names>G.D.</given-names>
</name>
<name>
<surname>Ferreira</surname>
<given-names>G.L.C.</given-names>
</name>
<name>
<surname>Bollaerts</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Bauchau</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Shinde</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>Pandemrix™ and narcolepsy: A critical appraisal of the observational studies</article-title>
<source/>Hum. Vaccines Immunother.
          <year>2015</year>
<volume>12</volume>
<fpage>187</fpage>
<lpage>193</lpage>
<pub-id pub-id-type="doi">10.1080/21645515.2015.1068486</pub-id>
<pub-id pub-id-type="pmid">26379011</pub-id>
</element-citation>
</ref>
<ref id="B216-pathogens-08-00265">
<label>216.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McClenathan</surname>
<given-names>B.M.</given-names>
</name>
<name>
<surname>Edwards</surname>
<given-names>K.M.</given-names>
</name>
</person-group>
<article-title>Vaccine safety: An evolving evidence-based science</article-title>
<source/>Br. J. Clin. Pharmacol.
          <year>2019</year>
<pub-id pub-id-type="doi">10.1111/bcp.14080</pub-id>
</element-citation>
</ref>
<ref id="B217-pathogens-08-00265">
<label>217.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaczmarek</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Duong</surname>
<given-names>U.T.</given-names>
</name>
<name>
<surname>Ware</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Lambert</surname>
<given-names>S.B.</given-names>
</name>
<name>
<surname>Kelly</surname>
<given-names>H.A.</given-names>
</name>
</person-group>
<article-title>The risk of fever following one dose of trivalent inactivated influenza vaccine in children aged &gt;/=6 months to &lt;36 months: A comparison of published and unpublished studies</article-title>
<source/>Vaccine
          <year>2013</year>
<volume>31</volume>
<fpage>5359</fpage>
<lpage>5365</lpage>
<pub-id pub-id-type="doi">10.1016/j.vaccine.2013.09.005</pub-id>
<pub-id pub-id-type="pmid">24055353</pub-id>
</element-citation>
</ref>
<ref id="B218-pathogens-08-00265">
<label>218.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Halsey</surname>
<given-names>N.A.</given-names>
</name>
<name>
<surname>Talaat</surname>
<given-names>K.R.</given-names>
</name>
<name>
<surname>Greenbaum</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mensah</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Dudley</surname>
<given-names>M.Z.</given-names>
</name>
<name>
<surname>Proveaux</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Salmon</surname>
<given-names>D.A.</given-names>
</name>
</person-group>
<article-title>The safety of influenza vaccines in children: An Institute for Vaccine Safety white paper</article-title>
<source/>Vaccine
          <year>2015</year>
<volume>33</volume>
<issue>Suppl. 5</issue>
<fpage>F1</fpage>
<lpage>F67</lpage>
<pub-id pub-id-type="doi">10.1016/j.vaccine.2015.10.080</pub-id>
<pub-id pub-id-type="pmid">26822822</pub-id>
</element-citation>
</ref>
<ref id="B219-pathogens-08-00265">
<label>219.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stone</surname>
<given-names>C.A.</given-names>
<suffix>Jr.</suffix>
</name>
<name>
<surname>Rukasin</surname>
<given-names>C.R.F.</given-names>
</name>
<name>
<surname>Beachkofsky</surname>
<given-names>T.M.</given-names>
</name>
<name>
<surname>Phillips</surname>
<given-names>E.J.</given-names>
</name>
</person-group>
<article-title>Immune Mediated Adverse Reactions to Vaccines</article-title>
<source/>Br. J. Clin. Pharmacol.
          <year>2019</year>
<pub-id pub-id-type="doi">10.1111/bcp.14112</pub-id>
</element-citation>
</ref>
<ref id="B220-pathogens-08-00265">
<label>220.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iaconelli</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Xuan</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Karmacharya</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>HDAC6 Modulates Signaling Pathways Relevant to Synaptic Biology and Neuronal Differentiation in Human Stem-Cell-Derived Neurons</article-title>
<source/>Int. J. Mol. Sci.
          <year>2019</year>
<volume>20</volume>
<elocation-id>1605</elocation-id>
<pub-id pub-id-type="doi">10.3390/ijms20071605</pub-id>
</element-citation>
</ref>
<ref id="B221-pathogens-08-00265">
<label>221.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shimabukuro</surname>
<given-names>T.T.</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>DeStefano</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)</article-title>
<source/>Vaccine
          <year>2015</year>
<volume>33</volume>
<fpage>4398</fpage>
<lpage>4405</lpage>
<pub-id pub-id-type="doi">10.1016/j.vaccine.2015.07.035</pub-id>
<pub-id pub-id-type="pmid">26209838</pub-id>
</element-citation>
</ref>
<ref id="B222-pathogens-08-00265">
<label>222.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rizzo</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Rezza</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ricciardi</surname>
<given-names>W.</given-names>
</name>
</person-group>
<article-title>Strategies in recommending influenza vaccination in Europe and US</article-title>
<source/>Hum. Vaccines Immunother.
          <year>2018</year>
<volume>14</volume>
<fpage>693</fpage>
<lpage>698</lpage>
<pub-id pub-id-type="doi">10.1080/21645515.2017.1367463</pub-id>
</element-citation>
</ref>
<ref id="B223-pathogens-08-00265">
<label>223.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>O’Leary</surname>
<given-names>S.T.</given-names>
</name>
<name>
<surname>Riley</surname>
<given-names>L.E.</given-names>
</name>
<name>
<surname>Lindley</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Allison</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Albert</surname>
<given-names>A.P.</given-names>
</name>
<name>
<surname>Fisher</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Jiles</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Crane</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Hurley</surname>
<given-names>L.P.</given-names>
</name>
<name>
<surname>Beaty</surname>
<given-names>B.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Obstetrician-Gynecologists’ Strategies to Address Vaccine Refusal Among Pregnant Women</article-title>
<source/>Obstet. Gynecol.
          <year>2019</year>
<volume>133</volume>
<fpage>40</fpage>
<lpage>47</lpage>
<pub-id pub-id-type="doi">10.1097/AOG.0000000000003005</pub-id>
<pub-id pub-id-type="pmid">30531564</pub-id>
</element-citation>
</ref>
<ref id="B224-pathogens-08-00265">
<label>224.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Donzelli</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Influenza Vaccinations for All Pregnant Women? Better Evidence Is Needed</article-title>
<source/>Int. J. Environ. Res. Public Health
          <year>2018</year>
<volume>15</volume>
<elocation-id>2034</elocation-id>
<pub-id pub-id-type="doi">10.3390/ijerph15092034</pub-id>
<pub-id pub-id-type="pmid">30231471</pub-id>
</element-citation>
</ref>
<ref id="B225-pathogens-08-00265">
<label>225.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bresee</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Lafond</surname>
<given-names>K.E.</given-names>
</name>
<name>
<surname>McCarron</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Azziz-Baumgartner</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Chu</surname>
<given-names>S.Y.</given-names>
</name>
<name>
<surname>Ebama</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hinman</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Xeuatvongsa</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bino</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Richardson</surname>
<given-names>D.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The partnership for influenza vaccine introduction (PIVI): Supporting influenza vaccine program development in low and middle-income countries through public-private partnerships</article-title>
<source/>Vaccine
          <year>2019</year>
<volume>37</volume>
<fpage>5089</fpage>
<lpage>5095</lpage>
<pub-id pub-id-type="doi">10.1016/j.vaccine.2019.06.049</pub-id>
<pub-id pub-id-type="pmid">31288998</pub-id>
</element-citation>
</ref>
<ref id="B226-pathogens-08-00265">
<label>226.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ellingson</surname>
<given-names>M.K.</given-names>
</name>
<name>
<surname>Dudley</surname>
<given-names>M.Z.</given-names>
</name>
<name>
<surname>Limaye</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Salmon</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>O’Leary</surname>
<given-names>S.T.</given-names>
</name>
<name>
<surname>Omer</surname>
<given-names>S.B.</given-names>
</name>
</person-group>
<article-title>Enhancing uptake of influenza maternal vaccine</article-title>
<source/>Expert Rev. Vaccines
          <year>2019</year>
<volume>18</volume>
<fpage>191</fpage>
<lpage>204</lpage>
<pub-id pub-id-type="doi">10.1080/14760584.2019.1562907</pub-id>
<pub-id pub-id-type="pmid">30587042</pub-id>
</element-citation>
</ref>
<ref id="B227-pathogens-08-00265">
<label>227.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Halder</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kelso</surname>
<given-names>J.K.</given-names>
</name>
<name>
<surname>Milne</surname>
<given-names>G.J.</given-names>
</name>
</person-group>
<article-title>A model-based economic analysis of pre-pandemic influenza vaccination cost-effectiveness</article-title>
<source/>BMC Infect. Dis.
          <year>2014</year>
<volume>14</volume>
<elocation-id>266</elocation-id>
<pub-id pub-id-type="doi">10.1186/1471-2334-14-266</pub-id>
<pub-id pub-id-type="pmid">24884470</pub-id>
</element-citation>
</ref>
<ref id="B228-pathogens-08-00265">
<label>228.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Metcalf</surname>
<given-names>C.J.E.</given-names>
</name>
<name>
<surname>Ferrari</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Graham</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Grenfell</surname>
<given-names>B.T.</given-names>
</name>
</person-group>
<article-title>Understanding Herd Immunity</article-title>
<source/>Trends Immunol.
          <year>2015</year>
<volume>36</volume>
<fpage>753</fpage>
<lpage>755</lpage>
<pub-id pub-id-type="doi">10.1016/j.it.2015.10.004</pub-id>
<pub-id pub-id-type="pmid">26683689</pub-id>
</element-citation>
</ref>
<ref id="B229-pathogens-08-00265">
<label>229.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eichner</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Schwehm</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Eichner</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Gerlier</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Direct and indirect effects of influenza vaccination</article-title>
<source/>BMC Infect. Dis.
          <year>2017</year>
<volume>17</volume>
<elocation-id>308</elocation-id>
<pub-id pub-id-type="doi">10.1186/s12879-017-2399-4</pub-id>
<pub-id pub-id-type="pmid">28441935</pub-id>
</element-citation>
</ref>
<ref id="B230-pathogens-08-00265">
<label>230.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Switzer</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Babiuk</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Loeb</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Determining optimal community protection strategies for the influenza vaccine</article-title>
<source/>Expert Rev. Vaccines
          <year>2019</year>
<volume>18</volume>
<fpage>755</fpage>
<lpage>764</lpage>
<pub-id pub-id-type="doi">10.1080/14760584.2019.1642110</pub-id>
<pub-id pub-id-type="pmid">31288585</pub-id>
</element-citation>
</ref>
<ref id="B231-pathogens-08-00265">
<label>231.</label>
<element-citation publication-type="web">
<person-group person-group-type="author">
<collab>National Insititue of Health and Care Excellence</collab>
</person-group>
<article-title>Evidence Reviews for Increasing Uptake in Children</article-title>
<comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.nice.org.uk/guidance/ng103/resources/flu-vaccination-increasing-uptake-pdf-66141536272837">https://www.nice.org.uk/guidance/ng103/resources/flu-vaccination-increasing-uptake-pdf-66141536272837</ext-link></comment>
<date-in-citation content-type="access-date" iso-8601-date="2019-08-20">(accessed on 20 August 2019)</date-in-citation>
</element-citation>
</ref>
<ref id="B232-pathogens-08-00265">
<label>232.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Betsch</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Bohm</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Detrimental effects of introducing partial compulsory vaccination: Experimental evidence</article-title>
<source/>Eur. J. Public Health
          <year>2016</year>
<volume>26</volume>
<fpage>378</fpage>
<lpage>381</lpage>
<pub-id pub-id-type="doi">10.1093/eurpub/ckv154</pub-id>
<pub-id pub-id-type="pmid">26297722</pub-id>
</element-citation>
</ref>
<ref id="B233-pathogens-08-00265">
<label>233.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Omer</surname>
<given-names>S.B.</given-names>
</name>
<name>
<surname>Betsch</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Leask</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Mandate vaccination with care</article-title>
<source/>Nature
          <year>2019</year>
<volume>571</volume>
<fpage>469</fpage>
<lpage>472</lpage>
<pub-id pub-id-type="doi">10.1038/d41586-019-02232-0</pub-id>
<pub-id pub-id-type="pmid">31332351</pub-id>
</element-citation>
</ref>
<ref id="B234-pathogens-08-00265">
<label>234.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poland</surname>
<given-names>G.A.</given-names>
</name>
</person-group>
<article-title>MMR vaccine and autism: Vaccine nihilism and postmodern science</article-title>
<source/>Mayo Clin. Proc.
          <year>2011</year>
<volume>86</volume>
<fpage>869</fpage>
<lpage>871</lpage>
<pub-id pub-id-type="doi">10.4065/mcp.2011.0467</pub-id>
<pub-id pub-id-type="pmid">21878599</pub-id>
</element-citation>
</ref>
<ref id="B235-pathogens-08-00265">
<label>235.</label>
<element-citation publication-type="journal">
<article-title>Retraction-Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children</article-title>
<source/>Lancet
          <year>2010</year>
<volume>375</volume>
<fpage>445</fpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(10)60175-4</pub-id>
<pub-id pub-id-type="pmid">20137807</pub-id>
</element-citation>
</ref>
<ref id="B236-pathogens-08-00265">
<label>236.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taylor</surname>
<given-names>L.E.</given-names>
</name>
<name>
<surname>Swerdfeger</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Eslick</surname>
<given-names>G.D.</given-names>
</name>
</person-group>
<article-title>Vaccines are not associated with autism: An evidence-based meta-analysis of case-control and cohort studies</article-title>
<source/>Vaccine
          <year>2014</year>
<volume>32</volume>
<fpage>3623</fpage>
<lpage>3629</lpage>
<pub-id pub-id-type="doi">10.1016/j.vaccine.2014.04.085</pub-id>
<pub-id pub-id-type="pmid">24814559</pub-id>
</element-citation>
</ref>
<ref id="B237-pathogens-08-00265">
<label>237.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zerbo</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Modaressi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Goddard</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Fireman</surname>
<given-names>B.H.</given-names>
</name>
<name>
<surname>Daley</surname>
<given-names>M.F.</given-names>
</name>
<name>
<surname>Irving</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Jackson</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Donahue</surname>
<given-names>J.G.</given-names>
</name>
<name>
<surname>Qian</surname>
<given-names>L.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Vaccination Patterns in Children After Autism Spectrum Disorder Diagnosis and in Their Younger Siblings</article-title>
<source/>JAMA Pediatr.
          <year>2018</year>
<volume>172</volume>
<fpage>469</fpage>
<lpage>475</lpage>
<pub-id pub-id-type="doi">10.1001/jamapediatrics.2018.0082</pub-id>
<pub-id pub-id-type="pmid">29582071</pub-id>
</element-citation>
</ref>
<ref id="B238-pathogens-08-00265">
<label>238.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vanderslott</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Study shows lower vaccination rates for younger siblings after autism spectrum disorder diagnosis in older siblings</article-title>
<source/>Evid. Based Nurs.
          <year>2019</year>
<volume>22</volume>
<fpage>119</fpage>
<pub-id pub-id-type="doi">10.1136/ebnurs-2018-102971</pub-id>
<pub-id pub-id-type="pmid">31142571</pub-id>
</element-citation>
</ref>
<ref id="B239-pathogens-08-00265">
<label>239.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lane</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>MacDonald</surname>
<given-names>N.E.</given-names>
</name>
<name>
<surname>Marti</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dumolard</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Vaccine hesitancy around the globe: Analysis of three years of WHO/UNICEF Joint Reporting Form data-2015–2017</article-title>
<source/>Vaccine
          <year>2018</year>
<volume>36</volume>
<fpage>3861</fpage>
<lpage>3867</lpage>
<pub-id pub-id-type="doi">10.1016/j.vaccine.2018.03.063</pub-id>
<pub-id pub-id-type="pmid">29605516</pub-id>
</element-citation>
</ref>
<ref id="B240-pathogens-08-00265">
<label>240.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nihlen Fahlquist</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Vaccine hesitancy and trust. Ethical aspects of risk communication</article-title>
<source/>Scand. J. Public Health
          <year>2018</year>
<volume>46</volume>
<fpage>182</fpage>
<lpage>188</lpage>
<pub-id pub-id-type="doi">10.1177/1403494817727162</pub-id>
<pub-id pub-id-type="pmid">28847220</pub-id>
</element-citation>
</ref>
<ref id="B241-pathogens-08-00265">
<label>241.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Debellut</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Hendrix</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ortiz</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Lambach</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Neuzil</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Bhat</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Pecenka</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Forecasting demand for maternal influenza immunization in low- and lower-middle-income countries</article-title>
<source/>PLoS ONE
          <year>2018</year>
<volume>13</volume>
<elocation-id>e0199470</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0199470</pub-id>
<pub-id pub-id-type="pmid">29933402</pub-id>
</element-citation>
</ref>
<ref id="B242-pathogens-08-00265">
<label>242.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Launay</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Tsatsaris</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>Maternal influenza immunisation in resource-limited settings</article-title>
<source/>Lancet Infect. Dis.
          <year>2016</year>
<volume>16</volume>
<fpage>983</fpage>
<lpage>984</lpage>
<pub-id pub-id-type="doi">10.1016/S1473-3099(16)30121-9</pub-id>
<pub-id pub-id-type="pmid">27261068</pub-id>
</element-citation>
</ref>
<ref id="B243-pathogens-08-00265">
<label>243.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tapia</surname>
<given-names>M.D.</given-names>
</name>
<name>
<surname>Sow</surname>
<given-names>S.O.</given-names>
</name>
<name>
<surname>Tamboura</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Teguete</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Pasetti</surname>
<given-names>M.F.</given-names>
</name>
<name>
<surname>Kodio</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Onwuchekwa</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Tennant</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Blackwelder</surname>
<given-names>W.C.</given-names>
</name>
<name>
<surname>Coulibaly</surname>
<given-names>F.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: A prospective, active-controlled, observer-blind, randomised phase 4 trial</article-title>
<source/>Lancet Infect. Dis.
          <year>2016</year>
<volume>16</volume>
<fpage>1026</fpage>
<lpage>1035</lpage>
<pub-id pub-id-type="doi">10.1016/S1473-3099(16)30054-8</pub-id>
<pub-id pub-id-type="pmid">27261067</pub-id>
</element-citation>
</ref>
<ref id="B244-pathogens-08-00265">
<label>244.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Breteler</surname>
<given-names>J.K.</given-names>
</name>
<name>
<surname>Tam</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Jit</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ket</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>De Boer</surname>
<given-names>M.R.</given-names>
</name>
</person-group>
<article-title>Efficacy and effectiveness of seasonal and pandemic A (H1N1) 2009 influenza vaccines in low and middle income countries: A systematic review and meta-analysis</article-title>
<source/>Vaccine
          <year>2013</year>
<volume>31</volume>
<fpage>5168</fpage>
<lpage>5177</lpage>
<pub-id pub-id-type="doi">10.1016/j.vaccine.2013.08.056</pub-id>
<pub-id pub-id-type="pmid">24012574</pub-id>
</element-citation>
</ref>
<ref id="B245-pathogens-08-00265">
<label>245.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ortiz</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Neuzil</surname>
<given-names>K.M.</given-names>
</name>
</person-group>
<article-title>Influenza immunization of pregnant women in resource-constrained countries: An update for funding and implementation decisions</article-title>
<source/>Curr. Opin. Infect. Dis.
          <year>2017</year>
<volume>30</volume>
<fpage>455</fpage>
<lpage>462</lpage>
<pub-id pub-id-type="doi">10.1097/QCO.0000000000000392</pub-id>
<pub-id pub-id-type="pmid">28777109</pub-id>
</element-citation>
</ref>
<ref id="B246-pathogens-08-00265">
<label>246.</label>
<element-citation publication-type="web">
<person-group person-group-type="author">
<collab>Global_Alliance_for_Vaccines_and_Immunisation_Alliance</collab>
</person-group>
<article-title>Vaccine Investment Strategy</article-title>
<comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.gavi.org/about/strategy/vaccine-investment-strategy/">https://www.gavi.org/about/strategy/vaccine-investment-strategy/</ext-link></comment>
<date-in-citation content-type="access-date" iso-8601-date="2019-11-24">(accessed on 24 November 2019)</date-in-citation>
</element-citation>
</ref>
<ref id="B247-pathogens-08-00265">
<label>247.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grijalva</surname>
<given-names>C.G.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Self</surname>
<given-names>W.H.</given-names>
</name>
<name>
<surname>Ampofo</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Pavia</surname>
<given-names>A.T.</given-names>
</name>
<name>
<surname>Stockmann</surname>
<given-names>C.R.</given-names>
</name>
<name>
<surname>McCullers</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Arnold</surname>
<given-names>S.R.</given-names>
</name>
<name>
<surname>Wunderink</surname>
<given-names>R.G.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Association Between Hospitalization With Community-Acquired Laboratory-Confirmed Influenza Pneumonia and Prior Receipt of Influenza Vaccination</article-title>
<source/>JAMA
          <year>2015</year>
<volume>314</volume>
<fpage>1488</fpage>
<lpage>1497</lpage>
<pub-id pub-id-type="doi">10.1001/jama.2015.12160</pub-id>
<pub-id pub-id-type="pmid">26436611</pub-id>
</element-citation>
</ref>
<ref id="B248-pathogens-08-00265">
<label>248.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ortiz</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Neuzil</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Ahonkhai</surname>
<given-names>V.I.</given-names>
</name>
<name>
<surname>Gellin</surname>
<given-names>B.G.</given-names>
</name>
<name>
<surname>Salisbury</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Read</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Adegbola</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Abramson</surname>
<given-names>J.S.</given-names>
</name>
</person-group>
<article-title>Translating vaccine policy into action: A report from the Bill &amp; Melinda Gates Foundation Consultation on the prevention of maternal and early infant influenza in resource-limited settings</article-title>
<source/>Vaccine
          <year>2012</year>
<volume>30</volume>
<fpage>7134</fpage>
<lpage>7140</lpage>
<pub-id pub-id-type="doi">10.1016/j.vaccine.2012.09.034</pub-id>
<pub-id pub-id-type="pmid">23026690</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="pathogens-08-00265-f001" orientation="portrait" position="float">
<label>Figure 1</label>
<caption>
<p>Diagram of the Orthomyxoviridae influenza virus. The virus consists of neuraminidase (NA), matrix protein 1 (M1), matrix 2 proton pump (M2), hemagglutinin (HA), polymerase acid subunits (PB1, PB2, PA), non-structural (NS1, NS2) and nucleoprotein (NP). Current vaccine strategies target the head regions of HA, which are highly variable between viral strains. Universal influenza vaccines target less-variable regions of the virus, such as the HA stalk, which will provide coverage for a range of influenza virus strains.</p>
</caption>
<graphic xlink:href="pathogens-08-00265-g001"></graphic>
</fig>
<fig id="pathogens-08-00265-f002" orientation="portrait" position="float">
<label>Figure 2</label>
<caption>
<p>Factors involved in defense against influenza virus infection, which can also contribute to lung damage and ARDS. Cells of the immune system (e.g., macrophages; T cells; B cells; neutrophils) and lung (e.g., alveolar epithelial type I AECI; alveolar epithelial type II AECII; ciliated cells; goblet cells) in addition to factors such as surfactants, mucins, and antimicrobial proteins, interact to protect the host from influenza virus. Direct cytopathic effects of influenza virus infection and excessive inflammation lead to damage of alveoli, which can compromise respiratory function.</p>
</caption>
<graphic xlink:href="pathogens-08-00265-g002"></graphic>
</fig>
</floats-group>
</article>
</pmc-articleset>